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Electroencephalo gram A method that utilises electrodes to record cortical 
activity. 
I Entrainment The coupling between the timing ofa circadian rhythm (e.g. 
sleep-wake cycle) and an external zeitgeber (e.g. light). 
Interdaily stability The regularity ofthe rest-activity rhythm to environmental 
zeitgebers across time. 
I ~nt:ad~ily_:ria~~it~_____ __ I~h~~~g:e:~n_~t~_::~~c~~t~~h~~m: __ . _______ _ 
Movement and The percentage oftime spent moving during the estimated 
fragmentation index sleep period plus the percentage of immobility phases of 
one minute, as a proportion of the number of immobile 
phases with no activity recorded. 
I Negative affect I The experience a f negative emotions, -such as-guilt and 
fear. 
r 
---------1'---.--------.---.---------.-------.--. 
Night time activity level I The mean of the five hour period with the lowest activity 
I level in the average 24 hour pattern. 
fNT---------·-.. ---··---·--- r-----· .. -----------·-·---· .. ·-·-----····----·--.. --·-··---".--.--_.-.,_ ... -. I Night waking time I The proportion oftime spent in bed awake. 
Onset time of day time 
activity level 
Onset time of night time 
activity level 
Partial autocorrelation 
function 
The start time of the ten hour time period with the highest 
activity level. 
The start time of the five hour period with the lowest 
activity level. 
A partial autocorrelation function (PACF) measures the 
serial dependency of data across time. A correlation 
I 
coefficient is provided for each time lag once the effects 
of smaller time lags have been removed. 
I 
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Polysomnography A method that comprises electroencephalogram recording 
in combination with eye movement and muscle activity 
monitoring to estimate the sleep-wake cycle. Monitoring 
typically occurs within the laboratory. 
Positive affect The experience of positive emotions, such as enthusiasm 
and alertness. 
Rapid cycling Bipolar disorder when four or more episodes occur within a 
given year. 
I R~I~i~e ~-';:;plit~d~-- ------ - I-'fh~ -~~pljt-~d~--~ithe-~~~t=~~ti~ity~hYth~ ~~~~~;-t-~e:---- .. -.. -
I I 
Is-elfe;te~;;'- ---------------I-A;;-~di~id~_;p;p7yclt~Tc;gTc-;:i-~;-~i~;Jf.-------
f"Sieep duration The proportion oftime spent in bed sleeping. 
I 
I-sleep--efficie'~-~y .-------------- The percentage oiii~-~~-p~~t-~;Ieep whii~iin-bed.-- --- --- .- ....... . 
r-Sleep latency The amount of time elapsed after going to bed before sleep 
onset. 
fcial rhythms II Behaviours that individuals conduct on a daily basis, such as 
I getting up or going to bed, and eating or drinking. 
I SOciotropy---------r tendency to be dependent on others. 
I SUbsyndromal 
I Time in bed The time between bedtime and get up time. 
Zeitgeber A regular environmental signal that synchronises circadian 
rhythms to the 24 hour day. 
Zeitstorer A time disturber that may act as a source for circadian 
rhythm disruption. 
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Summary of day-to-day variability in bipolar disorders 
Background Bipolar disorder is characterised by recurrent acute episodes of mania and 
depression with the common occurrence of subsyndromal symptoms between episodes. 
Episode recurrence and frequent inter-episode symptoms have made identification of the 
factors that influence relapse an important focus for research in bipolar disorder. 
Objective. To determine whether dysregulation in bipolar disorder would be exhibited, 
outwith acute mania, in day-to-day variability and whether variability was associated with 
risk of relapse. 
Design. A prospective daily monitoring study was conducted with bipolar disorder and 
general population samples. Twenty participants with a bipolar episode experienced in the 
previous two years were recruited from a Lithium Clinic. A control group often 
participants from the general population were recruited by opportunity sampling. 
Main outcome measures. Biological, behaviour, cognition, and affect measures included 
self-report measures of behavioural activation/inhibition, social rhythms, self esteem, 
positive affect, negative affect, elation, depression and objective actigraph estimation of the 
sleep-wake cycle and circadian rhythms. 
Results. Lower self esteem, lower positive affect, higher negative affect, higher depression 
levels and greater variability in self esteem, night waking and sleep efficiency across 14 days 
were evident in bipolar disorder. Survival analyses suggested greater variability in self 
esteem and sleep efficiency predicted earlier admission in bipolar disorder. 
Conclusions. Greater day-to-day variability in bipolar disorder was observed compared to 
the general population. Underlying disturbances in biological, cognition and affect 
measures were evident in bipolar disorder. Findings were clinically important since sleep 
and self esteem disturbances may be considered as potentially modifiable in reducing risk of 
relapse in bipolar disorder. 
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Chapter 1 The longitudinal course of bipolar disorder 
In order to prepare for the study, a comprehensive review of the research literature with 
regard to psychobiosocial functioning in bipolar disorders was conducted. Psychological, 
biological, and social factors, which may influence the course of bipolar disorder, were 
examined. Key searches of computerised databases were conducted: MEDLINE (1966-
2001); PsycINFO (1985-2001); EMBASE (1980-2001). Reference lists in key papers and 
review articles were also searched. Ongoing internet access to key journals ensured being 
kept abreast of current issues and new research. Key journals that published research for 
bipolar disorder samples included: British Journal of Psychiatry; American Journal of 
Psychiatry; Archives of General Psychiatry; and the Journal of Affective Disorders. Review 
papers outlining diathesis stress models of bipolar disorder as well as research investigating 
specific diathesis-stress associations were obtained. The search criteria for daily variability 
were focused on affect, cognition and behavioural fluctuations. Although the present study 
recruited a bipolar disorder sample, publications with a wide range of participant samples 
were obtained for daily variability. This criterion reflected the limited research conducted 
to date on inter-episode variability in bipolar disorders. The literature on day-to-day 
variability will be critiqued in chapter two. This chapter will provide a critique of the 
literature obtained for diathesis stress models of bipolar disorder. Firstly, a description of 
bipolar disorder, including symptoms of the disorder, current treatment and long term 
prognosis will be outlined. 
1.1. Description of bipolar disorder 
Bipolar disorder is a severe and chronic mood disorder characterised by recurrent episodes 
of depression and mania. Bipolar disorder subtypes include: bipolar I disorder, 
characterised by one or more manic and/or mixed episodes and at least one major 
depressive episode; and bipolar II disorder, characterised by at least one hypomanic episode 
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and one or more major depressive episodes (Muller-Oerlinghausen et aI, 2002). Rapid 
cycling of mood, in which four or more episodes occur within a given year, occurs in 10 to 
15% of individuals with bipolar disorder (Muller-Oerlinghausen et aI, 2002). Rapid cycling 
tends to be more common in bipolar II disorder (Tondo & Baldessarini, 1998; Kilzieh & 
Akiskal, 1999). Rapid cycling tends to disappear over time indicating that this pattern may 
be a transient phase in the course of the disorder rather than a distinct subtype per se 
(Winokur et aI, 1994; Kilzieh & Akiskal, 1999; Akiskal et aI, 2000). Less severe bipolar 
disorder symptoms are evident in cyclothymia (DSM-IV; American Psychiatric Association, 
1994); these symptoms are sub-threshold and do not meet criteria for bipolar lor bipolar II 
disorders. Cyclothymia can be characterised by chronic hypomanic and depressive mood 
swings with infrequent euthymia (Akiskal et aI, 2000). Age at onset for bipolar disorder 
tends to range from late teens to late twenties (Miklowitz et aI, 1996; Weissman et aI, 1996; 
Muller-Oerlinghausen et aI, 2002), although onset can occur later (Bebbington & Ramana, 
1995; Hays et aI, 1998). There is no significant gender difference in the prevalence of 
bipolar disorder (Kessler et aI, 1994; Bebbington & Ramana, 1995; Weissman et aI, 1996; 
Muller-Oerlinghausen et aI, 2002). The UK lifetime prevalence of bipolar disorder is 
uncertain (DasGupta & Guest, 2002), but can be estimated at around one to two per cent of 
the adult population (Bebbington & Ramana, 1995). 
1.2 Symptoms of bipolar depression and mania 
Heterogeneity exists in the expression of bipolar disorder symptoms (Johnson et aI, 2000c). 
Core symptoms include changes in mood, cognition and behaviour. Bipolar depression 
tends to be characterised by hypersomnia and psychomotor retardation although insomnia 
and psychomotor agitation may also occur in some instances (Leibenluft & Frank, 2001). 
Mania and hypomania are characterised by elevated or irritable mood, racing thoughts, rapid 
speech, increased psychomotor activity, and decreased sleep (Cassidy et aI, 1998; Leibenluft 
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& Frank, 2001). Criteria for depressive and manic episodes are provided in Tables 1.1 and 
1.2. Episodes of bipolar depression tend to be more frequent and have a longer duration 
compared to episodes of mania (Sachs et ai, 2000). Mixed episodes may also occur; the 
criterion for a mixed episode is a period lasting at least one week when symptoms of both 
mania and depression are present nearly every day (DSM-IV; American Psychiatric 
Association, 1994). 
Table 1.1: DSM-IV Diagnostic criteria for a major depressive episode 
1. Two week period during which at least five of the following symptoms have been present 
nearly every day and represent a change from previous functioning; at least one symptom is 
either depressed mood or loss of interest or pleasure: 
• Depressed mood most of the day 
• Decreased interest or pleasure in all, or almost all, activities most of the day 
• Significant change in appetite or weight 
• Sleep disturbance: insomnia or hypersomnia 
• Psychomotor agitation or retardation (observable by others) 
• Fatigue or loss of energy 
• Feelings of worthlessness or excessive / inappropriate guilt 
• Diminished ability to think or concentrate, or indecisiveness 
• Recurrent thoughts of death or recurrent suicidal ideation, a suicide attempt or specific 
plan for committing suicide. 
2. The symptoms cause clinically significant distress or impairment in social, occupational, 
or other important areas of functioning. 
3. The symptoms are not due to the direct physiologic effects ofa substance or a general 
medical condition. 
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Table 1.2: DSM-IV Diagnostic criteria for manic episode and hypomanic episode 
1. A distinct period of abnormally or persistently elevated, expansive, or irritable mood 
lasting at least one week (or any duration if hospitalisation is required). 
2. During the period of mood disturbance, three (or more) of the following symptoms have 
persisted and have been present to a significant degree: 
• Inflated self esteem or grandiosity 
• Decreased need for sleep (e.g. feels rested after only three hours of sleep) 
• Talkativeness: increase in both speech rate and amount 
• Flight of ideas or a sense that thoughts are racing 
• Distractibility 
• Increase in activity or psychomotor agitation 
• Excessive involvement in pleasurable activities with potential for painful consequences 
e.g. unrestrained buying sprees, sexual indiscretions, and foolish business investments. 
3. In a manic episode, the mood disturbance is sufficiently severe to cause marked 
impairment in occupational functioning, usual activities or relationships with others, to 
necessitate hospitalisation, or be associated with the presence of psychosis. 
4. A hypomanic episode requires a minimum of only four days of symptoms; in addition, a 
hypomanic episode is associated with an unequivocal change in function observable by 
others, but it is not associated with marked impairment, hospitalisation, or psychosis. 
5. Symptoms not due to direct physiologic effects ofa substance/general medical condition. 
In addition to bipolar disorder symptoms experienced during acute episodes, inter-episode 
symptoms may also occur. Causes of inter-episode or subsyndromal symptoms may be 
categorised as: prodromaVearly symptoms of relapse; residual symptoms from previous 
episode; co-morbidity with Axis lor Axis II disorders; stress; medication side effects; and 
inter-episode cyclothymia and minor mood cycling (Fava, 1999; Morriss, 2002). 
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Subsyndromal symptoms are not severe enough to meet criteria for an episode, although 
such symptoms may still cause considerable distress (Lam et aI, 1999). The existence of 
subsyndromal symptoms between episodes is common in bipolar disorder (Keller et aI, 
1992; Gitlin et aI, 1995). Recent prospective studies reported participants with bipolar I 
disorder were symptomatically ill 47.3% of weeks over a mean 12.8 year follow-up period 
(N=146 bipolar I disorder; Judd et aI, 2002), whilst participants with bipolar II disorder 
were symptomatic 53.9% of weeks over a mean 13.4 year follow-up (N=86 bipolar II 
disorder, Judd et aI, 2003b). Subsyndromal symptoms were present for 74% of 
symptomatic weeks in bipolar I disorder and 40.9% in bipolar II disorder (Judd et aI, 2002, 
2003b). The presence ofsubsyndromal symptoms has been associated with an increased 
likelihood of relapse in bipolar disorder (Keller et aI, 1992). 
1.3 Current treatment of bipolar disorder 
The primary treatment of bipolar disorder is pharmacotherapy; lithium carbonate is the 
prophylactic treatment of choice in the UK (Prien & Potter, 1990; Gershon & Soares, 1997; 
Schou, 1997; Keck et aI, 2000). Approximately 20 to 40% of individuals with bipolar 
disorder do not respond to lithium treatment or experience intolerable side effects (Prien & 
Potter, 1990; Maj, 2000); anticonvulsants, such as carbamazepine and sodium valproate, 
tend to be utilised for such individuals (Prien & Potter, 1990). Lithium carbonate and 
anticonvulsants tend to be more effective in stabilising symptoms of mania than symptoms 
of depression (Keck & McElroy, 1996), although no differential effect of lithium in 
preventing depressive or manic relapses has been reported (Coryell et aI, 1997). 
Antidepressant medication may be utilised for bipolar depression, with combined use of a 
mood stabiliser. Since antidepressants may precipitate mania, most clinicians believe it is 
contraindicated to utilise antidepressants in the absence ofa mood stabiliser (Leibenluft & 
Suppes, 1999). Non-adherence to medication may have a substantial impact on the course 
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of bipolar disorder with around 75% of relapses associated with non-adherence (Scott, 
1995; Silverstone et aI, 1998). Although pharmacotherapy is the primary treatment for 
bipolar disorder, 25 to 50% of individuals do not adhere to medication (Prien & Potter, 
1990). 
Relapse may occur in bipolar disorder even when pharmacotherapy is optimal which leads 
to the need for adjunctive intervention. Historically, intervention research had primarily 
focused on pharmacotherapy, but in recent years reviews ofrandomised controlled trials 
have reported promising fmdings that psychotherapy may be a useful additional treatment to 
pharmacotherapy in bipolar disorder (Jones, 2004; Scott & Gutierrez, 2004). Published 
fmdings from several randomised controlled trials of psychotherapy for bipolar disorder to 
date include cognitive therapy (Cochran, 1984; Perry et ai, 1999; Zaretsky et ai, 1999; Lam 
et aI, 2000, 2003, 2005; Scott et ai, 2001,2006; Ball et ai, 2006), family focused psycho-
education (Miklowitz et ai, 2000, 2003; Rea et aI, 2003), group psychoeducation (Colom et 
aI, 2003a, 2003b) and interpersonal and social rhythm therapy (Frank et ai, 1994, 1999, 
2005). Overall, most of the evidence suggests that psychological interventions can improve 
outcome in bipolar disorder. 
Cognitive therapy trials have reported reduced relapse rates and improvement in symptoms 
following intervention. An early investigation by Cochran (1984) observed fewer bipolar 
relapses at six month follow up for a six session cognitive behavioural intervention 
compared to treatment as usual (N=14 cognitive behavioural intervention, N=14 treatment 
as usual). Zaretsky et ai's (1999) pilot study found a 20 session cognitive behaviour 
therapy intervention improved both bipolar depressed and unipolar depressed symptoms to 
a similar extent; follow-up impact of the intervention on relapse rate was not assessed (N=8 
bipolar depression, N=8 age and gender matched unipolar depression). A median nine 
2S 
session early symptom monitoring intervention was found to significantly reduce relapse 
into mania, but not depression, at 18 month follow up (N=34 early symptom monitoring, 
N=35 treatment as usual; Perry et aI, 1999). Lam et al (2003) reported a significantly 
lower bipolar relapse rate at 12 month follow up for approximately 20 sessions of cognitive 
therapy compared to treatment as usual; 44% compared to 75% relapsed (N=51 cognitive 
therapy, N=52 control). When participants were followed up after 30 months, the 
intervention had no impact on relapse rate after the frrst year, although the time spent in 
bipolar episodes was reduced in the cognitive therapy group (Lam et aI, 2005). Scott et 
aI's (2001) pilot study observed a 60% reduction in relapse rate at 18 month follow up 
compared to the 18 month period preceding cognitive therapy; the intervention comprised a 
maximum of25 sessions (N=29). Subsequently, Scott et aI's (2006) multi-centre trial for 
22 sessions of cognitive behavioural therapy reported the intervention had no significant 
impact on relapse at 18 month follow up (N=127 cognitive behavioural therapy, N= 126 
treatment as usual). However, subgroup analyses suggested the intervention was effective 
in reducing relapse for individuals who had experienced less than 12 previous bipolar 
episodes. Finally, Ball et al (2006) recently reported a 20 session cognitive therapy 
intervention did not have a significant impact on relapse rate at 12 month follow up, 
although the intervention was observed to decrease depressive symptoms at post-treatment 
(N=25 cognitive therapy, N=27 treatment as usual). There has been some indication that 
the benefits of cognitive therapy may diminish over time and be differentially effective 
according to length of history (Ball et aI, 2006; Scott et aI, 2006). However, cognitive 
therapy may still be considered a useful intervention to reduce relapse and improve 
subsyndromal symptoms over the chronic course of bipolar disorder. 
Randomised controlled trials for other psychological interventions for bipolar disorder 
include family focused psycho-education, group psycho-education, and interpersonal and 
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social rhythm therapy. A 21 session family focused psycho-education intervention for 
bipolar disorder significantly reduced relapse both at 12 months (N=31 family focused 
psycho-education, N=70 crisis management; Miklowitz et al (2000) and 24 month follow up 
(Miklowitz et aI, 2003) compared to a less intensive two session crisis management 
intervention. Furthermore, Rea et al (2003) reported 21 session family focused psycho-
education for bipolar disorder significantly reduced relapses and hospitalisations at 12 
month follow up compared to individually focused treatment (N=28 family focused psycho-
education, N=25 individually focused treatment). Colom et al (2003a) compared 21 
session group psycho-education for bipolar disorder to a control intervention that 
comprised 21 sessions of non-structured group meetings (N=60 group psycho-education, 
N=60 age and gender matched control). Group psycho-education was reported to 
significantly reduce bipolar relapse at two year follow up (Colom et aI, 2003a). Another 
investigation by Colom et al (2003b) reported a 20 session group psycho-education for 
highly compliant individuals with bipolar disorder significantly reduced relapse at two year 
follow up, compared to 20 sessions of non-structured group meetings (N=25 group 
psycho-education, N=25 control). Finally, interpersonal and social rhythm therapy has also 
been indicated to reduce depressive symptoms in bipolar disorder at 12 month follow up 
compared to intensive clinical management (N=90; Frank, 1999). The two year follow-up 
(Frank et aI, 2005) reported interpersonal and social rhythm therapy as an acute treatment 
was effective in reducing bipolar relapse; no difference was observed in the effectiveness of 
interventions as maintenance treatments for bipolar disorder (N=61 acute interpersonal and 
social rhythm therapy, N=64 acute intensive clinical management). Overall, these fmdings 
indicate these psychosocial interventions, along with cognitive therapy, may improve 
outcome in bipolar disorder. However, adjunctive interventions may be most effective at 
the early stages of the disorder, have less impact as the disorder progresses (Scott et aI, 
2006) with diminishing effects over time (Ball et aI, 2006) . 
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1.4 Prognosis in bipolar disorder 
Bipolar disorder tends to have a progressive course. With each new episode, there is an 
increased likelihood of future relapse as well as a tendency for the severity of each episode 
to increase (Post et ai, 1981, 1986; Goodwin & Jamison, 1990; Koukopoulos et ai, 1995; 
Kessing et aI, 1998). Even with prophylactic treatment, the risk offuture episodes remains 
high with a relapse rate of around 25 to 50% in one year following an episode of mania 
(Prien & Potter, 1990; Keller et aI, 1992; Gitlin et aI, 1995; Kessing et aI, 1998; Maj et aI, 
1998). The likelihood of relapse in bipolar disorder increases over time: 65% relapse rate 
over two years (N=128; Silverstone et aI, 1998), 82% relapse rate over seven years 
(N=181; Coryell et aI, 1995), and 95% relapse rate over the course often years (N=206; 
Judd et ai, 2003a). 
Bipolar disorder has a profound effect on long term functioning. Coryell et ai's (1993) 
prospective five year study indicated mania and depression were associated with enduring 
psychosocial impairment, even when remission was sustained. Individuals with bipolar 
disorder were less likely to be in employment, and if employed, earned significantly less than 
a matched comparison group (N=148 bipolar disorder, N=148 first degree relatives with no 
lifetime history of affective disorder; Coryell et aI, 1993). Coryell et al (1993) also 
reported bipolar disorder had an impact on long term relationships; individuals with bipolar 
disorder were less likely to get married, but if marriage did occur, divorce or separation was 
more likely than in the comparison group. Indeed, a recent review of 19 studies (total 
N=1450 bipolar disorder) reported approximately 30 to 60% of individuals with bipolar 
disorder have impaired social and occupational functioning (MacQueen et aI, 2001). 
The importance of genetic factors in the aetiology of bipolar disorder has been robustly 
demonstrated by family, twin and adoption studies (Craddock & Jones, 1999, 2001; 
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McGuffin et aI, 2003). However, genetic factors do not entirely explain the variance in the 
expression of bipolar disorder. Severity and frequency of episodes are two independent 
dimensions, which determine the clinical course of bipolar disorder. The severity ofa 
bipolar episode is likely to vary as a consequence of the combination of biological and 
psychosocial factors (Depue et aI, 1987). Psychosocial factors may play an important role 
in determining the timing and frequency of symptoms and the type and outcome of bipolar 
episodes (Depue et aI, 1987; Ellicott et aI, 1990; Malkoff-Schwartz et aI, 1998; Lam et aI, 
1999). Recent reviews of psychosocial treatment approaches for bipolar disorder have 
reported that such interventions may decrease relapse risk (Jones, 2004; Scott & Gutierrez, 
2004). Further, evidence from randomised controlled trials suggests the effectiveness of 
psychological interventions may depend on the timing oftreatment (Frank et aI, 2005) and 
the individual's history of bipolar disorder (Scott et aI, 2006). Thus, prognosis in bipolar 
disorder may require an understanding of the interaction between biological, psychological 
and social factors. The current study postulated that as bipolar disorder is primarily a 
biological disorder, change in biological vulnerability would precede change in 
psychological and social factors. The preceding sections outlined a description of the 
symptoms, treatment and prognosis in bipolar disorder. In brief, the key issues raised are 
provided in Table 1.3. 
Table 1.3: Summary of symptoms, treatment and prognosis in bipolar disorders 
• Bipolar disorder is characterised by acute episodes of mania and depression. 
• Inter-episode symptoms are common in bipolar disorder and increase risk of relapse. 
• Pharmacotherapy is the primary treatment for bipolar disorder; psychosocial interventions 
may be an effective adjunct. 
• Biological, psychological and social factors influence the course of bipolar disorder. 
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1.5 A psychobiosocial model of bipolar disorder 
The course of bipolar disorder may be influenced by biological, psychological and social 
factors. These factors may also interact with each other to determine the disorder's course. 
Psychobiosocial models of bipolar disorder provide a theoretical description of the 
interaction between biological vulnerabilities and psychosocial factors. Weak regulation 
has been theoretically postulated as the diathesis for bipolar disorder (Depue et ai, 1987). 
Stress may activate the diathesis: the underlying biological vulnerability. In turn, a diathesis 
prior to activation may not be latent, thus influencing stress generation (Monroe & Simons, 
1991). There are three major diathesis-stress models for bipolar disorder: behavioural 
sensitisation and kindling; life events and circadian rhythm disruption; and biological 
dysregulations and the behavioural activation system. Life events and circadian rhythm 
disruption may occur together or in isolation. Each diathesis-stress model will be discussed 
in turn before pulling the evidence together. 
1.5.1 Behavioural sensitisation and kindling 
The behavioural sensitisation and kindling model proposed sensitisation to stress and 
episode sensitisation occur over time (Post, 1992). Behavioural sensitisation describes 
sensitisation to stress, whereby repeated exposure leads to increased vulnerability to less 
stress. Episode triggers (e.g. loss ofa close relationship) may become conditioned over 
time to the extent that anticipation of stress (e.g. concern over losing relationship) may 
trigger an episode. In addition, stress that would not initially precipitate an acute episode, 
on repeated exposure over time, may become sufficient to induce relapse (Post & Weiss, 
1995). Kindling describes episode sensitisation whereby an episode was hypothesised to 
increase vulnerability to future relapse (Post, 1992). Previous episodes leave 'scars' which 
eventually lead to episodes occurring in the absence of exogenous precipitating factors and 
becoming autonomously driven (Post et aI, 1986; Post & Weiss, 1995). 
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Post et al (1986) suggested evidence for kindling included the tendency for bipolar disorder 
to originate with episodes of depression and progress to mania, the increasing severity and 
frequency of episodes over time and the decreasing influence of life events in precipitating 
episodes as length of time from disorder onset increases. However, longitudinal evidence 
has indicated that kindling may not necessarily occur. Winokur et al (1994) reported no 
increase in cycle frequency over a prospective ten year follow-up as well as indicating that 
rapid cycling may cease over time (N=131 bipolar disorder). Ambelas' (1987) 
retrospective case note review starting from the fIrst episode of mania reported later manic 
episodes were precipitated by less stress (N=50 fITst manic episode). In contrast, more 
recently conducted retrospective (N=64 bipolar disorder; Hlastala et ai, 2000) and 
prospective (N=58 bipolar disorder; Swendsen et aI, 1995) studies with larger samples have 
reported the number of prior episodes does not appear to impact on reactivity to stress. 
Indeed, Johnson and Roberts' (1995) review concluded evidence of stress or episode 
sensitisation was preliminary. Naturalistic longitudinal studies may in future provide a 
better understanding of this model. For instance, longitudinal within-individual analysis 
over several years would be necessary to determine whether episodes later in the course of 
bipolar disorder are more independent of stress (Hammen & Gitlin, 1997). Overall, 
support for behavioural sensitisation and kindling in bipolar disorders is mixed, with the 
more robust evidence from prospective studies with larger samples not providing empirical 
support for this diathesis-stress model. 
1.5.2 Life events 
Stressful life events have been proposed to activate biological vulnerability and precipitate 
relapse in bipolar disorders. Life stress may include both positive (e.g. getting married, 
moving house) and negative events (e.g. losing job, death offamily member). The 
psychological meaning ofa life event, particularly an event that was not anticipated, may be 
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strong enough to directly affect an individual's mood (Frank et aI, 1994). One difficulty in 
measuring life events is determining whether the life event is independent or a consequence 
of a developing bipolar episode (Hunt et aI, 1992; McPherson et aI, 1993). For example, 
the onset of mania tends to be associated with impulsive behaviour that may result in the 
experience ofa stressful event (Johnson & Roberts, 1995). Numerous studies investigating 
life events and their association with bipolar relapse have been conducted to explore this 
proposed diathesis-stress association. 
Retrospective evidence has provided some evidence supporting an association between life 
events and bipolar relapse with other evidence suggesting no association. Retrospective 
evidence has suggested life events may be more critical in precipitating manic relapse up to 
four months prior to episode onset (N=20 bipolar disorder, Kennedy et ai, 1983; N=50 frrst 
manic episode, N=50 surgical controls, Ambelas, 1987) and bipolar relapse within two 
weeks ofa hurricane, particularly in individuals with subsyndromal symptoms (N=69 bipolar 
disorder, Aronson & Shukla, 1987). Life events occurring six to 12 months prior to a 
manic episode do not appear to have influenced onset, when considered in retrospect (N=28 
bipolar disorder, Joffe et aI, 1989; N=24 bipolar disorder, Sclare & Creed, 1990). The 
difficulty in collating evidence from this retrospective evidence includes the small sample 
sizes, different comparisons of groups (i.e. within-person and between-person comparisons) 
and life events measured over a range of time periods. Furthermore, retrospective evidence 
may be limited by recall bias; in particular, as episode length tends to differ across mania 
and depression, with mania having a shorter duration, individuals may fmd it easier to recall 
life events prior to mania (Johnson, 2005). Thus, although some retrospective evidence 
suggests life events may be associated with subsequent bipolar relapse, fmdings are limited 
by methodological shortfalls. 
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Prospective evidence may be considered to be methodologically stronger than retrospective 
evidence, particularly since retrospective investigation may be polluted by the effort to fmd 
potential triggers after an episode has occurred (Johnson, 2005). However, prospective 
investigations have also been inconsistent; some studies have reported an association 
between life events three months prior to bipolar relapse (N=61 bipolar disorder, Ellicott et 
aI, 1990; N=62 bipolar disorder, Hunt et aI, 1992; N=52 bipolar disorder, Hammen & 
Gitlin, 1997), whereas others have reported no significant relationship of life events two to 
three months prior to bipolar relapse (N=58 bipolar disorder, McPherson et aI, 1993) or 
specifically for bipolar depressive relapse (N=27 bipolar disorder, Pardoen et aI, 1996). 
Similar to retrospective studies, prospective investigations may have limited by the small 
samples recruited and by not investigating episode polarity separately (e.g. Ellicott et aI, 
1990). Overall, investigation of life events in bipolar disorder have observed either non-
significant or small effects, perhaps due to small sample sizes, but may also be due to the 
interaction between life events and relapse in bipolar disorder requiring consideration of 
other characteristics. 
1.5.2.1 Life stress and cognitive vulnerability 
The interaction between life stress and relapse in bipolar disorder may require consideration 
of cognitive vulnerability. For instance, Swendsen et aI's (1995) one year prospective 
study reported personality factors interacted with life stress to predict relapse in bipolar 
disorder (N=58 bipolar disorder). Cognitive vulnerability may be considered as personality 
or cognitive characteristics that influence an individual's vulnerability to stress. Stressful 
life events, with personal meaning for an individual, may activate negative thoughts about 
the self that precipitate or exacerbate symptoms (Robins & Block, 1988; Hammen et aI, 
1989, 1992). Cognitive vulnerability has been reported to interact with life stress to predict 
increases in manic and depressive symptoms for bipolar disorder (N=49 bipolar disorder; 
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Reilly-Harrington et ai, 1999) and subsyndromal mood disorder samples (N=43 
subsyndromal mood disorder; Alloy et ai, 1999). Some research investigating cognitive 
vulnerability and life stress measured sociotropy and autonomy as stable cognitive 
characteristics. Sociotropy reflects the tendency to be dependent on others, and high levels 
have been proposed to increase vulnerability to interpersonal life stress (Robins & Block, 
1988; Hammen et ai, 1989; Robins, 1990). Autonomy reflects the tendency to be 
independent and achievement oriented; high levels have been proposed to increase 
vulnerability to life stress involving perceived personal failure or lack of control (Robins & 
Block, 1988; Hammen et aI, 1989; Robins, 1990). Both sociotropy and autonomy are 
cognitive styles that vary in the extent to which they dominate an individual's psychological 
functioning; an individual's response to congruent life stress may be influenced by their 
respective level (Clark & Beck, 1991). For instance, in a bipolar disorder sample, symptom 
exacerbation was significantly associated with the interaction between sociotropy and 
interpersonal events, although no relationship was reported for symptom onset (N=49 
bipolar disorder, Hammen et aI, 1992). No association between autonomy and 
achievement-related events was evident. Therefore, the presence of activated cognitive 
vulnerability in combination with congruent life stress may exacerbate symptoms and 
increase the risk of relapse. 
1.5.2.2 Life stress and bipolar disorder 
Although evidence has suggested life events may precipitate relapse in bipolar disorders, 
previous research (e.g. Hammen et aI, 1992; Ellicott et aI, 1990) may have obscured the life 
events association by not considering manic and depressive relapses separately. More 
recent investigations have considered episode polarity and life events since different types of 
life stress may precipitate mania and depression. A recent review of life events in bipolar 
disorder concluded negative life events appear to impact on bipolar depression, whilst goal 
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attainment life events appear to impact on mania (Johnson, 2005). However, it is not yet 
conclusive if a life event type may be linked specifically to an episode po larity; the critical 
determinant of polarity may be the underlying biological vulnerability. To illustrate, 
bereavement is a negative life event that may cause depressive symptoms in the general 
population, although clinical evidence suggests mania may follow bereavement. The 
relationship between episode polarity and life stress requires further investigation, with 
consideration of cognitive vulnerability (Johnson & Roberts, 1995; Johnson, 2005). 
1.5.3 Circadian rhythm disruption 
Circadian rhythm disruption has been proposed to cause relapse in bipolar disorders. 
Circadian rhythms are recurring patterns of variation in behaviour and physiology that occur 
over a 24 hour period (Thomson, 1984; Wehr, 1984). Examples of circadian rhythms 
include the sleep-wake cycle and daily variations in body temperature (Wehr, 1984). 
Circadian rhythms are entrained to a 24 hour period by regular and recurrent environmental 
signals: exogenous zeitgebers (Wirz-Justice, 1995). An example of a zeitgeber is natural 
light from the daily rising and setting of the sun. Individuals with bipolar disorder are 
theoretically predisposed to circadian rhythm disruption, sleep-wake cycle abnormalities in 
particular (Frank et ai, 2000). Features such as diurnal mood variation, early morning 
wakening, a seasonal pattern of relapse and the recurrence of mania and depression have 
been suggested to be associated with circadian rhythm disruption in bipolar disorder (Wehr 
& Goodwin, 1983; Haug, 1992; Ehlers et aI, 1993). Some interventions that manipulate 
the circadian system (e.g. partial sleep deprivation) may decrease depressive symptoms, 
whereas others (e.g. extended bed rest) may decrease manic symptoms, indicating circadian 
rhythm disruption may be involved in the pathogenesis of mood disorders (Szuba et aI, 
1991; Wirz-Justice, 1995). 
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Observations have suggested that social rhythms, such as the timing of eating, sleeping, and 
exercising, maintain the timing of circadian rhythms (Monk et aI, 1991; Ehlers et aI, 1993; 
Malkoff-Schwartz et aI, 1998). For instance, Monk et al (1994) observed greater 
regularity of daily social rhythms was associated with fewer perceived sleep problems in the 
general population (Study 1; N=96 general population). Consequently, since social 
rhythms maintain circadian rhythms, it is likely that social rhythm disruption may cause 
disruption in circadian rhythms. To illustrate, a long distance flight may disrupt social 
rhythms (e.g. mealtimes, bedtime) leading to circadian rhythm disruption (changes in sleep-
wake cycle). Endogenous circadian rhythms (e.g. melatonin, temperature) do not instantly 
change with the shift in the sleep-wake cycle from a long distance flight (Wirz-Justice, 
1995). Thus, circadian rhythms require synchronisation or entrainment to the time zone of 
the new environment. Flights with more than two hours time change have been reported to 
precipitate an acute episode in vulnerable individuals; flights from east to west were 
associated with depression, whilst mania was associated with west to east flights (N=186 
hospital admissions from Heathrow airport; Jauhar and Weller, 1982). Flying east to west 
may be considered as lengthening the day, whereas flying west to east, time may be 
considered as lost as the day is effectively shortened. However, since psychiatric 
information was obtained retrospectively with no information on a participant's mental state 
prior to admission, relapse may have occurred regardless ofwhether a flight was taken. 
Thus, social rhythm disruption that leads to circadian rhythm disruption has been tentatively 
associated with relapse in bipolar disorder. Larger. prospective longitudinal studies may 
provide more understanding of social and circadian rhythm disturbances and the initiation, 
exacerbation and maintenance of bipolar relapse. 
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1.5.3.1 Theoretical descriptions of circadian rhythm disruption and bipolar relapse 
Ehlers et ai's (1988) theoretical review proposed circadian rhythm disruption has a causal 
role in the precipitation of depression. Ehlers et al proposed a model that integrated 
biological and psychosocial factors of depression. The main proposition was social 
zeitgebers (personal relationships, social demands, tasks) may entrain circadian rhythms. 
Changes in social zeitgebers may disrupt social rhythms and therefore lead to disruption in 
circadian rhythms. To illustrate, loss ofa partner (social zeitgeber) may change bedtime 
and get out of bed times (social rhythms) leading to changes in the timing of sleep and wake 
(circadian rhythms), resulting in a mood change. Ehlers et al (1993) revised their 
hypothesis of circadian rhythm disruption in depression to include the concept of a 
zeitstorer. A zeitstorer was defmed as a time disturber and was proposed to act as a source 
for circadian rhythm disruption. Zeitstorers include physical, chemical, or psychosocial 
events. Ehlers et al provided examples of social zeitstorers ranging from temporary (long 
distant flight) to more permanent disturbance (shift work; newborn baby). The presence of 
a zeitgeber entrains circadian rhythms to the 24 hour day, whereas the occurrence of a 
zeitstorer disturbs circadian rhythms (Frank et aI, 2000). Although Ehlers et al (1988, 
1993) focused on the implications of social zeitgebers and zeitstorers for depression, more 
recent theoretical descriptions by these authors have emphasised social zeitgebers and 
zeitstorers may also be related to mania (Frank et aI, 2000). 
Healy and Williams' (1988) theoretical review also proposed circadian rhythm disruption 
has a causal role in the precipitation of depression; a routine may be important in 
maintaining mood balance whereas circadian rhythm disruption may cause persistent 
dysphoria. Circadian rhythm disruption may interact with psychological variables through a 
tendency for individuals to cognitively distort experiences. Cognitive distortions were 
hypothesised to lead to activation of dysfunctional attitudes and decreases in self esteem. 
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Dysfunctional attitudes may be considered as negative beliefs and assumptions that an 
individual holds. For example, an individual may believe that he/she should perform well at 
all activities. Circadian rhythm disruption may cause tiredness or diminished concentration 
that an individual could negatively attribute to being lazy or stupid. This misattribution of 
internal states may cause the rhythm disruption to lead to depression, with misattributions 
maintaining the depression. Healy and Williams' (1989) subsequently proposed a 
theoretical interaction of biological and psychological factors in the pathogenesis of mania. 
Disruptions in circadian rhythms were proposed to have a tendency to lead to mild 
dysphoria, psychomotor activation, and thought disorder. Healy and Williams' 
hypothesised such changes lead to an episode of mania when cognitive distortions, similar 
to those found in depression, occurred. For instance, over-activity produced by circadian 
rhythm disturbance may result in an individual making misattributions of increased personal 
effectiveness and self esteem. Cognitive distortions have been posited to lead to features of 
mania such as grandiosity and euphoria (Johnson & Roberts, 1995). Dysphoria tends to be 
the primary affective disturbance in both mania and depression. An implication from Healy 
and Williams' model is that mania and depression may be precipitated by similar 
psychosocial factors. Furthermore, Jones' (2001) more recent conceptualisation also 
suggested an individual's psychological appraisal of dysphoria caused by circadian rhythm 
disruption may determine whether symptoms of depression or mania are initiated in bipolar 
disorder. 
1.5.3.2 Life stress and circadian rhythms 
Life stress may disrupt social rhythms leading to circadian rhythm disruption that may result 
in a mood disturbance (Ehlers et aI, 1988; Healy &Williams, 1989; Johnson & Roberts, 
1995; Brown et ai, 1996). In some instances, the extent of schedule disruption that occurs 
from life stress may be more important than the emotional threat/loss experienced (Johnson 
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& Roberts, 1995). Accordingly, preservation of normal social rhythms may buffer 
individuals from relapsing following life stress (Ehlers et aI, 1993; Brown et aI, 1996). For 
example, bereavement is a life stress that may cause both emotional distress and schedule 
disruption, leading to relapse in vulnerable individuals. Maintaining a routine following 
bereavement may minimise the risk of relapse from circadian rhythm disruption. A 
retrospective study reported higher rates of social rhythm disrupting life stress, during eight 
weeks prior to episode onset, was associated with onset of mania compared to a control 
eight week period (N=39 bipolar disorder; Malkoff-Schwartz et aI, 1998). Although no 
association was evident for depressive episodes, Malkoff-Schwartz et al (1998) suggested 
this may be due to more gradual disruption of social rhythms prior to onset of depression. 
Research evidence has suggested life stress and circadian rhythm disruption may occur prior 
to episode onset in bipolar disorder. Future research needs to identify whether life stress 
can precipitate bipolar relapse in isolation. Circadian rhythm disruption subsequent to life 
stress may be the critical factor in determining relapse. Also, life stress and circadian 
rhythm disruption may vary in the extent to which they precipitate each bipolar polarity. A 
large number of studies have investigated life events and bipolar relapse. Fewer studies 
investigating circadian rhythm disruption and bipolar disorder were identified suggesting 
further prospective investigation is necessary to clarify their association. 
1.5.4 Behavioural activation system dysregulation 
The third diathesis-stress model for bipolar disorder posits the dysregulation ofa 
behavioural activation system. Gray (1989, 1990, 1994) proposed the existence of two 
neurologically based emotion systems that influence mood and mood-related behaviour: a 
behavioural activation system (BAS) and a behavioural inhibition system (BIS). Although 
a third emotion system, a fight/flight system (FFS) had also been postulated by Gray, the 
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FFS has not been theoretically linked to bipolar disorder, and thus will not be discussed 
further. Gray's theory proposed the BAS is an appetitive motivational system, which 
responds to rewards (e.g. praise from another individual). In contrast, the HIS is an 
aversive motivational system that responds to punishment (e.g. physical threat from 
another). An emotional experience is postulated to reflect the current combination of 
activity within these emotion systems (Gray, 1994). Biological and selfreport measures 
have been used to assess behavioural activation and inhibition levels. Although research 
has suggested associations between neurological activity and BASIBIS levels (Sutton & 
Davidson, 1997; Gotlib et aI, 1998) such evidence is beyond the scope ofthis thesis and will 
not be discussed further. The following sections provide a more detailed outline of the 
BAS and HIS. 
1.5.4.1 Behavioural Activation System (BAS) 
Activation of an individual's BAS is postulated to cause movement towards goals, since the 
BAS is proposed to be sensitive to signals of reward, non-punishment, and escape from 
punishment (Depue & Iacono, 1989; Harmon-Jones & Allen, 1997; Corr, 2001). 
Theoretically, the BAS is related to positive affect (PA). and is responsible for the 
experience of positive feelings (e.g. hope, elation). High BAS levels have been significantly 
associated with higher average daily PA across a 14 day period, although BAS levels were 
not associated with greater reactivity to positive events (N=86 undergraduates; Study 2, 
Gable et aI, 2000). This suggests that individuals who self-report higher cross-sectional 
behavioural activation also report higher PA from day-to-day. The theoretical direction of 
BAS being responsible for the experience of PA was supported by a further study that 
observed the BAS significantly predicted average PA (N= 155 undergraduates; Study 3, 
Gable et aI, 2000). However, Gable et aI's (2000) samples were not assessed for risk of 
bipolar affective disorders (e.g. Hypomanic Personality Scale; Eckblad & Chapman, 1986), 
40 
which may have contributed to the strength of the associations observed. The BAS has 
also been theoretically related to anger (Depue & Iacono, 1989; Harmon-Jones et aI, 2002). 
Self-report high BAS levels have been significantly associated with high levels of anger, 
with BAS being a predictor of anger (N=164 undergraduates, Study 1; N=41 
undergraduates, Study 2; Harmon-Jones, 2003). Thus, theoretical postulation and 
empirical evidence have suggested BAS activation may be responsible for the experience of 
both PA and anger, in the context of goal pursuit. 
1.5.4.2 Behavioural Inhibition System (BIS) 
Activation of an individual's BIS is postulated to inhibit behaviour that may lead to negative 
outcomes. The BIS is proposed to be sensitive to signals of punishment, non-reward, 
novelty and innate fear stimuli (Harmon-Jones & Allen, 1997; Corr, 2001). The BIS is 
theoretically related to negative affect (NA) and is responsible for the experience of 
negative feelings (e.g. fear, sadness). High BIS levels have been significantly associated 
with higher average daily NA across a 14 day period and greater reactivity to negative 
events (N=86 undergraduates; Study 2, Gable et aI, 2000). This suggests that individuals 
who self-report higher cross-sectional behavioural inhibition also report higher NA from 
day-to-day. The BIS also significantly predicts average NA (N=155 undergraduates; Study 
3, Gable et aI, 2000). Higher BIS levels were also associated with lower average PA 
(Study 2), although BIS levels were not found to significantly predict average PA (Study 3, 
Gable et aI, 2000). 
1.5.4.3 The BAS and BIS as joint subsystems 
Corr (2001, 2002a) described the joint subsystems hypothesis whereby the BIS and BAS 
may potentially influence both punishment and reward-mediated behaviours. Mutual 
inhibition has been proposed to exist between the two systems with facilitatory and 
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antagonistic effects exerted by both systems (Pickering et ai, 1999). The BIS is suggested 
to antagonise responses made by the BAS and vice versa (i.e. the BIS inhibits the BAS). 
Corr (2001) highlighted experimental animal evidence has suggested the link from BIS to 
BAS may be stronger than the BAS to BIS link; the threat of punishment outweighing the 
incentive of reward. In any given situation, punishment and reward signals may be present 
to varying degrees, suggesting each system will concurrently facilitate and inhibit behaviour; 
the overall BIS and BAS level may determine the behaviour that occurs. For instance, an 
individual's BAS may be activated when meeting a desirable individual; behaviour to initiate 
a relationship may then occur. However, if the individual has previously tried 
unsuccessfully on several occasions to maintain a serious relationship, then the BIS may be 
activated and the individual may be less likely to pursue a relationship that may ultimately 
fail. The activation level of each system may determine which behaviour is exhibited. 
Engagement ofthe motivational systems leads to the experience of affect, whereas 
disengagement may be considered as an absence of affect (Carver et ai, 2000). 
Disengagement of the BAS suggests an individual will not be experiencing positive feelings 
such as excitement or enthusiasm, whilst BIS disengagement suggests absence of 
nervousness and other negative feelings. 
1.5.4.4 Behavioural activation and bipolar disorder 
Individuals with dysregulated behavioural activation systems have been suggested to be 
vulnerable to extreme biological, affective and behavioural variability (Depue et aI, 1987; 
Depue & Iacono, 1989; Lovejoy & Steuerwald, 1995). Depue and Gray have both 
suggested that bipolar disorder is associated with BAS dysregulation (Depue et ai, 1987; 
Gray, 1990). Bipolar disorder is characterised by episodes of mania and depression; 
extremes of biological, behaviour, cognition and affect levels are evident across episode 
polarities. The course of the disorder as well as the presence of symptoms may be 
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determined by an individual's behavioural activation level (Depue et ai, 1987). Individuals 
theoretically vary in their average level of behavioural activation and inhibition, and also in 
their variability around these levels. The average level of activation or inhibition may 
determine the resulting mood when dysregulation occurs (Depue & Zald, 1993). Research 
evidence has reported the BIS played a less important role for mania or depression, 
compared to the BAS in major depressive and at risk bipolar disorder samples (Meyer et ai, 
1999; Kasch et ai, 2002). This evidence supports Depue et ai's (1987) theoretical proposal 
that the BAS is responsible for the experience ofmania and depression in bipolar disorder. 
Bipolar depressive and manic symptoms have been suggested to be a consequence of 
extreme BAS levels; high behavioural activation may facilitate mania whilst low behavioural 
activation may facilitate depression (Depue & Zald, 1993). Individuals who are prone to 
BAS dysregulation and greater variability are posited to be more sensitive to signs of 
reward, which promotes goal directed activity; extreme sensitivity to reward may cause 
mania if behaviour, cognition and affect are influenced by the pursuit of goals (Harmon-
Jones & Allen, 1997). Mania can be characterised by either irritable mood or elated mood 
(DSM-IV; American Psychiatric Association, 1994). Since the BAS has been associated 
with both PA and anger (e.g. Gable et aI, 2000; Harmon-Jones, 2003), BAS dysregulation 
theory provides a logical explanation that in goal pursuit either irritated or elated mania may 
occur. Depression may occur with low BAS sensitivity (Harmon-Jones & Allen, 1997; 
Kasch et aI, 2002), since individuals who are insensitive to reward signals may experience 
less positive affect. 
The dysregulations model suggests mania and depression may be precipitated by different 
environmental events. Johnson et aI's (2000c) prospective study reported increased manic 
symptoms in the two month period following goal-attainment life events with no observed 
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change in depressive symptoms (N=43 bipolar disorder). Goal-attainment events include 
passing exams and being offered a job. This fmding provides support for BAS activation 
by positive rewarding events, which may then become hyperactive in mania. In contrast, 
goal-attainment life events do not appear to impact on depression (Johnson, 2005). 
Negative life events have been reported in a recent review (Johnson, 2005) to increase 
bipolar depressive symptoms; negative life events do not appear to impact on mania. Thus, 
some evidence suggests that mania may be precipitated by goal attainment events whilst 
bipolar depression may be precipitated by negative life events. 
Expectancies may playa role in affective responses to appetitive and aversive stimuli 
(Carver et aI, 2000). Corr's (2002b) theoretical analysis suggested the relationship 
between individual differences in BAS sensitivity and reaction to reward is moderated by 
reward expectancies. Corr (2002b) proposed that if actual reward is equal to or greater 
than expected reward, the BAS is activated; with lower actual reward than expected, the 
BIS is activated. For instance, ifan individual attending ajob interview is offered the 
position at a higher grade and salary than expected, then the BAS may be activated. 
Conversely, a job offer at a lower grade/salary than expected may cause BIS activation. 
Similarly, Carver et al (2000) suggested BAS and BIS may be able to yield both positive 
and negative affect through the interaction of future expectancies. For instance, high BAS 
sensitivity may lead to high levels of positive affect when appetitive stimuli are present. 
High negative affect, however, may be produced instead, when expectancies to obtain 
rewards are low. Cross-sectional research has suggested a lack of positive experiences and 
positive expectancies mediates the relationship between BAS responsiveness and depressive 
symptoms (N=171 undergraduates; Beevers & Meyer, 2002). Ifan individual has few 
positive experiences and also has low positive expectancies, the extent of BAS activation in 
response to reward may consequently be lower. Low BAS responsiveness was related to 
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higher anhedonic depressive levels, but structural equation modelling indicated this direct 
effect was not significant, when positive experiences and positive expectancies were 
considered as mediating variables (Beevers & Meyer, 2002). Further investigation, 
particularly with prospective monitoring, may be necessary to indicate whether the 
moderating role of reward expectancies is supported. 
Meyer et aI's (1999) cross-sectional study reported BAS sensitivity was related to 
symptoms of mania whereas both BIS and BAS sensitivities were related to symptoms of 
depression. The sample comprised 357 undergraduates, of which 63 were categorised as at 
risk for a mood disorder (N==13 depression-prone, N==6 hypomania-prone, N==44 
cyclothymia-prone). Behavioural activation (BAS) levels, but not BIS levels, predicted 
symptoms of mania; BAS and mania symptoms were positively correlated. Both BAS and 
BIS levels predicted symptoms of depression; BAS was negatively correlated whilst BIS 
was positively correlated with depressive symptoms. Associations between behavioural 
activation! inhibition and current hypomanic/depressive symptoms were weaker for the 'not 
at risk' subgroup (N==294); BAS was significantly correlated with hypomanic symptoms but 
not with depressive symptoms, whilst no significant correlations were evident between BIS 
and hypomania or depression. 
Meyer et aI's (2001) prospective study assessed symptoms of mania and depression monthly 
and BISIBAS levels bi-monthly (N==59 bipolar disorder, mean 20 month follow-up). The 
BAS was analysed as three subscales: reward responsiveness, drive and fun seeking 
(Section 3.4.2 provides more description of the self report BISIBAS Scales used by Meyer 
et al). Cross-sectional analyses found no relationship between the three BAS subscales and 
manic or depressive symptom severity. The BIS was not related to mania, but a positive 
correlation between BIS and depressive symptoms was reported. Furthermore, 
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longitudinal analyses found the BIS fluctuated with changes in depressive symptoms. No 
fluctuations were observed with BAS and manic/depressive symptoms, or with BIS and 
manic symptoms. However, higher BAS reward responsiveness following recovery 
predicted manic symptom intensification over six months; BAS drive and fun seeking 
subscales were not significant predictors, nor was the BIS level. Neither the BIS nor BAS 
scale predicted change in depression over time. Meyer et al highlighted methodological 
differences were evident between the bipolar disorder sample and a previous 'at risk' sample 
(Meyer et ai, 1999). Meyer et al (1999) used self report measures of symptoms in contrast 
to clinician interviews, and also collected BISIBAS and symptom measures at the same 
time-point; these differences may account for the stronger associations observed by Meyer 
et al (1999). Thus, further prospective investigation of behavioural activation/inhibition 
and bipolar symptoms is necessary to identifY whether an association does exist. 
1.5.5 A psychobiosocial model of bipolar disorder revisited 
The diathesis-stress models described emphasise an underlying instability or dysregulation in 
the pathogenesis of bipolar disorders. Behavioural activation dysregulation, circadian 
rhythm disruption, occurrence of life stress and illness duration/previous episodes have all 
been suggested to influence the course of bipolar disorder. Each model is supported by 
research evidence, although at this time-point, evidence is not conclusive as to whether the 
models are competing or complementary conceptualisations (Lam et ai, 1999). Summary 
points about the diathesis stress models are available in Table 1.4. Cross-sectional or 
retrospective small sample studies can be considered methodologically weak compared to 
prospective longitudinal investigations with larger samples. In brief, the evidence suggests 
a multivariate approach may be necessary to determine the most likely conceptualisation of 
the diathesis stress associations in bipolar disorder: further prospective within-person 
investigations are required. 
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Table 1.4: Summary of diathesis stress models of bipolar disorder 
• The behavioural sensitisation and kindling model has a strong theoretical base, although 
supportive empirical evidence has been limited. 
• Life stress and circadian rhythm disruption may precipitate relapse in bipolar disorder. 
• Behavioural activation may precipitate symptoms of mania and depression 
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Chapter 2 Variability in behaviour, cognition and mood in bipolar disorders 
Temporal variability may reflect vulnerability to bipolar disorder in the absence of an acute 
episode. Chapter two will outline research fmdings on variability in behaviour, cognition 
and affect. Research evidence for interactions between affect and behaviour, and between 
affect and cognition will also be reviewed. A greater understanding of inter-episode 
variability may aid the identification of factors that predict relapse in bipolar disorder. 
Determining the aspects of variability associated with symptoms of depression and mania 
respectively may be critical. Bipolar symptoms may be associated with a general overall 
variability or with specific variation. Firstly, a brief review ofsubsyndromal symptoms in 
bipolar disorders will be provided. The clinical importance of subsyndromal symptoms, 
particularly as early symptoms of relapse, suggests an improved understanding of inter-
episode variability is an essential area of research in bipolar disorder. 
2.1 A systematic review of manic and depressive prodromes 
A systematic literature review of prodromal symptoms in bipolar and unipolar disorders has 
suggested individuals can identify early symptoms of relapse (Jackson et ai, 2003; Appendix 
H). Prodromes can be described as cognitive, affective, and behavioural early symptoms of 
a disorder that appear before an episode of depression or mania (Altman et aI, 1992; Keitner 
et ai, 1996). Seventeen studies published between 1964 and 2001, met inclusion criteria 
for the review. Results indicated a median 82% (range 70-100%) of individuals can 
identify early symptoms of bipolar depression (Molnar et ai, 1988; Smith & Tarrier, 1992; 
Lam & Wong, 1997). The median prevalence ofearly bipolar depressive symptoms was: 
mood change (48%), psychomotor change (41 %), increased anxiety (36%), appetite change 
(36%), suicidality (29%), sleep disturbance (24%), and other symptoms (22%). A median 
93% (range 75-100%) of individuals were able to identifY early symptoms of mania (Molnar 
et ai, 1988; Sclare & Creed, 1990; Smith & Tarrier, 1992; Lam & Wong, 1997; Wong & 
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Lam, 1999). The median prevalence of early manic symptoms was: sleep disturbance 
(77%), psychotic symptoms (47%), mood change (43%), psychomotor change (34%), other 
symptoms (30%), appetite change (20%), and increased anxiety (16%). While most 
individuals identified early symptoms of mania and bipolar depression, no consistent early 
symptom of bipolar depression was evident. In contrast, sleep disturbance was identified as 
a robust early symptom of mania. Thus, inter-episode symptoms can be identified by 
individuals with bipolar disorder. 
Prospective monitoring of subsyndromal symptoms may provide an improved understanding 
of specific symptoms associated with manic and depressive prodromes. Inter-episode 
symptoms commonly occur in bipolar disorder (Judd et aI, 2002, 2003b) and may include 
changes in individuals' behaviour, cognition, or affect levels. Fluctuations may be 
considered as ongoing biological vulnerability to bipolar disorder. Accordingly, inter-
episode variation in bipolar disorder may differ from fluctuations observed over time in the 
general population. The following three sections provide brief literature reviews for 
variability in behaviour, cognition, and affect in mood disorders and the general population. 
2.2 Variability in behaviour 
Since bipolar disorder is a biological disorder with recurrent episodes over time, it is 
possible that recurrent patterns of behavioural variation may influence prognosis. 
Disruption in circadian rhythms, as described earlier, may be implicated in the pathogenesis 
of depression and mania. Vulnerability to circadian rhythm dysregulation in mood 
disorders may be characterised by day-to-day instability in inter-episode periods (Siever & 
Davis, 1985; Wirz-Justice, 1995). Thus, variability in behaviour may be considered as an 
important indicator of underlying circadian rhythm dysregulation during inter-episode 
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periods. Variation in behaviour will be discussed in terms of social rhythm variability and 
sleep-wake cycle variability. 
2.2.1 Variability in social rhythms 
The regularity of social rhythms in unipolar and bipolar disorder samples may differ from 
the regularity observed in the general population. Lower social rhythm regularity has been 
observed in individuals during a depressive episode compared to general population 
individuals over five days (N=19 unipolar or bipolar depression, N= 19 general population; 
Szuba et aI, 1992). Although Szuba et aI's (1992) clinical sample comprised individuals 
with either current unipolar or current bipolar depression, social rhythm regularity was not 
analysed separately for each diagnostic group (N=]] unipolar depression, N=8 bipolar 
depression). It is therefore unclear whether lower regularity would have been observed in 
both unipolar and bipolar disorders samples compared to the general population, if the 
analysis had considered three participant groups. Brown et al (1996) also reported lower 
social rhythm regularity in individuals with current major depression who had experienced a 
spousal bereavement (N=44), compared to general population (N=45), bereaved with minor 
depression (N=26), and bereaved, but not depressed, samples (N=24) over 14 days. The 
current major depression sample comprised 34 individuals who were experiencing a first 
episode of depression and ten individuals who were experiencing a recurrence of 
depression. It was unclear whether this clinical sample included any individuals with 
bipolar depression. Although social rhythm disruption is evident in the presence of an 
acute depressive episode, regularity over a 12 week period, does not appear to differ from 
the general population when unipolar depression is in remission (N=20 recurrent unipolar 
depression, in remission, N=15 general population; Monk et aI, 1991). However, larger 
intraindividual variability in weekly social rhythm regularity was reported in remitted 
unipolar depression compared to the general population (Monk et aI, 1991). Furthermore, 
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a recent investigation by Ashman et al (1999) observed that social rhythm regularity did not 
appear to vary systematically across different mood states in bipolar disorder over a mean 
95 days monitoring (N=9 rapid cycling bipolar disorder, N=9 general population). In 
comparison to individuals from the general population who were monitored for 14 days, 
individuals with rapid cycling bipolar disorder displayed less regularity in their social 
rhythms. This fmding suggests greater variability in social rhythms may be observed during 
inter-episode periods in bipolar disorder compared to the general population. Overall, 
prospective investigations, albeit with small sample sizes over relatively brief monitoring 
periods, have observed social rhythm disturbances in mood disorders compared to the 
general population. 
The impact of depression on the number of daily activities that individuals perform is less 
clear. Brown et al (1996) reported fewer activities were performed by individuals with 
major depression and recent spousal bereavement, compared to non-bereaved general 
population individuals. In contrast, two studies suggest no differences in the number of 
activities performed by individuals with current depression (Szuba et aI, 1992) or remitted 
depression (Monk et al (1991) compared to the general population. Although Ashman et 
al (1999) did not observe the number of activities performed to vary across bipolar mood 
states, fewer activities were completed by bipolar disorder compared to general population 
individuals. Differences between the general population and bipolar disorder, but not 
between different bipolar mood states, in social rhythms may suggest the presence of 
general social rhythm disturbance. Thus, some evidence suggests differences in the 
frequency of activities performed between mood disorders and the general population, 
whilst other evidence suggests no difference in activity frequency. In general, social 
rhythm studies in mood disorders have been completed with fairly small samples, sometimes 
with mixed diagnoses (e.g. Szuba et aI, 1992); future research should address these 
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limitations to elucidate social rhythm disturbance in mood disorders. In particular, further 
prospective research with bipolar disorder samples across inter-episode periods as well as 
during acute episodes is necessary to identifY the robustness of Ashman et ai's (1999) initial 
observations. 
2.2.2 Variability in sleep and wake 
Variability in the sleep-wake cycle may represent an underlying dysregulation of circadian 
rhythms. Sleep may be considered as a biologically driven behaviour: the timing and 
duration of sleep is regulated by the circadian system as well as by the behaviour of the 
individual (Wehr, 1984). External circumstances, the occurrence of life stress (Wehr, 
1992; Riemann & Berger, 1998), or social rhythm disruption (Ashman et ai, 1999) may 
cause sleep disturbance. Sleep disruption may include difficulty in falling asleep, 
maintaining sleep, increased time spent awake, and early morning wakening (Riemann & 
Berger, 1998). 
Sleep patterns during bipolar episodes have been indicated to differ from sleep patterns 
observed for the general population. Indeed, sleep disruption is used as a diagnostic 
criterion for both mania and depression (DSM-IV; American Psychiatric Association, 
1994). A sleep electroencephalogram (EEG) study reported individuals with current major 
depression displayed greater sleep latency and night waking time, with lower sleep 
efficiency and sleep duration compared to the general population, with no observed 
differences for time spent in bed (N=67 unipolar and bipolar depression, N=66 general 
population; Mendlewicz & Kerkhofs, 1991). Hudson et ai's (1992) polysomnographic 
(PSG) study observed individuals with current mania or depression displayed lower sleep 
duration and sleep efficiency compared to general population individuals (N=19 current 
mania, N=19 current depression, N=19 general population). Hudson et al (1992) 
S2 
highlighted similar sleep disruption across mania and depression suggested the same 
underlying mechanism may be responsible. Furthermore, prospective longitudinal studies 
suggest a relationship between the sleep-wake cycle and prognosis in bipolar disorder. 
Regulating the timing and duration of sleep through extended bed rest and darkness has 
been indicated to stabilise rapid cycling bipolar disorder in two recent case studies (Wehr et 
aI, 1998; Wirz-Justice et aI, 1999). Similarly, an 18 month investigation of the day-to-day 
relationship between sleep and mood reported decreased sleep duration was the best 
predictor ofmanial hypomania the following day; the relationship between sleep duration 
and depression was less consistent (N=11 rapid cycling bipolar disorder; Leibenluft et aI, 
1996). Thus, prospective evidence has consistently suggested an association between the 
sleep-wake cycle and mood in bipolar disorder. 
Prospective investigations using actigraphy to monitor the sleep-wake cycle have reported 
inconsistent sleep disturbances in bipolar disorder during inter-episode periods (Millar et aI, 
2004; Harvey et aI, 2005; Jones et aI, 2005). Actigraphy is a method that objectively 
estimates the sleep-wake cycle from movement detected by a device worn on the wrist 
(Section 3.4.1 provides further information on actigraphy). Millar et al (2004) reported no 
significant differences in averaged sleep measures but greater variability in night waking and 
sleep duration in bipolar disorder over five days (N=19 bipolar disorder, in remission, N=19 
general population). Harvey et al (2005) observed increased sleep duration and reduced 
sleep efficiency in bipolar disorder over eight days (N=14 bipolar disorder, in remission, 
N=20 insomnia, N=20 general population). Variability in sleep measures were not reported 
by Harvey et al (2005). Finally, although Jones et al (2005) did not observe any differences 
in the average level or variability of sleep measures over seven days, circadian rhythm 
disturbance of the rest-activity cycle was evident in bipolar disorder (N=19 bipolar disorder, 
in remission, N=19 general population). Actigraph studies that have investigated the sleep-
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wake cycle during inter-episode bipolar disorder have been limited by monitoring small 
samples of individuals over relatively brief prospective time periods. However, preliminary 
evidence suggested some sleep disturbance may be apparent in two of the three studies. 
Larger studies over longer time periods may elucidate the extent of inter-episode sleep 
disturbance in bipolar disorder. 
2.2.3 Sleep disruption and symptoms of depression 
Sleep disruption has been indicated in recent meta-analysis studies to be a risk factor for 
depression (Cole & Dendukuri, 2003; Riemann & Voderholzer, 2003) and has also been 
reported as a common early symptom of depression (Breslau et aI, 1996; Perl is et aI, 1997). 
Furthermore, research has indicated that a night of total sleep deprivation can induce a 
temporary improvement in mood in around 60% of individuals experiencing depression (Wu 
& Bunney, 1990; Riemann et aI, 1993; Szuba et aI, 1994; Berger et aI, 1997; Riemann & 
Berger, 1998; Emilien & Maloteaux, 1999). However, depression reappears in most 
individuals following recovery sleep, even for as little as two hours sleep (Gillin et aI, 1984; 
Wehr, 1989; Wu & Bunney, 1990). Antidepressant effects of sleep deprivation tend to be 
more marked in the early morning, which suggests that circadian rhythms may also be 
involved in mood regulation (Boivin et aI, 1997). In addition, diurnal mood variation has 
been associated with greater mood change following sleep deprivation (Gillin et aI, 1984; 
Roy-Byrne et aI, 1984; Haug, 1992; Leibenluft & Wehr, 1992; Wehr, 1992). In contrast, 
sleep deprivation has not been found to produce mood elevation in individuals from the 
general population (Roy-Byrne et aI, 1984; Wirz-Justice, 1995). The antidepressant effect 
of sleep deprivation has led to the proposal that sleep disturbance may not only be a 
symptom, but also be related to the pathogenesis of mood disorders (Wu & Bunney, 1990; 
Wehr, 1992). 
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2.2.4 Sleep disruption and symptoms of mania 
Sleep disruption is a common symptom of mania, which frequently involves decreased sleep 
duration, (Bunney et ai, 1972; Wehr, 1984, 1990; Hudson et aI, 1988; Riemann & Berger, 
1998) although total insomnia can sometimes occur at the onset of mania (Wehr, 1990). 
Serretti and Olgiati (2005) reported a reduced need for sleep was a symptom of mania in 
approximately 98% of individuals with bipolar disorder (N=280 bipolar disorder). The 
most robust early symptom of mania identified by a systematic review was sleep disturbance 
(Jackson et aI, 2003). Sleep deprivation can trigger the onset ofa manic episode in bipolar 
disorder (Wehr et aI, 1987; Wehr, 1991, 1992; Van den Hoofdakker, 1997; Barbini et aI, 
1998). Furthermore, sleep loss may even trigger a switch from depression to mania or 
hypomania, at least in rapidly cycling individuals (Wehr et aI, 1982; Wehr, 1989; Wu & 
Bunney, 1990). Thus, research has consistently indicated that sleep disruption may be a 
triggering factor in the pathogenesis of mania. 
Wehr et al (1987) outlined a hypothesis regarding sleep reduction as a final common 
pathway in the pathogenesis of mania. Wehr et al (1987) proposed a self-reinforcing 
mechanism of sleep loss and progressive mood improvement: sleep disruption has the 
capacity to cause mania, and mania in tum to reduce sleep and so on. This mechanism may 
create an ongoing vicious circle resulting in mania becoming autonomous (Wehr, 1992; 
Wehr et aI, 1987). Support for Wehr et ai's hypothesis is evident from Barbini et ai's 
(1996) recent findings, where sleep loss appeared to act as both a precipitant of mania and 
as an augmenting factor during an episode of mania. Barbini et al (1996) investigated sleep 
loss in 34 individuals with bipolar disorder, who were currently experiencing an episode of 
mania. Sleep loss and mania were monitored over a consecutive three day period. The 
results indicated a significant inverse relationship between sleep duration and symptoms of 
mania: the shorter the sleep duration, the greater the level of manic symptoms observed the 
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following day. Thus, sleep disturbance has been theoretically and clinically linked to manic 
relapse in bipolar disorder. 
2.2.5 Variability in behaviour and bipolar disorder 
Overall, evidence suggests variability in social rhythms may differ between bipolar disorder 
and the general population. Lower social rhythm regularity has been observed in currently 
depressed (Szuba et ai, 1992; Brown et ai, 1996) and rapid cycling bipolar disorder 
(Ashman et ai, 1999) samples. There is no indication that social rhythms may vary with 
mood state, at least in rapid cycling bipolar disorder, but this can only be considered a 
preliminary fmding. Variability in the sleep-wake cycle may also differ between the general 
population and acute bipolar episodes. For instance, sleep disturbance is evident in both 
elated and depressed states in comparison to the general population (Hudson et aI, 1992). 
During inter-episode periods, some studies (Millar et ai, 2004; Harvey et ai, 2005) have 
observed sleep disturbances in bipolar disorder, whilst others (Jones et aI, 2005) have not. 
Although previous investigations of behavioural variability in bipolar disorder had the 
methodological advantage of being conducted prospectively, fmdings are preliminary as 
small samples were recruited and monitored over relatively short time periods. 
2.3 Variability in cognition 
Cognition may be defmed as an individual's psychological thought processes. The course 
of bipolar disorder reflects variation in cognition, with acute episodes characterised by 
cognitive distortions. Cognitive symptoms of depression may include feelings of 
worthlessness/low self esteem, whereas grandiosity/inflated self esteem may be present in 
elation or mania. Retrospective studies indicate early symptoms of bipolar relapse may 
include cognitive changes, such as lowered concentration and self esteem (Smith & Tarrier, 
1992; Keitner et aI, 1996). Cognitive theories (e.g. Beck, 1987) have postulated 
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individuals with depression have a generalised negative view of the self. Psychoanalytic 
theories (e.g. Neale, 1988) also postulate individuals with bipolar disorder have a negative 
view of self and that mania occurs as a defence against low self esteem and the associated 
depression. Thus, self rated cognition may be considered a theoretically important 
construct for depression and mania. Changes in self esteem are included as diagnostic 
criteria for bipolar relapse in DSM-IV (Tables 1.1 and 1.2). Thus, the literature review for 
variation in cognition focused on the self esteem construct. 
Self esteem (SE) may be considered as an individual's view of the self: what an individual 
thinks about them-self. For instance, an individual may view them-self as an attractive, 
interesting, likeable person. The stability of this self view may vary since an individual may 
have a different view of them-self in different situations. To illustrate, an individual who is 
popular within their family, but has difficulty making friends at work may have lower SE in 
the workplace. A multidimensional SE model of depression has proposed four different 
aspects of the SE construct: level, regulation, reactivity and variability (Roberts & Monroe, 
1994, 1999). The level and regulation of SE over time may influence mood. Self esteem 
regulation includes strategies to maintain SE as well as reactivity and variability ofSE. 
Deficits in these aspects may represent increased cognitive vulnerability to mood change 
(Roberts & Monroe, 1999). Each SE aspect will be outlined in turn and research evidence 
for a role in precipitating mood change discussed. 
2.3.1 Level of self esteem 
Differences in SE emerge between the general population and individuals with bipolar 
disorder during acute episodes. Research evidence has also suggested differences in SE 
exist during inter-episode periods in bipolar disorder compared to the general population. 
Although Pardoen et aI's (1993) cross-sectional investigation reported no significant 
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differences in SE level between individuals with bipolar disorder and general population 
individuals (N=27 bipolar disorder, minimum remission six months; N=26 general 
population), more recent cross-sectional studies, with larger samples, indicate differences in 
SE level. Lower SE levels in euthymic bipolar disorder compared to the general population 
have been reported by Shapira et al (1999; N=27 bipolar disorder, N=27 general 
population), Serretti et al (1999; N=99 bipolar disorder, N=} 00 general population), and 
Blairy et al (2004; N=144 bipolar disorder, N=144 general population). The minimum 
remission periods for the bipolar disorder samples were three months (Serretti et aI, 1999; 
Blairy et aI, 2004) and 12 months (Shapira et aI, 1999). The four studies used the same SE 
measure (Rosenberg Self Esteem Questionnaire). Two studies matched each bipolar 
disorder individual to a general population individual for age and gender (Shapira et aI, 
1999; Blairy et aI, 2004). No evidence has suggested the inter-episode SE level for bipolar 
disorder may be higher than in the general population. Thus, evidence has indicated the SE 
level for individuals with bipolar disorder, during inter-episode periods, are similar or lower 
than general population SE levels. 
The presence of low SE levels during inter-episode periods of bipolar disorder may explain 
low SE in bipolar depression, but it is less evident how inflated SE associated with mania 
may occur. One explanation was provided by Healy and Williams (1989), who proposed 
that individuals misattribute dysphoria from circadian rhythm disturbance, which could lead 
to mood elevation (Section 1.5.3.1). Alternatively, psychodynamic explanations have also 
been postulated. For instance, Neale (1988) hypothesised unstable self esteem was a 
characteristic of bipolar disorder. When life stress threatens to lower SE, grandiosity or 
inflated SE was proposed to occur to defend against negative cognitions; this defence was 
hypothesised to lead to mood elevation. Some research evidence may support this 
theoretical defensive function of mania. Winters and Neale (1985) observed that whilst 
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general population and bipolar disorder individuals reported similar SE levels, individuals 
with unipolar and bipolar disorders made similar internal inferences regarding the cause of 
failures, which suggests the presence ofa low self worth schema (N=16 bipolar disorder, in 
remission, N=16 unipolar depression, in remission, N=16 general population). Lyon et al 
(1999) also concluded their fmdings were consistent with the manic defence hypothesis; 
participants with current bipolar depression or mania both attributed more negative events 
to internal factors and recalled more negative words compared to general population 
participants (N=15, current mania, N=15 current bipolar depression, N=15 general 
population). Thus, these fmdings suggest individuals with bipolar disorder may possess a 
cognitive schema oflow SE in both bipolar depressive and manic episodes, as well as during 
inter-episode periods. 
2.3.2 Self esteem regulation 
Regulation may be necessary to keep an individual's SE at the same level. Structural 
deficits in an individual's SE regulation processes have been proposed to increase 
vulnerability to mood change (Roberts & Monroe, 1994, 1999). Deficits may include over-
reliance on limited personal or social sources of SE. For instance, Lam et al (1999) 
highlighted from clinical observation, that some individuals with bipolar disorder 
concentrate on one domain in their life (e.g. work) and derive SE specifically from this 
domain. Lowered SE may arise as a consequence of loss of status associated with bipolar 
disorder, particularly in terms oflong term employment problems (Scott, 1995). 
Furthermore, the extent of awareness of daily activity performance and the resulting change 
in how the individual views them-self following task success or failure, has also been 
suggested as an important factor in SE regulation (Greenier et aI, 1999). Heightened 
awareness of daily activity performance may hinder the regulation of stable SE. In this 
way, relatively small stressors may have a large impact on SE (e.g. spilling a drink at a 
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meeting). An individual with heightened awareness may interpret this accident as evidence 
of incompetence, with a resulting negative impact on their SE level. Individuals with 
strong SE regulation may be less likely to let a small accident influence how they view 
them-self overall. Deficits in SE regulation would therefore contribute to SE variability. 
Kemis et al (l993a) reported variability in specific self-evaluations (competence, social 
acceptance, physical attractiveness) were associated with SE variability in a general 
population sample (Study 2, N=104 undergraduates). Furthermore, SE variability was 
positively associated with greater self-ratings of the importance of physical attractiveness 
and competence in determining self-worth; importance of social acceptance and SE 
variability were not significantly associated. These fmdings suggest deficits in SE 
regulation through heightened awareness of how individuals consider they perform in day-
to-day life, may lead to temporally variable SE. 
Self esteem regulation processes may also describe strategies used to maintain and protect 
SE (Roberts & Monroe, 1999). Social comparison, interpersonal feedback, self-
verification and self-enhancement strategies may all be utilised for SE regulation. The use 
of strategies has been associated with different SE levels (e.g. Kemis et aI, 1997) indicating 
that aspects of the SE construct interact. Roberts & Monroe (1999) provide a more 
comprehensive review of the research evidence outlining strategies for SE regulation. 
2.3.3 Variability and reactivity of self esteem 
Self esteem variability refers to the magnitude of short term fluctuations over time, whilst 
reactivity refers to the extent that SE changes in response to stimuli, such as life stress and 
dysphoric mood (Kern is, 1993; Roberts et ai, 1995). The reactivity and variability of SE 
may be considered as a continuum whereby moderate reactivity would occur in the general 
population (Roberts & Monroe, 1992; Kernis et aI, I 993a; Butler et aI, 1994). Research 
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evidence has suggested positive associations between SE variability and SE reactivity, and 
negative associations between SE variability/reactivity and SE level (Kern is et aI, 1992, 
1998; Greenier et aI, 1999). Kernis and Waschull (1995) reported their previous fmdings 
(Kernis et aI, 1993b; paper presentation, N=60 undergraduates) whereby SE variability was 
positively associated with greater self-reported impact of negative events. Similarly, 
Greenier et aI's (1999) prospective investigation observed individuals who exhibited greater 
SE variability reported greater reactivity to both positive and negative daily events (N=130 
undergraduates). A prospective self report study observed daily life stress had a greater 
impact on mood in low SE individuals (N=67 undergraduates; Campbell et ai, 1991). 
Similarly, Brown and Mankowski's (1993) three studies consistently found negative mood 
led to negative self-evaluations in low SE, but not high SE, individuals (Study 1, N=51 
undergraduates; Study 2, N=73 undergraduates; Study 3, N=I02 undergraduates). In 
contrast, positive mood had no differential impact on self-evaluations in low SE compared 
to high SE individuals (Study 1, N=51 undergraduates; Brown and Mankowski, 1993). 
Thus, prospective studies with undergraduate samples have suggested the impact of life 
stress and dysphoric mood on an individual may depend on the individual's variability and 
levelofSE. 
Prospective investigations, using undergraduate samples, have consistently reported high SE 
variability individuals were more likely to experience depressive symptoms following life 
stress than low SE variability individuals (N=192 undergraduates, Roberts & Monroe, 
1992; N=122 undergraduates, Roberts & Gotlib, 1997; N=213 undergraduates, Roberts & 
Kassel, 1997; N=98 undergraduates, Kernis et aI, 1998). Associations between SE 
variability and depressive symptoms were evident for individuals initially low in symptoms 
in two studies (Roberts & Monroe, 1992; Roberts & Kassel, 1997); this suggests SE 
variability may be more important in onset, rather than persistence, of mood symptoms. 
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Furthermore, prospective investigation has observed greater SE reactivity to daily life stress 
in current and previously depressed individuals compared to never depressed individuals 
(N=S7 current major depression, N=76 previous major depression, N=72 never depressed 
undergraduates; Butler et aI, 1994). Thus, SE variability may be considered as a diathesis 
for depressive symptoms; SE variability in combination with life stress or daily hassles has 
been associated with onset of depressive symptoms. 
A mood-state hypothesis has been suggested by some authors (e.g. Teasdale, 1988) which 
postulates individuals with a biological vulnerability for mood disorders have stronger 
associations between cognition and mood than the general population. Research evidence 
to support the mood-state hypothesis has been mixed. Roberts and Kassel's (1996) cross-
sectional study reported SE level was mood-state dependent in depression-prone 
individuals, but this was not evident in control individuals (N=88 remitted dysphoria, N=74 
non-dysphoric undergraduates). In particular, SE level was significantly correlated with 
negative affect, but not positive affect, in depression-prone individuals. In contrast to the 
mood-state hypothesis, Roberts and Gamble's (2001) cross-sectional study reported a 
stronger association between SE level and negative affect in never depressed individuals 
(N=ll previously depressed; N=99 never depressed adolescents). Although a significant 
positive correlation between SE level and positive affect was evident, this association did 
not differ between previously depressed and never depressed individuals. Prospective 
investigation ofmood and SE in clinical samples compared to the general population may 
provide improved understanding of associations between mood and cognition. 
Despite the extensive investigation ofSE variability and depressive symptoms in the general 
population, little research has been conducted with individuals with current clinical 
depression or mania. A recent cross-sectional study reported SE level varied across 
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individuals with hypomania, bipolar depression or bipolar disorder in remission; higher SE 
levels were observed in individuals with remitted bipolar disorder compared to individuals 
with current hypomania or depression (N=26 remitted bipolar disorder, N=13 hypomania, 
N=38 bipolar depression; Scott & Pope, 2003). Further investigation of the temporal 
relationship between SE and mood is necessary to improve understanding of how SE 
fluctuations relate to elevation or depression of mood in clinical samples. Future 
investigations monitoring SE prospectively across different mood states within individuals 
would provide a stronger method to detect differences in bipolar disorder, although 
longitudinal monitoring may be required to observe individuals across all clinical mood 
states. 
2.4 Variability in mood 
Bipolar disorder is characterised by acute episodes of extreme mood as well as mood 
fluctuations during inter-episode periods. Theoretical models of mood (e.g. Batson et aI, 
1992; Larsen, 2000) have differentiated three aspects of emotional experience: affect, 
emotion, and mood. Affect may be considered as the individual affective components or 
tone associated with a mood or emotion state (Larsen, 2000). Moods and emotions have 
been posited by these theoretical models to differ in their duration and intensity. Mood 
duration may be longer than emotion since mood is thought to be influenced by future 
expectations (Batson et aI, 1992; Larsen, 2000). Emotion intensity may be greater than 
mood intensity as emotions are thought to occur over more discrete time periods (Batson et 
aI, 1992; Larsen, 2000). The onset and maintenance of elated and depressed moods in 
bipolar disorder is of more clinical interest than the experience of emotions per se. Affect 
is necessary for the creation of mood, although changes in affect may not always lead to 
changes in mood (Batson et aI, 1992). Thus, day-to-day fluctuations in affect may be 
critical in understanding variability between elation, depression and euthymia in bipolar 
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disorder. Affect is comprised of both valence (positive-negative) and intensity (strong-
weak) (Batson et aI, 1992). The literature review will focus on variability in affect, but will 
briefly discuss mood variability in clinical samples. 
2.4.1 Level of positive and negative affect 
Two dominant dimensions of subjective emotional experience are positive affect (PA) and 
negative affect (NA); each affect can be measured as either a trait or a state (Watson & 
Clark, 1984; Watson & Tellegen, 1985; Watson, 1988; Watson et ai, 1988b; Clark & 
Watson, 1991). Positive affect refers to the level of enthusiasm, activity, and alertness that 
an individual feels; negative affect refers to the level of subjective distress, and includes 
aversive mood states, such as anger, disgust, guilt, fear, and nervousness (Watson et ai, 
1988b; Lonigan et ai, 1999). High levels or intensity ofPA and NA represent states of 
emotional arousal whereas low levels represent a relative absence of affect (Watson & 
Tellegen, 1985; Watson, 1988). 
Differences in PA and NA levels have been demonstrated. Cross-sectional investigations 
have reported higher PA than NA levels in general population (N=4217; Watson et ai, 
1988a) and undergraduate (N=153; Roberts & Gamble, 2001) samples. Gable et aI's 
(2000) prospective studies observed higher daily PA than NA level across seven days 
(Study 2, N=50) and 14 days (Study 3, N=155) in undergraduate samples. Egloffet al 
(1995) also reported higher PA level compared to NA, when affect was prospectively 
measured three times a day for a seven day period (N=49 undergraduates). Furthermore, 
Lovejoy and Steuerwald's (1995) prospective investigation indicated higher daily PA 
compared to daily NA over 28 days in undergraduates with either no psychiatric diagnosis 
or a subsyndromal mood disorder (N=16 intermittent depression, N=12 cyclothymia, N=19 
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undergraduates, no current psychiatric diagnosis). Overall, cross-sectional and prospective 
evidence has indicated the average PA level tends to be higher than the average NA level. 
Prospective studies have observed differences in affect levels between mood disorders and 
the general population. Lovejoy and Steuerwald (1995) reported higher daily NA in 
subsyndromal mood disorders in comparison to the general popUlation; daily PA did not 
differ between groups across 28 days (N=16 intermittent depression, N=12 cyclothymia, 
N=19 undergraduates, no current psychiatric diagnosis). Myin-Germeys et al (2003) 
conducted an experience sampling method (ESM) study whereby affect was self-rated on 
ten occasions per day, following unpredictable alarms from a wristwatch device, across a six 
day period. Myin-Germeys et al (2003) reported higher NA and lower PA in currently 
depressed individuals compared to the general population (N=46 current major depression, 
N=49 general population). No difference for NA level was evident between the general 
population and remitted bipolar disorder, although PA level was significantly lower in 
bipolar disorder (N=38 bipolar disorder, full or partial remission for minimum 2 months; 
Myin-Germeys et aI, 2003). Thus, preliminary evidence has suggested affect levels during 
acute episodes and inter-episode periods may differ across mood disorders and general 
population samples. 
Positive and negative affect levels are likely to be different during acute episodes of 
depression and mania, in comparison to inter-episode periods. Episodes of depression may 
be characterised by high NA and low PA (Watson et aI, 1988b; Clark & Watson, 1991; 
Lonigan et aI, 1999; Gencoz, 2002). A prospective general population study reported 
higher NA and lower PA in depressed compared to non-depressed individuals (N=37 
undergraduates; Hopko et aI, 2003). In contrast, episodes of mania may be characterised 
by high NA and high P A. For instance, Cassidy et at (1998) reported symptoms of mania 
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that may be considered as high NA (e.g. irritability, guilt) and high PA (e.g. increased 
humour). Lovejoy and Steuerwald's (1992) cross-sectional investigation of subsyndromal 
affective symptoms and trait affect reported depressive symptoms were positively correlated 
with NA and negatively correlated with PA, when hypomania was controlled for. Although 
a positive correlation between hypomanic symptoms and NA was evident, this was reported 
to be due to shared variance with depressive symptoms; hypomanic symptoms and PA were 
positively correlated, when depression was controlled for (N=53 subsyndromal affective 
disorder, N=268 undergraduates, no psychiatric diagnosis; Lovejoy & Steuerwald, 1992). 
Thus, the high NA-Iow PA characteristic of depression has been supported (Lovejoy & 
Steuerwald, 1992; Hopko et aI, 2003) but not the high NA-high PA characteristic of mania 
(Lovejoy & Steuerwald, 1992). However, since a subsyndromal samples were used with 
one cross-sectional investigation, stronger associations may be observed with prospective 
monitoring ofa clinical sample. Prospective investigation of affect levels in mood disorders 
may provide a better understanding of how affect varies during acute episodes as well as 
across inter-episode periods. 
2.4.2 Variability and reactivity of affect 
Affect variability may be considered as the extent of fluctuations in affect over time, whilst 
affect reactivity refers to the extent that affect changes in response to life stress or events. 
Evidence has indicated that affect variability is a stable dispositional characteristic in the 
general population (Cooper & McConville, 1990; Penner et aI, 1994; McConville & 
Cooper, 1997), with observed individual differences in variability (Cooper & McConville, 
1990). For instance, Penner et al (1994) reported intraindividual affect variability exhibited 
temporal stability over a 14-day monitoring period, when the first five day and last five day 
periods were compared (N=S4 general population). Positive associations between PAINA 
level and PAINA variability have been reported by a prospective study, suggesting 
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individuals who experience relatively high affect may also exhibit greater variability in affect 
over time (N=29 undergraduates; Hepburn & Eysenck, 1989). Consistent variability across 
positive and negative affects has been observed. Prospective general population 
investigations have reported positive associations between PA and NA variability, which 
suggests individuals who display large PA variability also display large variability in NA 
(N=29 undergraduates, Hepburn & Eysenck, 1989; N=17 general population, McConville 
& Cooper, 1995; N=78 general population, McConville & Cooper, 1997). Thus, while 
intraindividual stability in affect variability has been indicated, interindividual differences in 
affect variability may exist, particularly when comparing the general population to clinical 
populations. 
Investigation of affect variability in general population and mood disorder samples has not 
been extensive. A study by Lovejoy and Steuerwald (1995) prospectively compared PA 
and NA in subsyndromal unipolar or bipolar disorder and general population individuals 
(N=47 undergraduates; N=16 intermittent depressive disorder; N=12 cyclothymia, N=19 no 
current psychiatric diagnosis). Greater daily PA variability was observed for cyclothymia, 
compared to general population, individuals; daily NA variability was significantly greater in 
both cyclothymia and intermittent depression individuals in comparison to the general 
population (Lovejoy & Steuerwald, 1995). Roberts and Gotlib's (1997) prospective study 
reported affect variability (PA and NA) did not predict depressive symptoms, either alone or 
in interaction with life stress (N=122 undergraduates). This may suggest that affect 
variability may be a vulnerability factor for mood disorders, but not for mood change in the 
general population. Further research is necessary in both general and clinical populations 
to determine the clinical significance of affect variability. 
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Day-to-day fluctuations or variability in affect may be influenced by the extent that affect is 
reactive to life stress. For instance, Bolger et aI's (1989) prospective investigation 
reported approximately 20% of negative mood variability was accounted for by negative 
daily stress (N=332 general population). Other research has reported both positive and 
negative affect reactivity to life stress is evident in the general population. Negative events 
have been associated with increased NA (Clark & Watson, 1988; David et aI, 1997; Van 
Eck et aI, 1998; Gable et aI, 2000), whereas reactivity ofPA to negative events has been 
less substantial (David et aI, 1997; Van Eck et aI, 1998; Gable et aI, 2000). Positive events 
have been associated with increased PA (Clark & Watson, 1988; David et aI, 1997; Gable et 
aI, 2000). Negative affect reactivity to positive events has not been observed (David et aI, 
1997; Gable et aI, 2000). Overall, evidence has suggested specific affect reactivity with 
negative events impacting on NA and positive events impacting on PA in the general 
population. 
Individuals with mood disorders experience extremes of affect during episodes of mania and 
depression. Consequently, it is possible that affect reactivity to daily life stress may be 
greater in mood disorders compared to the general population. Peeters et aI's (2003) 
experience sampling method investigation (ten ESM ratings each day over a six day period) 
reported affect reactivity to daily life stress differed between currently depressed and 
general population individuals (N=46 current major depression, N=39 general population). 
Currently depressed individuals displayed greater affect reactivity to positive events/ 
situations; larger increases in PA and larger decreases in NA were evident in current 
depression compared to the general population. In contrast, affect reactivity to negative 
events/situations was observed to be greater in the general population group, with larger 
increases in NA and decreases in PA. Another ESM study by the same authors, 
investigated affect reactivity to current daily life stress by comparing Peeters et aI's current 
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depression sample with bipolar disorder participants and a different general population 
sample (N=46 current major depression, N=38 bipolar disorder, minimum two months 
full/partial remission, N=49 general population; Myin-Germeys et aI, 2003). Myin-
Germeys et al (2003) reported greater NA reactivity to life stress in currently depressed 
compared to general population individuals, with no difference in PA reactivity. 
Furthermore, greater PA reactivity to life stress was observed in remitted bipolar disorder 
compared to the general population group, with no difference in NA reactivity. Thus, 
preliminary evidence suggests affective reactivity may differ between mood disorders and 
the general population, and may also depend on the valence (positive or negative) and 
intensity (life events vs. daily life stress) of life stress. 
Although evidence has indicated affect reactivity to life stress may occur in both general 
population and mood disorder samples, differences in affect recovery have been suggested 
to exist. Affect recovery following reactivity, whereby affect stabilises and returns to the 
prior level, may be slower in individuals with mood disorders. Goplerud and Depue (1985) 
observed longer duration of mood recovery following life stress in dysthymia and 
cyclothymia compared to the general popUlation (N=4 dysthymia, N=31 cyclothymia, N=24 
general population). Similarly, Peeters et al (2003) observed longer affect recovery in 
currently depressed compared to general population individuals; prior negative events were 
reported to have a persistent effect on NA level in current depression. Thus, longer affect 
recovery following reactivity to life stress has been suggested in mood disorders. 
2.5 Literature review conclusions 
Individuals experience biological, behaviour, self esteem and affect day-to-day variability. 
Preliminary evidence has suggested the extent of this variability differs between the general 
population and individuals with mood disorders. Greater day-to-day variability has been 
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observed in unipolar and bipolar disorders, as well as in subsyndromal mood disorders. 
The difference between bipolar disorder and the general population may be the ability to 
regulate behaviour, cognition and mood following psychosocial stress (Depue & Iacono, 
1989; Johnson et ai, 2000c). Whereas general population individuals may be influenced by 
stress temporarily, greater variability in bipolar disorders may increase reactivity to stress or 
delay mood recovery (Goplerud & Depue, 1985; Myin-Germeys et ai, 2003). Indeed, 
some previous investigations have suggested that mood fluctuations might be an indirect 
measure of life stress (Kennedy-Moore et ai, 1992; Gable & Nezlek, 1998). Research to 
date, however, has not concurrently monitored inter-episode variability in biological, 
behaviour, self esteem and affect measures in bipolar disorders. 
Although similar psychological processes have been postulated to increase vulnerability to 
depression and mania (Healy & Williams, 1988; Reilly-Harrington et ai, 1999), research 
findings suggest different psychosocial factors are important for each polarity. Evidence 
has reported psychosocial factors (e.g. social support, self esteem, life events involving loss) 
may be important in the course of bipolar depression, whilst factors important to the course 
of mania may include sleep, social rhythms and life events involving goal attainment 
(Johnson et ai, 2000b, 2000c; Malkoff-Schwartz et ai, 2000). Most research has 
concentrated on psychological models of unipolar depression, and while this may be 
extended to refer to bipolar depression, there is no psychological model that presently exists 
which provides a comprehensive explanation for onset of mania (Scott, 2001). 
Understanding the importance of variability in behaviour, cognition and affect, and how 
they interact, may provide a step towards understanding why depressive symptoms occur in 
some instances, whilst manic symptoms present at other times. 
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2.6 Rationale for the study 
The literature review has identified that the biological vulnerability of bipolar disorder 
interacts with the individual's mood, cognition and behaviour as well as the surrounding 
environment (e.g. life events). The five systems model provides a simple representation of 
how these five systems interact and is provided in Figure 2.1. This model has been used in 
cognitive behavioural selfhelp guides to explain the interaction between different aspects of 
an individual's life (Greenberger & Padesky, 1995; Scott, 2001; Williams, 2001). This five 
systems model is applicable to all individuals, and can be used in the current study to 
describe how variation in the other systems (environment, biological vulnerability, 
cognition, and behaviour) may lead to variation in mood for bipolar disorder. The 
sequence of change that precipitates relapse in bipolar disorder is uncertain, perhaps due to 
the numerous factors that can impact on clinical course and the scarcity of longitudinal 
studies that monitor the interaction of multiple factors on bipolar disorder. Since bipolar 
disorder may be considered a biological disorder (Craddock & Jones, 1999,2001) the 
current study posited that change in biological vulnerability would precede change in the 
other systems. Even with prophylactic medication, the biological vulnerability of bipolar 
disorder has a pervading presence observed through high relapse rates (e.g. Judd et aI, 
2003a) and commonly experienced subsyndromal symptoms (Judd et aI, 2002, 2003b). 
The impact of the environment (e.g. life events) has been briefly discussed in a diathesis 
stress context but was not monitored in the current study. The study rationale outlines the 
importance of the interactions between the four remaining systems: biological vulnerability, 
behaviour, cognition, and mood. 
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Figure 2.1: A psychobiosocial model of bipolar disorder 
Environment 
Biological 
/ vulnerability ~ 
Mood Cognition 
~ Behaviour / 
Bipolar disorder is recurrent in nature, and as such identification of the factors that predict 
relapse has always been an essential element of core research (Ellicott et aI, 1990). 
Research evidence has indicated several factors may playa role in the precipitation of 
relapse in bipolar disorder. These factors include: biological vulnerability, life stress, social 
rhythm disruption, medication non-adherence and cognitive vulnerability. Inconsistent 
findings from previous research may be due to variable interactions, where the effects of 
one variable depend on the level of another variable (Simons et aI, 1995). Whilst research 
to date has been important in highlighting the relationship between the disorder and certain 
factors, a more comprehensive model of how several factors interact to influence the course 
of disorder may provide a greater understanding of bipolar disorder. It is critical for 
research to investigate several constructs to identify whether general dysregulation or 
specific instability in one construct underlies vulnerability to mood disorders during inter-
episode periods. One investigation reported temporal self esteem variability, but not affect 
variability, predicted onset of depressive symptoms in a general population sample, 
suggesting specific instability is critical (N=122 undergraduates; Roberts & Gotlib, 1997). 
Looking at one construct in isolation may suggest specific dysregulation whereas it is 
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possible that a more general dysregulation exists across several constructs in bipolar 
disorder, even during inter-episode periods. 
Bipolar disorder is characterised by recurrent episodes of acute mania and depression. 
Symptoms of bipolar episodes encompass changes in cognition and behaviour in addition to 
these extremes of mood. A reduced need for sleep during mania has been reported in 97 to 
99% of individuals with bipolar I and II disorders (N=158 bipolar I disorder, N=122 bipolar 
II disorder; Serretti & Olgiati, 2005), whilst social rhythm disruption has also been 
associated with mania (Malkoff-Schwartz et aI, 1998). Furthermore, increased self esteem 
was reported as a symptom of mania in 87% of individuals with bipolar I disorder and in 
64% with bipolar II disorder (Serretti & Olgiati, 2005). However, subsyndromal 
fluctuations in affect, self esteem and behaviour may also be present in inter-episode periods 
(Cassano et aI, 1999; Akiskal et aI, 2000). Subsyndromal fluctuations may playa role in 
the precipitation of relapse as well as long term outcome (Fava, 1999; Morriss, 2002; 
Jackson et aI, 2003). For instance, sleep disruption has been identified as a robust early 
symptom of mania (Jackson et aI, 2003). Furthermore, ongoing biological dysregulation 
may represent an underlying vulnerability to bipolar disorder. For instance, a recent study 
reported individuals with euthymic bipolar disorder had a disturbed sleep-wake cycle 
compared to the general population (Millar et aI, 2004). Monitoring the sleep-wake cycle 
may be the most clinically useful evaluation of circadian rhythm disruption in bipolar 
disorder since it is amenable to change. Thus, understanding bipolar mood fluctuation in 
the context of biological dysregulation as well as fluctuations in affect, self esteem and 
behaviour may be essential for the investigation ofsubsyndromal fluctuation in bipolar 
disorder. 
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2.7 Aims of thesis 
The core vulnerability of bipolar disorders may be represented as instability of biological 
regulatory control. Diathesis-stress models for bipolar disorder propose the existence of an 
underlying instability with biological, behaviour, self esteem and affect extremes evident 
across acute bipolar episodes. Consistent with instability models of bipolar disorder, the 
current study posited inter-episode instability may be exhibited in day-to-day variability. 
The research hypothesis was greater day-to-day variability in prospective measures of 
biological, behaviour, self esteem, and affect would be observed in a bipolar disorder sample 
in comparison to individuals recruited from the general population. In addition, the 
average levels of measures were hypothesised to differ between bipolar disorder and general 
population groups, in line with previous fmdings. Thus, the present study investigated the 
average level and variability of biological, behaviour, self esteem and affect measures. 
The present study built on previous evidence by addressing gaps in the research conducted 
to date. Although research interest in temporal variability has rapidly increased in recent 
years, most studies have recruited general population or subsyndromal samples. It remains 
unclear to what extent that such fmdings could be considered representative of clinical 
mood disorder populations. Furthermore, most research investigations in bipolar disorder 
have focused on acute episodes whilst relatively few studies have investigated biological, 
behaviour, cognition, and affect regulation across inter-episode periods. The importance of 
inter-episode periods in the long term course of bipolar disorder has become evident in light 
of fmdings from recent large prospective longitudinal studies investigating weekly 
symptomatic status in bipolar disorders. Evidence from two longitudinal studies across 
approximate 13 year periods (Judd et aI, 2002, 2003b) reported individuals with bipolar I 
and bipolar II disorders were symptomatic approximately 47 to 54% of the time; 
subsyndromal symptoms accounted for 41 to 74% of the time spent symptomatic. The 
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objective of the current study was to address these gaps in existing knowledge by 
prospective monitoring of individuals with bipolar disorder across inter-episode periods. 
Three research aims were identified. The fITst aim was to investigate whether greater 
variability in biological, behaviour, self esteem and affect measures were evident in 
individuals with bipolar disorder compared to individuals from the general population. The 
second research aim was to investigate whether mean biological, behaviour, self esteem and 
affect levels differed between bipolar disorder and the general population. Differences in 
the variability ofmeasures between bipolar disorder and general population groups may be 
considered to have clinical importance if variability was associated with outcome in bipolar 
disorder. The third aim was to investigate the clinical importance of variability in bipolar 
disorder. Greater variability in individuals with bipolar disorder was hypothesised to be 
associated with increased vulnerability to relapse across time. 
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Chapter 3 Methodology 
The purpose of the current research was to investigate behavioural, cognitive and affective 
variability in bipolar disorders. Variability of circadian rhythms and behavioural activation, 
as measures of underlying diathesis vulnerabilities, were also investigated. Daily self-report 
measures of the key variables were identified to use in combination with objective 
monitoring of the sleep-wake cycle. Forth Valley Primary Care NHS Trust Ethics 
Committee approved the Research Protocol (Appendix A). Management approval was 
obtained from the Chief Executive and Medical Director of Forth Valley Primary Care NHS 
Trust. A sample of participants with bipolar disorder and a general population sample were 
recruited to identifY variability between groups and within-individuals. 
3.1 Participants 
Individuals who met criteria for a clinical diagnosis of bipolar I or bipolar II disorders 
(fulfilled DSM-IV criteria, according to casenotes) were recruited from a Lithium Clinic in 
Forth Valley Primary Care NHS Trust between September 2001 and March 2002. A staff 
psychiatrist confirmed case diagnosis. A control group from the general population was 
also recruited. Control group individuals were selected through opportunity sampling from 
personal and occupational sources. 
3.1.1 Inclusion criteria for participants with bipolar disorder 
1. Currently in contact with general adult psychiatry services. 
2. Met DSM-IV criteria for bipolar I or bipolar II disorder 
3. Not currently experiencing mania 
4. Willingness to provide informed consent. 
5. Consultant approval to approach individual to participate. 
6. Experienced a recent episode in the past two years. 
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7. Aged 18 to 65 years. 
3.1.2 Exclusion criteria for participants with bipolar disorder 
1. Current involvement with another research project. 
2. Unable to give written informed consent. 
3. Inability to speak English. 
3.2 Design 
A prospective design was used since retrospective assessment may not reliably reflect actual 
day-to-day variability. Cross-sectional self-report measures of self esteem variability have 
not been reported to be strongly associated with self esteem variability obtained from 
prospective repeated assessments (Kernis, 1993; Kernis et ai, 1989, 1992). For instance, 
Kernis et al (1992) found variability of self esteem, measured at lOam and 10pm over a four 
day period, was weakly associated with self-report measures of how much individuals 
estimated their self esteem ratings would vary over time (r=0.22, N=112, p<0.03). 
Furthermore, the use of a prospective design provided data on both average level and 
variability of measures over time. 
Daily self-report measures were selected to assess variability over time, with interval-
contingent monitoring at the end of each day. Prospective research studies with general 
population samples have reported mood does not tend to carry over across days (David et 
aI, 1997; Suls et aI, 1998), making daily monitoring suitable for measuring change across 
time. Less frequent monitoring may obscure the extent of variability in bipolar disorders 
(Hennen,2003). Monthly symptom monitoring has been reported to identify fewer manic 
and depressive symptoms in comparison to prospective daily monitoring in a bipolar 
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disorder sample (N=JO; Denicoff et aI, 1997). Prospective daily monitoring may also 
minimise the potential bias of retrospective recall (Reis & Gable, 2000; Bolger et aI, 2003). 
Self-report questionnaires were selected to assess day-to-day variability. Interviews were 
rejected as time consuming and obtrusive for daily prospective monitoring. A self-report 
measure of behavioural activation was completed weekly. Actigraphy, a method for 
objective estimation ofthe sleep-wake cycle, was used in addition to a self-report measure 
of time spent in bed to provide a more detailed description of sleep-wake variability across 
time. The use of self-report measures removed any potential interviewer bias, although 
validity was dependent on participants' ability and willingness to provide accurate 
information (John & Benet-Martinez, 2000; Reis & Gable, 2000). Similarly, collection of 
sleep-wake cycle data was contingent on participants continuously wearing an actigraphy 
device on their wrist. 
3.2.1 Pilot of study design 
The measures initially selected for the current study were piloted with volunteers from the 
general population and the Manic Depression Fellowship (N=2 general population, N=2 
bipolar disorder). Questionnaires to measure the factors that may influence relapse in 
bipolar disorder were identified. Nine questionnaires were selected to pilot the study 
design. The questionnaires were short listed on the basis of research evidence of their 
construct's importance in bipolar disorder. Although all nine questionnaires were 
considered relevant to the research hypotheses, volunteers' feedback indicated the package 
was too large for people to retain interest in completing. The questionnaire package was 
reduced following this feedback. Questionnaires considered unlikely to vary on a day-to-
day basis were discarded for the current project. Questionnaires piloted but not used in the 
current study included: Sociotropy Autonomy Scale (Beck et aI, 1983; Bieling et aI, 2000); 
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24 item Dysfunctional Attitudes Scale (Power et aI, 1994) ; List of Threatening Experiences 
(Brugha & Cragg, 1990); Multidimensional Perfectionism Scale (Hewitt & Flett, 1999); and 
an unpublished Tablet and Routines Questionnaire. The daily questionnaires along with a 
weekly behavioural activation measures were retained to investigate variability from day-to-
day. The questionnaires selected for the current study were: Social Rhythm Metric; 
Rosenberg Self Esteem Questionnaire; Positive And Negative Affect Schedule; and 
Behavioural Inhibition system and Behavioural Activation System Scales. These measures 
will be described in more detail in Section 3.4. 
3.2.2 Study design modification 
Initially, the current study intended to replicate and expand Ashman et aI's (1999) study 
design. Participants were recruited and completed the questionnaires for the current study 
on this basis. When a participant with bipolar disorder had completed a minimum eight 
week period of monitoring, an age and gender matched participant from the general 
population was recruited. Between-group comparisons were intended to compare a two 
week period in general population participants compared to the full monitoring period in 
bipolar disorder participants. However, following statistician advice, participant groups 
were compared over equivalent time periods. Since this decision was taken after data 
collection had been completed, further participants from the general population were unable 
to be recruited. The study design modification was considered to be a more conservative 
investigation of differences between bipolar disorder and general population samples. 
3.3 Procedure 
Prior to recruitment, a list of individuals with bipolar disorder identified as suitable for 
inclusion was sent to the treating consultant psychiatrist. An information sheet describing 
the research project was provided (Appendix B). Only individuals with written consent 
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from their consultant psychiatrist were approached regarding the project. Individuals were 
initially provided with a patient information sheet, which outlined the purpose of the study 
and described what participating would involve. Individuals who agreed to participate 
were asked to sign a consent form and received a copy of this for their own records 
(Appendix B). The information sheet and consent form both explicitly stated that 
individuals were free to withdraw from the research at any point and that there were no 
direct benefits to individuals in participating in the project. General population participants 
were recruited following recruitment of the bipolar disorder participants (Section 4.1.3 
provides additional information on the recruitment of individuals from the general 
population). Individuals. if interested, were provided with feedback regarding the 
questionnaires and actigraphic assessments they completed. 
Figure 3.1 provides a flowchart for the completion of questionnaires and actigraph 
monitoring over a two week period. Individuals completed the first day of self-report 
questionnaires with the research assistant (Alison Jackson) present. The procedure for 
completing questionnaires and how to use the actigraph- measuring device were explained 
in detail. Individuals then completed three daily questionnaires to measure behaviour, self 
esteem and affect at the same tirne at the end of each day. A self-report measure of 
behavioural activation and inhibition was completed once a week. Completion of measures 
at the same time each evening was an attempt to control for the effect of diurnal variation in 
bipolar disorder participants. The time of day has been reported to impact on how mood 
ratings are completed in a bipolar disorder sample; mood ratings in the evening were higher 
than morning ratings (Feldman-Nairn et aI, 1997). If individuals failed to complete a daily 
rating, they were asked to complete it immediately on rising the following morning. If 
more than one day had elapsed. the questionnaires for the missed day were not used. 
Completed questionnaires were collected from the participants every two weeks. 
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Figure 3.1: Flowchart of questionnaire completion and actigraph monitoring 
Start actigraph Day 1 
monitoring of sleep- .- Complete SRM, PANAS & RSEQ at end of day 
wake cycle for 14 days Complete BISIBAS Scales at end of day 
• Day 2 
Complete SRM, PANAS & RSEQ at end of day 
• Day 3 
Complete SRM, PANAS & RSEQ at end of day 
• Day 4 
Complete SRM, PANAS & RSEQ at end of day 
.. 
DayS 
Complete SRM, PANAS & RSEQ at end of day 
• Day 6 
Complete SRM, PANAS & RSEQ at end of day 
~ 
Day 7 
Complete SRM. PANAS & RSEO at end of day 
• Day 8 
Complete SRM, PANAS & RSEQ at end of day 
Complete BISIBAS Scales at end of day 
.. 
Day 9 
Complete SRM, PANAS & RSEQ at end of day 
• Day 10 
Complete SRM. PANAS & RSEO at end ofdav 
• 
Day 11 
Complete SRM. PANAS & RSEO at end ofdav 
• Day 12 
Complete SRM. PANAS & RSEO at end ofdav 
.. 
Day 13 
Comolete SRM. PANAS & RSEO at end of day 
+ 
Day 14 
Complete SRM, PANAS & RSEQ at end of day 
Collect actigraph 
Return actigraph 
.1-
for next 14 day 
to download period, ifnot 
data ~ Return completed questionnaires & coHect -+ worn for the 
questionnaires for following 14 day period previous 14 days 
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Individuals were requested to continuously wear an actiwatch (an actigraphy-measuring 
device worn on the wrist) to monitor sleep and activity patterns. Although the general 
population participants were monitored with actigraphy for their entire participation period 
(two to four week periods), this was not possible for the bipolar disorder participants due to 
the limited availability ofactiwatch models during the time period of the study. Data 
collection occurred over II months, from 19th September 200 I to 19th August 2002. The 
monitoring period for bipolar disorder participants ranged from two to 24 weeks. Since 
variability in the rest-activity rhythm in addition to mean levels of sleep-wake variables was 
of interest, it was decided to monitor bipolar participants on alternative two week periods to 
coincide with the collection of completed questionnaires. This method was expected to 
provide more information on rest-activity variability across time rather than measuring the 
rest-activity cycle on one occasion only. Furthermore, the generation of circadian rhythm 
variables from actiwatch data required a minimum consecutive seven day period (Section 
3.4.1.1 provides more information on circadian rhythm variables). Actiwatch data were 
downloaded at regular intervals and the actiwatch reset. 
3.4 Measures 
Biological, behaviour, cognition and affect changes are characteristic of bipolar episodes. 
However, subsyndromal symptoms also occur in a large proportion of individuals with 
bipolar disorders during inter-episode periods (Keller et aI, 1992; Gitlin et aI, 1995; Judd et 
aI, 2002). Biological, behaviour, cognition and affect regulation may differ between 
individuals with bipolar disorder and the general population, with bipolar disorder 
characterised by dysregulation and greater variability over time (Depue & Iacono, 1989; 
Johnson et aI, 2000c). The presence ofsubsyndromal symptoms may therefore indicate 
ongoing dysregulation. Furthermore, previous investigations with general population 
samples have reported associations between depressive symptoms and self esteem variability 
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(e.g. Kernis et aI, 1998) and affect variability (McConville & Cooper, 1996). This evidence 
suggested the importance of investigating the role that variability may play in the clinical 
course of mood disorders. Measures were selected for the current study that could 
potentially go on to be used to monitor an individual's variability in clinical practice if inter-
episode day-to-day variability was found to be of clinical importance in bipolar disorder. 
Measures were selected to investigate biological, behaviour, self esteem and affect variation 
across time. Diathesis-stress models of bipolar disorder have theoretically postulated 
underlying biological vulnerabilities: dysregulations in circadian rhythms (Healy & Williams, 
1988, 1989) and behavioural activation (Depue et aI, 1987; Gray, 1990). Accordingly, 
circadian rhythms and behavioural activation measures were used to assess whether this 
postulated diathesis dysregulation in bipolar disorder exists during inter-episode periods. 
The circadian rhythm of the sleep-wake cycle and self-report behavioural activation and 
inhibition levels were monitored. 
Daily variability in behaviour, cognition and affect were monitored to investigate the extent 
of inter-episode fluctuation. Measures of sleep and social rhythms were used to assess 
variability in behaviour. Diathesis-stress models have also theoretically postulated self-
rated cognition as an important factor in the onset of symptoms in mood disorders (Healy & 
Williams, 1988, 1989). Furthermore, cognitive theories of depression have proposed a 
negative view of self as a distinctive characteristic of depression (e.g. Beck, 1987). Since 
bipolar episodes are characterised by self esteem fluctuations, self esteem was therefore 
selected as the most pertinent cognitive measure of how individuals with bipolar disorder 
view themselves. Affect variability in both positive and negative affect as well as ratings of 
elation and depression were measured. Although the measures selected have been widely 
used for daily monitoring in general population samples, less evidence exists for use in 
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bipolar disorder samples. This may reflect the limited interest to date in considering inter-
episode periods relative to acute bipolar episodes. Research interest for general population 
day-to-day variability, particularly for self esteem and affect, has rapidly increased in recent 
years. Interest in variability in bipolar disorder across inter-episode periods has also 
burgeoned recently. The present study aimed to contribute to increased understanding of 
daily variability by applying established measures in a bipolar disorder sample across inter-
episode periods where day-to-day variability was hypothesised to exceed that reported by a 
sample drawn from the general population. 
3.4.1 Measures ofthe sleep-wake cycle 
The present study monitored the sleep-wake cycle as an objective evaluation of circadian 
rhythms. Other circadian rhythm measures, such as temperature and melatonin levels, were 
considered impractical for daily monitoring in an individual's normal environment. 
Furthermore, sleep disturbance has been indicated as an early symptom of bipolar relapse 
(Jackson et ai, 2003), suggesting that disturbances in the sleep-wake cycle may be evident 
during inter-episode periods. Methods for the objective estimation of the sleep-wake cycle 
include polysomnography (PSG) and actigraphy. The PSG method utilises electrodes to 
record cortical activity as an estimate of sleep and wake. Monitoring typically occurs 
within the laboratory although home PSG recording also occurs. Although PSG is 
regarded as the gold standard for evaluating sleep, limitations include its relative expense. 
cumbersome and physically intrusive procedure and impracticality for longitudinal 
monitoring, particularly for monitoring an individual's wake period throughout the day 
(Blood et ai, 1997; Lockley et aI, 1999). Thus, whilst PSG may be ideal for measuring 
sleep over a few days, PSG was not considered suitable for the present study which aimed 
to measure both sleep and wake over a longer time period. 
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Actigraphy is a method that allows continuous, relatively unobtrusive estimation of the 
sleep-wake cycle in the environment of an individual's daily life and may be a particularly 
useful method for the longitudinal monitoring of circadian rhythms (Royant-Parola et ai, 
1986; Sadeh et ai, 1995; Kushida et ai, 2001). An actigraph comprises a sensitive 
accelerometer microprocessor unit that is worn on the wrist. Physical motion is translated 
to numeric representation through an acceleration sensor; the intensity, amount and duration 
of movement is integrated and recorded (Sadeh et ai, 1995). An actigraph identifies sleep 
periods from the level of physical activity detected (Lockley et ai, 1999) and can also 
differentiate between sedentary and physical activities (Patterson et ai, 1993). Actigraphy 
was selected to provide an objective estimation of sleep. Sleep-wake cycle monitoring also 
provided data on circadian rhythms. 
The sleep-wake cycle may also be measured by an individual's subjective estimation. 
Although actigraphy has high sensitivity in comparison to self-reports (Teicher, 1995), 
actigraphy has been indicated to report a longer sleep period and greater sleep disturbance 
compared to subjective sleep measurement (Lockley et ai, 1999). Actigraphy and 
subjective measurement agree when determining sleep rhythms and changes in sleep 
patterns (Lockley et aI, 1999). The Social Rhythm Metric provided subjective estimation 
of time in bed; participants recorded the time they went to bed and the time they got out of 
bed (Section 3.4.3.1). 
3.4.1.1 Actigraphy (Appendix C) 
The present study used continuous actigraph monitoring of motor activity and sleep over a 
14 day period for each individual. The American Sleep Disorders Association (1995) 
recommended actigraphy should be conducted over a minimum three day period. 
Application ofa longer 14 day period provided circadian rhythm data and was also 
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consistent with the collection of questionnaires. Each participant wore an actiwatch on 
their non-dominant wrist for 14 consecutive days and nights. The non-dominant wrist was 
used as significantly higher mean activity levels from the dominant wrist during both sleep 
and wakefulness have been reported (Sadeh et al, 1994). The "Actiwatch-score" and 
"Actiwatch-plus" models were used (developed by Cambridge Neurotechnology Ltd.). 
The "Actiwatch-score" model is displayed in Figure 3.2. The recommended one minute 
epoch length was used for accuracy, which is a practice standard for actigraph monitoring 
(American Sleep Disorders Association, 1995; Cambridge Neurotechnology Ltd, 2000). 
The epoch comprised the activity counts [or each one minute time period. Raw actigraphic 
data were downloaded using the Actiwatch Sleep Analysis software programme. The 
actiwatch, with raw data collected, was placed face down on a reader, and data were 
downloaded to the computer. 
Figure 3.2: Actiwatch-score model 
Bed-time and Get up time were manually inputted according to the daily time recorded on 
the Social Rhythm Metric (Section 3.4.3.1). Diary estimates of bed-time and wake-time 
have been reported as reliable compared to actigraph based times (Monk et al, 1994). If 
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the Bed-time or Get up time were not recorded on the Social Rhythm Metric, visual 
inspection of the actigraph data provided an estimated time. A similar method to estimate 
time in bed was employed by Mendlowicz et al (1999). In addition to recording bed-time 
and get up times on the Social Rhythm Metric, participants used this questionnaire to record 
the occasions when the actiwatch was removed (e.g. to have a bath). The actiwatch 
software sleep-wake scoring algorithm computed each epoch as 'sleep' or 'wake.' The 
time at which sleep started each night and the time when sleep ended each morning were 
also automatically calculated with the sleep-wake scoring algorithm. Sleep was estimated 
to start when a minimum ten minute period, with one or less minutes of movement 
following bedtime occurred. The 'Sleep Start' variable was calculated as the time when 
this period began. For example, if an individual went to bed at 11 pm and the first ten 
minute period meeting the criteria occurred between 11 :40 to 11 :50pm, Sleep Start was 
calculated as 11 :40pm. Sleep was estimated to end when a ten minute consecutive period 
of activity, preceding the recorded 'Get up time' occurred. The 'Sleep End' variable was 
calculated as the time when this period began. For example, ifan individual got out of bed 
at 8:30am and a ten minute period of activity occurred between 8:20 to 8:30am, Sleep End 
was calculated as 8:20am. Finally, the recommended medium default sensitivity was used. 
The sensitivity setting refers to the use of activity scores by the sleep-wake scoring 
algorithm to estimate sleep and wake. 
The Actiwatch sleep analysis software (Cambridge Neurotechnology Ltd.) calculates a large 
number of variables. An example of the sleep variables calculated by the actiwatch 
software is provided in Appendix C. Time in bed was calculated from the Social Rhythm 
Metric daily getting up and going to bed times whilst the remaining sleep variables were 
calculated for each night of actiwatch monitoring. The sleep variables of interest to the 
present study were those identified in the literature as being disrupted in acute bipolar 
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episodes. Decreased sleep duration, decreased sleep efficiency and increased night waking 
time have been associated with both mania and depression (Hudson et aI, 1992; Leibenluft 
et aI, 1996; Serretti & Olgiati, 2005). Subsyndromal sleep disruption may also exist during 
inter-episode periods. A previous study by Millar et al (2004) reported the sleep of 
individuals with bipolar disorder during inter-episode periods differed from the sleep of 
individuals from the general population across measures of sleep duration, latency, 
efficiency and night waking time. Published means and standard deviations for sleep 
variables are available in Table 3.1. 
The sleep variables investigated in the present study were: 
• Time in bed: the difference between self-report bed-time and get up times. 
• Sleep duration: the total amount of sleep between sleep start and sleep end, minus night 
waking time. 
• Night waking time: the amount oftime spent awake between the recorded bed-time and 
get up time. 
• Sleep efficiency: the percentage of time spent asleep whilst in bed. Sleep efficiency at 
85% or less marks the criterion for disrupted sleep (Wicklow & Espie, 2000). 
• Sleep latency: the amount of time elapsed before sleep onset following bed-time. 
• Movement and Fragmentation index: the percentage of time spent moving during the 
estimated sleep period (sleep start to sleep end) plus the percentage of immobility phases 
of one minute, as a proportion of the number of immobile phases with no activity 
recorded. Higher scores on the movement and fragmentation index indicate more 
restlessness or sleep disruption. 
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Table 3.1: Actigraph published means and standard deviations for sleep variables 
Values are means (standard deviations), in minutes unless stated otherwise 
Study Time in Sleep Sleep Night Sleep 
bed latency duration waking efficiency (%) 
Mendlowicz et al (1999) 
N=32 general population 516 (84) 24 (11) 470 (72) 26 (16) 
-
Kushida et al (2001) 
-
N=100 sleep disorders 
-
414 (60) 
-
86 (7) 
Millar et al (2004) 
-
N=I9 bipolar I disorder, 20 (22) 434 (92) 59 (26) 83 (9) 
-
euthymic 
N=I9 general population 8 (7) 388 (53) 49 (18) 87 (4) 
In addition, weekly variables were calculated to provide the circadian rhythm of the rest-
activity cycle. Circadian rhythm disruption has been posited to underlie the precipitation of 
bipolar relapse (Ehlers et ai, 1988; Healy & Williams, 1988, 1989). Circadian rhythm 
disruption during mania and depression has been prospectively observed (Wehr et ai, 1980). 
Subsyndromal disruption of circadian rhythms may also exist during inter-episode periods; 
melatonin secretion disruption has been observed in individuals with euthymic bipolar 
disorder (N=29 euthymic bipolar disorder; Nurnberger et aI, 2000). Circadian rhythm 
disruption has been indicated to occur over several variables, measured by actigraphy, in 
Alzheimer's disease (Witting et aI, 1990; Van Someren et ai, 1999) and in seasonal affective 
disorder (Teicher et ai, 1997; Winkler et ai, 2005). For instance, disruption in the rest-
activity rhythm may be indicated by elevated activity levels during the night. An example 
ofthe variables calculated with the non-parametric circadian rhythm analysis is provided in 
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Appendix C. The variables investigated in the present study for the presence ofrest-
activity disruption in bipolar disorders were: 
• Interdaily stability (IS): indicates the strength or regularity of the rest-activity rhythm to 
environmental zeitgebers across time (Van Someren et ai, 1999). Interdaily stability 
was calculated as ''the ratio between the variance of the average 24-hour pattern around 
the mean and the overall variance" (Van Someren et aI, 1996, 1997). Interdaily 
stability measures the consistency of rest and activity between days. Higher day-to-day 
variability of activity is associated with decreased IS (Witting et aI, 1990). 
• Intradaily variability (IV): indicates the fragmentation of the rest-activity rhythm. 
Intradaily variability was calculated as ''the ratio of the mean squares of the difference 
between consecutive hours (first derivative) and the mean squares around the grand 
mean (overall variance)" (Van Someren et ai, 1996, 1997, 1999). Intradaily variability 
measures the consistency of waves of rest and activity across the day. Daytime naps or 
night-time restlessness may increase IV (Witting et aI, 1990). 
• Night time activity level (L5): calculated as ''the mean of the five hour period with the 
lowest activity level in the average 24-hour pattern" (Van Someren et ai, 1996). 
Higher scores represent more night time restlessness. 
• Onset time of night time activity level (L5 onset): the start time of the five hour period 
with the lowest activity level. 
• Day time activity level (M 1 0): calculated as ''the mean of the ten hour period with the 
highest activity level in the average day" (Van Someren et aI, 1996). Higher scores 
represent a more active lifestyle. 
• Onset time of day time activity level (M 1 0 onset): the start time of the ten hour period 
with the highest activity level. 
• Relative amplitude (RA): calculated as (MIO-LS) / (MIO + LS) (Van Someren et ai, 
1997, 1999). Relative amplitude represents the wave between day time and night time 
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activities. Higher scores indicate greater amplitude in the rest-activity rhythm (Witting 
et aI, 1990). 
Disturbance in the rest-activity rhythm may be suggested by interdaily stability, intradaily 
variability, night time activity level, and relative amplitude variables. Lower interdaily 
stability, lower relative amplitude, higher intradaily variability and higher night time activity 
levels may suggest rest-activity rhythm disturbance. In contrast, day time activity level 
shows the extent of day time activity with higher levels indicating a more active lifestyle. 
Day time activity level does not provide an indication of rhythm disturbance, since high day 
time activity levels could equally be due to actions such as pacing in individuals with 
Alzheimer's disease (Van Someren et aI, 1996) or having an active occupation where 
individuals are constantly walking (e.g. bar staff). The onset times of day time and night 
time activity levels were calculated to observe whether a rhythm disturbance was due to a 
phase delay/advance where rest and activity occur later/earlier in individuals with bipolar 
disorder. 
3.4.1.2 Reliability and validity ofactigraphy 
Actigraphy has been established as a reliable and valid method of assessing the rest-activity 
cycle. High agreement rates (88 to 93%) between actigraph measurements and PSG 
recordings of sleep-wake activity are evident (Cole et aI, 1992; Sadeh et aI, 1994, 1995; 
Kushida et aI, 2001). However, poor actigraph prediction of PSG-determined sleep-wake 
has been reported (Pollak et aI, 2001). One limitation ofactigraphy is overestimation of 
sleep in individuals who lie in bed quietly when awake; similarly sleep may be 
underestimated in individuals who are very restless when asleep (Cole et aI, 1992; American 
Sleep Disorders Association, 1995; Sadeh et aI, 1995; Blood et aI, 1997; Verbeek et aI, 
2001). Environmental factors may determine levels ofslcep and motor activity (Sadeh et 
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ai, 1995). Environmental factors which may disrupt sleep include: noise; temperature; 
sleep restriction; sleep setting; and psychological factors (e.g. anxiety). Factors such as 
externally induced movement (e.g. travelling in a train) and artefacts such as placing the 
wrist on the chest while sleeping can make sleep indistinguishable from wake with actigraph 
recording (Patterson et ai, 1993; Sadeh et ai, 1994). However, the factors involved in 
actiwatch over- or underestimation of sleep may be relatively consistent for a given 
individual (Verbeek et ai, 2001). Although the limitations outlined may reduce reliability 
and validity in some instances, actigraphy remains a useful assessment tool that is widely 
used to measure rest-activity cycles in both general population and clinical samples. 
Actigraphy has been successfully utilised with a wide range of clinical disorders in which 
circadian rhythm disturbances are apparent, such as sleep disorders, Alzheimer's disease, 
seasonal affective disorder and bipolar disorder (Teicher et ai, 1997; Van Someren et ai, 
1999; Kushida et ai, 200 I; Millar et ai, 2004). Actigraphy was selected as the more useful 
objective estimation of sleep and circadian rhythms for the current study. Actigraphy could 
be equally useful in both research and clinical settings, although the relative expense of an 
actiwatch and the necessary software may limit its applicability to clinical practice. 
3.4.2 Measures of behavioural activation 
Behavioural activation dysregulation has been posited to occur in bipolar disorder (Depue et 
aI, 1987). Behavioural activation dysregulation may be associated with variability in affect, 
but may also influence behaviour and self esteem. Biological measures (e.g. cortical 
activity; Harmon-Jones & Allen, 1997) and self-report measures have both been used to 
assess behavioural activation levels. Biological measurement of behavioural activation was 
considered impractical for monitoring individuals' in their normal environment from week to 
week. Accordingly, the current study monitored behavioural activation with a self-report 
92 
measure of this neurologically based emotion system. There are several self-report 
measures which have been designed to measure behavioural activation and inhibition (see 
Corr, 2001 for a discussion of measures). Consensus as to which scale is the optimal 
BISIBAS measure is not evident (Corr, 2001). Indeed, some measures only consider one 
system (e.g. BIS scale; MacAndrew & Steele, 1991). It was important for the current 
study to measure both behavioural activation and inhibition, particularly since recent 
postulation suggests facilitatory and antagonistic effects between the systems (Pickering et 
aI, 1999). The current research selected Carver and White's (1994) BISIBAS Scales for its 
brevity and ease of completion. Recent bipolar disorder studies have used the BIS/BAS 
Scales (Meyer et aI, 1999,2001). Furthermore, previous general population research (e.g. 
Gable et aI, 2000) had used the BISIBAS Scales with the affect measure selected for the 
current study (PANAS; Watson et aI, 1988b). These similarities in selection of measures 
may assist between study comparisons of findings. Therefore, the BIS/BAS Scales were 
selected as the most useful measure of behavioural activation and inhibition in the current 
study. 
3.4.2.1 Behavioural Inhibition System and Behavioural Activation Systems 
(BISIBAS) Scales (Carver & White, 1994) (Appendix D) 
The BISIBAS Scales assess an individual's dispositional sensitivities for the two 
motivational systems of behavioural activation and behavioural inhibition. The BISIBAS 
Scales comprises 20 items developed with a college sample (N=732), consisting of one 
behavioural inhibition system (BIS) subscale and three behavioural activation system (BAS) 
subscales. The seven item BIS subscale measures reactions to the anticipation of 
punishment (e.g. "I worry about making mistakes"), with a score range seven to 28. The 
three BAS subscales are Reward Responsiveness, Drive and Fun Seeking. The five item 
BAS Reward Responsiveness subscale measures positive responses to the occurrence or 
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anticipation of reward (e.g. "When I get something I want, I feel excited and energised"); 
score range five to 20. The four item BAS Drive subscale measures the persistent pursuit 
of desired goals (e.g. "I go out of my way to get things I want"); score range four to 16. 
The four item BAS Fun Seeking subscale measures the desire for new rewards and the 
willingness/impulsiveness to approach potentially rewarding events (e.g. "I'm always willing 
to try something new if I think it will be fun"); score range four to 16. Items were scored 
on a four point Likert scale with no neutral response: 4 = strong agreement; 3 = agreement; 
2 = disagreement; and 1 = strong disagreement. The score for two items phrased positively 
for the BIS subscale were reversed (items 5 and 7). Higher scores indicate higher BIS or 
BAS sensitivity. Reported means and standard deviations for the BISIBAS subscales are 
available for undergraduate, community and bipolar disorder samples (Table 3.2). 
Table 3.2: BISIBAS published means and standard deviations 
Values are means (standard deviations) 
Study BIS BAS Reward BAS 
Responsiveness Drive 
Carver & White (1994) 
N=732 undergraduates 20.0 (3.8) 17.6(2.1) 12.1 (2.4) 
Harmon-Jones & Allen 
(1997) 
N=37 undergraduates 22.1 (2.9) 17.9 (2.0) 12.2 (2.3) 
Meyer et al (1999) 
N=294 undergraduates, 20.6 (3.8) 17.6 (2.1) 11.6 (2.6) 
no mood disorder risk 
N=63 undergraduates, at 20.6 (4.6) 16.7 (3.2) 11.2 (3.2) 
risk for mood disorder 
BAS Fun 
Seeking 
12.4 (2.3) 
12.8 (2.2) 
12.2 (2.4) 
12.2 (2.9) 
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Study BIS BAS Reward BAS BAS Fun 
Responsiveness Drive Seeking 
Meyer et al (2001) 
N=59 Bipolar Disorder 23.0 (3.8) 16.9 (2.4) 11.8 (2.6) 11.6 (2.8) 
Kasch et al (2002) 
N=41 depression 24.0 (3.3) 14.9 (3.5) 9.2 (2.5) 10.7 (2.4) 
N=21 general population 20.0 (3.8) 17.7 (2.3) 11.9 (2.9) 12.6 (2.0) 
Beevers & Meyer (2002) 
N= 171 undergraduates 20.7 (3.8) 17.3 (2.4) 11.4 (2.5) 12.1 (2.5) 
3.4.2.2 Reliability and validity of the BISIBAS Scales 
The BISIBAS Scales have been indicated to be a reliable and valid measure of behavioural 
activation and inhibition. Administration of the BISIBAS Scales with a positive and 
negative affect questionnaire (PANAS, Watson et aI, 1988a; Section 3.4.5.1) has 
demonstrated convergent and discriminant validity (N=498 undergraduates; Study 2, Carver 
& White, 1994). Negative affect was related to the BIS scale, but not to any of the BAS 
subscales. Positive affect was related to the three BAS subscales, but not to the BIS scale. 
Convergent and discriminant validity of the BISIBAS Scales have also been demonstrated in 
further exploratory factor analysis studies (Heubeck et aI, 1998; Jorm et aI, 1999), and a 
conflfmatory factor analysis study across three countries (Leone et aI, 2001). Laboratory 
experiments by Carver and White (1994) have demonstrated BIS and BAS sensitivity. 
Higher BIS sensitivity was associated with higher levels of nervousness when punishment 
cues were introduced (Study 3, N=69 undergraduates). Higher BAS sensitivity (reward 
responsiveness and drive) was associated with higher levels of happiness when reward cues 
were introduced (Study 4, N=90 undergraduates). Significant positive correlations (r = 
0.30 to 0.44) between the BAS subscales have been consistently reported (Carver & White, 
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1994; Heubeck et ai, 1998; Leone et ai, 2001; Ross et ai, 2002). Some research studies, 
however, have also indicated significant positive correlations (r = 0.28 to 0.34) between the 
BIS and BAS Reward Responsiveness subscale (Heubeck et ai, 1998; Leone et ai, 2001; 
Ross et ai, 2002). 
Four-factor structure (one BIS scale and three BAS subscales) has been demonstrated in a 
large community sample (N=2725, Jorm et ai, 1999) and further student samples (N=336, 
Heubeck et aI, 1998; N=679, Leone et ai, 2001; N=476, Ross et ai, 2002). Two-factor 
structure (one BIS scale; one BAS scale) has been supported by research utilising principal 
component analysis (Jorm et aI, 1999) but not by studies utilising confirmatory factor 
analysis (Heubeck et aI, 1998; Leone et aI, 2001). Furthermore, structural equation 
modelling has indicated the BAS subscales are independent and should be considered as 
separate constructs (Ross et ai, 2002). Analyses of the three BAS subscales (but no BAS 
total score analysis) were conducted in the present study in light of these findings. 
Adequate reliability has been demonstrated for the BISIBAS Scales. The BlS scale has 
reported alpha reliabiIities of 0.73 to 0.85. The BAS Reward Responsiveness, Drive and 
Fun Seeking subscales have reported alpha reliabiIities ranging from 0.65 to 0.84 (Carver & 
White, 1994; Heubeck et aI, 1998; Jorm et ai, 1999; Meyer et aI, 1999,2001; Beevers & 
Meyer, 2002; Ross et aI, 2002). 
3.4.3 Measures of soda I rhythms 
Circadian rhythms comprise 24 hour daily cycles in human physiology and behaviour 
(Czeisler & Dijk, 2001). Social rhythms are daily behaviours that maintain the timing of 
circadian rhythms (Monk et aI, 1991). Social rhythms, such as mealtimes, can be self-
reported. The Social Rhythm Metric (SRM) was selected as a selfreport measure of social 
rhythms. The SRM was developed by Monk et al (1990) and has been used in several 
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studies by the same research group. Although a literature search did not identify any 
alternative self report measures of social rhythms, the SRM was selected as a useful 
measure of daily activities in bipolar disorder. In particular, an interpersonal and social 
rhythm therapy trial (e.g. Frank et aI, 1994, 1999) has shown the clinical usefulness ofSRM 
monitoring of social rhythms in bipolar disorder. 
3.4.3.1 Social Rhythm Metric (SRM) (Monk et ai, 1990, 1991) (Appendix E) 
The SRM measures the regularity of an individual's social rhythms by recording the timing 
of daily events. The SRM consists of 17 daily activities of which 15 are specified (get out 
of bed; frrst contact with another person; have morning beverage; have breakfast; go outside 
for the frrst time; start work, school, housework, volunteer activities, child or family care; 
have lunch; take an afternoon nap; have dinner; physical exercise; have an evening 
snack/drink; watch evening TV news program; watch another TV program; return home for 
last time; and go to bed). Two activities are idiosyncratic (Activity A, Activity B) to that 
individual so that they can select activities which they engage in on most days of the week. 
Typical examples included walking a dog, reading, and having a bath. The SRM requires 
the individual to record the time at which an activity occurs and the number ofpeop\e 
present. 
The SRM yields several variables calculated with an outlier elimination algorithm provided 
by Monk et al (1991) (Appendix E: Algorithm for calculating scores on the Social Rhythm 
Metric). Data for each week were analysed to give a weekly score of social rhythms. The 
algorithm calculated a habitual time for each activity for each week. In the example 
provided (Appendix E), the habitual 'Get out of bed' time calculated from non-outlier data 
(Le. excluding the 5:30am early start) was 8:07am. An activity regularity score counted the 
number of , hit' times for an activity, which occurred within 45 minutes of the habitual time. 
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The activity regularity score is from zero (least regular) to seven (most regular). The 
regularity score for the 'Get out of bed' example was five. Two times (9:30am and 
5:30am) were excluded since they occurred more than 45 minutes outwith the habitual 'Get 
up time' for that week. Habitual times and regularity scores are not calculated for activities 
with less than three occurrences in a given week. The SRM regularity score provides an 
indicator ofthe level of regularity in the timing of all activities over the week. The SRM 
regularity score is calculated by totalling all the activity regularity scores and then dividing 
by the number of activities that occurred at least three times over the week. The SRM 
regularity score range is from zero to seven, with higher scores indicating higher regularity 
of social rhythms. 
In addition to measuring the regularity of activities, the SRM provides a measure ofthe 
number of activities that occur. An Activity Level Index (ALI) was calculated by totalling 
all activities that occur over the week. The ALI maximum score is 119 (17 activities 
multiplied by seven days). Similar to Ashman et al (1999), a Daily Activity Level Index 
(DALI) was calculated, which provided a total number of activities completed on a given 
day, with a DALI maximum score of 17. Table 3.3 provides ALI and SRM regularity 
scores for general population and mood disorder samples. 
The SRM measures the volume and extent of social interaction. A pilot of the monitoring 
package indicated participants found describing the extent of social interaction to be 
difficult and onerous (interaction categories were: people just present; people actively 
involved; other people very stimulating). The SRM was modified to only record the 
number of people present during each activity. Dividing the total number of activities done 
alone by the total number of all activities performed for that week provided a solitude ratio. 
The solitude ratio has a score range from zero to one, with scores closer to one indicating 
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higher levels of solitude. Although collected for the present study, social interaction 
fmdings will not be reported. 
Table 3.3: SRM published means and standard deviations 
Values are means (standard deviations) • Based on previous samples 
Study Regularity score Activity level index 
Monk et al (1990) 
N=50 general population 3.S5 (0.93) 
-
Monk et al (1991) 
N=IS general population 3.40(0.81) 82.60 (6.50) 
N=20 unipolar depression 3.45 (0.48) 80.20 (6.35) 
Szuba et al (1992) 
N=19 general population 3.9 (0.49) 
-
N=19 unipolar or bipolar depression 3.5 (0.49) 
-
Monk et al (1994) 
N=96 general population 3.43 (0.82) 83.1 (8.4) 
Ashman et al (1999) 
N=9 general population 3.84 (0.85) 94.00 (8.19) 
N=9 rapid cycling disorder 2.67 (0.54) 80.18 (7.57) 
Monk et al (2002) 
N=293 general population· 3.90 (0.83) 
-
3.4.3.2 Reliability and validity of the SRM 
The SRM was developed with a general population sample with good test-retest reliability 
across two week (r=0.44, N=49, p<O.OOI; Monk et ai, 1990) and mean 22 month (r=0.479, 
N=39, p<0.002; Study 2, Monk et ai, 1994) follow up periods. The validity of 
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retrospective SRM completion at the end of each day, compared to concurrent completion, 
has been established (Monk et aI, 1990). Fifty per cent of Monk et aI's (1990) sample 
completed the SRM retrospectively at the end of each day, whilst the other 25 participants 
completed the SRM concurrently, when an activity occurred. No significant differences 
between SRM regularity scores for retrospective and concurrent completion were observed 
over a two week period (retrospective SRM mean 3.42, standard deviation 0.98; concurrent 
SRM mean 3.60, standard deviation 0.83, t<I). Validity has also been supported by similar 
SRM-based and actigraph-based bed-time and get out of bed time estimates (Monk et aI, 
1994). The feasibility of daily SRM monitoring has been indicated in individuals with 
mood disorders as well as individuals from the general population (Monk et ai, 1991; Szuba 
et aI, 1992; Brown et aI, 1996; Ashman et aI, 1999). In particular, the SRM has been 
successfully used as a self-report measure of the social rhythms of individuals with bipolar 
disorder over long monitoring periods (N=9 rapid cycling bipolar disorder monitored for a 
mean 95 days; Ashman et aI, 1999). Thus, the SRM has been indicated to be a reliable and 
valid prospective measure of daily social rhythms in both general population and mood 
disorder samples. 
3.4.4 Measures of self esteem 
The DSM-IV diagnostic criteria for depressive and manic/hypomanic episodes include 
changes in self esteem. Feelings of worthlessness may be present in depression whilst 
inflated self esteem may be evident in mania (DSM-IV diagnostic criteria for depression and 
mania are available in Tables 1.1 & 1.2). Therefore, if self esteem is recognised to fluctuate 
between episodes of depression and mania, it is possible that subsyndromal variation in self 
esteem may also be evident during inter-episode periods. Furthermore, cognitive theories 
of depression postulate a negative view of the self is a distinctive characteristic ofafTective 
disorder (Beck, 1987). In order to examine this research question, the Rosenberg Self 
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Esteem Questionnaire (RSEQ) was selected as the self esteem (SE) measure. Although 
there are a variety of self report SE measures, the RSEQ is the most widely used measure. 
In particular, the RSEQ has been used previously for the prospective measurement of daily 
SE variability (e.g. Kernis et ai, 1991; Roberts & Gotlib, 1997). Use of the same measure 
enables across-study comparison without potential measurement confounding factors. 
Strengths ofthe RSEQ include its brevity and scaled response format for ease of 
completion. Previous studies with clinical samples have also indicated that individuals with 
bipolar disorder are willing to complete the RSEQ (e.g. Serretti et ai, 2005). 
3.4.4.1 Rosenberg Self Esteem Questionnaire (RSEQ) (Rosenberg, 1965) (Appendix F) 
The RSEQ is a ten item selfreport questionnaire, with five positively worded (e.g. On the 
whole I am satisfied with myself) and five negatively worded (e.g. At times, I think I am no 
good at all) items to measure positive and negative self esteem. The total score for both 
subscales provides a measure of global self esteem. Positively and negatively worded items 
were listed alternatively to reduce the effect of respondent set (Rosenberg, 1965). The 
RSEQ Likert scale has ranged from four to ten points in previous research. A four point 
Likert scale RSEQ has tended to be used in cross-sectional studies where SE level is the 
variable of interest. Studies investigating SE variability have used seven or ten point Likert 
scales for the RSEQ (e.g. Kernis et ai, 1991; Roberts & Gotlib, 1997). The current study 
selected a seven point Likert scale for the RSEQ (1 = strongly agree; 2 = agree; 3 = agree 
slightly; 4 = neutral; 5 = disagree slightly; 6 = disagree; 7 = strongly disagree). Participants 
rated each item for the 'present moment.' The scores for positively phrased items were 
reversed (statements 1,3,4,7, 10). Positive and negative self esteem subtotals were 
calculated, with a score range from five to 35 for each subscale. A RSEQ total score was 
calculated by adding the negative self esteem subtotal and the positive self esteem subtotal, 
with a score range from ten to 70. High scores indicate high self esteem. Means and 
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standard deviations for a seven point Likert scale RSEQ are available for undergraduate and 
bipolar disorder samples (Table 3.4). 
Table 3.4: RSEQ published means and standard deviations 
Values are means (standard deviations) 
Study N Participants 
Roberts et al (1995; Study 3) 95 U ndergrad uates 
Roberts & Gotlib (1997) 92 Undergraduates 
Johnson et al (2000b) 29 Bipolar J Disorder 
3.4.4.2 Reliability and validity of the RSEQ 
Self esteem 
52.9 (9.2) 
55.6 (9.4) 
44.1 (16.4) 
The RSEQ has a reported alpha reliability of 0.77 for Rosenberg's (1965) New York 
sample (Wylie, 1989). Alpha reliabilities for the RSEQ rated on a seven point Likert scale 
have been reported as 0.82-0.92 (Roberts & Gotlib, 1997) and 0.94 (Johnson et aI, 2000b). 
The RSEQ has been reported to have high convergent validity with psychiatrist's SE ratings 
for an individual and other self-report SE questionnaires; high discriminant validity has also 
been demonstrated between SE and SE stability (Rosenberg, 1979). Content overlap 
across measures of self esteem and depression may exist. Indeed, the RSEQ has been 
observed to correlate with depressive symptoms (e.g. Kernis et aI, 1998), which may 
suggest that the RSEQ could be considered as a proxy measure of mood. However, the 
RSEQ has been widely used as a measure of self esteem with bipolar disorder samples 
across inter-episode and acute episodes (e.g. Serretti et ai, 1999, 2005; Shapira et aI, 1999; 
Scott & Pope, 2003; Blairy et ai, 2004) and the clinical importance of variability rather than 
level per se was the main focus ofthe current investigation. The RSEQ was originally 
scored using a Guttman scale, where the ten RSEQ items are categorised into six scales. A 
positive score is given for answers indicating positive self esteem and the score range is 
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from zero to six (Rosenberg, 1965; Rosenberg's Appendix D provides more information on 
the RSEQ's Guttman scale scoring). The RSEQ has a reported coefficient of 
reproducibility of92% and a coefficient of scalability of72% using a Guttman scale 
(N=5024; Rosenberg, 1965). The RSEQ has been scored according to the Likert method 
with a large general popUlation sample (N=2300; Rosenberg, 1979) and yields similar 
results compared to the Guttman procedure. The Likert scale RSEQ is more typically 
administered. 
3.4.5 Measures of affect 
Bipolar disorder is characterised by episodes of mania and depression, although 
subsyndromal symptoms in inter-episode periods occurs in approximately 50% of 
individuals with this disorder (Keller et aI, 1992; Gitlin et aI, 1995). Jackson et aI's (2003) 
systematic review reported individuals identified mood change as an early symptom of 
relapse for bipolar depression (median 48%) and mania (median 43%). Day-to-day 
changes in mood may not necessarily be perceived simply as elation or depression. 
Therefore, a general measure of affect was also selected. Self-report ratings of elation and 
depression were used in combination with Watson et aI's (I 988b) Positive And Negative 
Affect Schedule (PANAS). Although there were several measures of affect available, the 
PANAS was selected as the most useful prospective measure of affect. The PANAS is a 
widely used questionnaire for measuring positive and negative affect and has been used in 
previous investigations (e.g. Roberts & Gotlib, 1997) to measure daily variability in affect. 
Thus, levels and variability of the PANAS subscales are available from previous research for 
study comparison. The PANAS has a scaled response format for ease and speed of 
completion. 
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3.4.5.1 Positive And Negative Affect Schedule (PANAS) (Watson et aI, 1988b) 
(Appendix G) 
The PANAS measures current mood state. The PANAS comprises two scales, consisting 
often items for each scale which measure positive and negative affect. Positive affect 
items were: interested; excited; strong; enthusiastic; proud; alert; inspired; determined; 
attentive; and active. Negative affect items were: distressed; upset; guilty; scared; hostile; 
irritable; ashamed; nervous; jittery; and afraid. Items were rated on a five point Likert scale 
to indicate the extent to which the individual 'has felt this way today' to measure affect 
fluctuations. The scale choices included: 1 = very slightly or not at all; 2 = a little; 3 = 
moderately; 4 = quite a bit; and 5 = extremely. High scores indicate high levels of affect. 
The score range is from ten to 50 for the positive and negative affect subscales. The 
PANAS has been used as a prospective measure of daily affect in general population and 
subsyndromal mood disorder samples (Table 3.5). 
Two additional items were included in the PANAS list to measure current mood state 
relevant to bipolar disorder: 'elated' and 'depressed.' The score range was from one to 
five for the elated and depressed affect items. It was deemed appropriate to include these 
items in the PANAS since other studies have used 'elated' as a measure of positive affect 
(Larsen & Ketelaar, 1991) and 'depressed' as a measure of negative affect (Van Eck et ai, 
1998). Elated and depressed items were scored as separate subtotals from the positive and 
negative affect subscales of the PANAS. Co-efficient alpha values for the positive and 
negative affect subscales were not affected by this modification of the PANAS. The alpha 
values observed in the current study for positive and negative affect subscales were 0.93 
and 0.96, which were similar to previous research (e.g. Watson et aI, 1988b; Roberts & 
Gamble,2001). Further, reliability analyses of 11 item subscales (positive affect and elated; 
negative affect and depressed) observed the same alpha values as for the 10 item analyses. 
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Therefore, the addition of elated and depressed items did not impact the internal consistency 
of the PANAS. 
3.4.5.2 Reliability and validity of the PANAS 
The PANAS was developed with large general population samples, using different time 
instructions for participants to rate how they felt: present moment (N=660); today (N=657); 
past few days (N=1002); past few weeks (N=586); past year (N=649); and in general 
(N=663) (Watson et ai, 1988b). The PANAS has been reported to be internally consistent, 
reliable and valid in the measurement of positive and negative affect (Watson et ai, 1988b). 
Watson et al (1988b) reported low PA-NA inter-correlations (r = -0.12 to -0.23) across 
different time frames. Test-retest reliability was reported to increase as the time frame 
lengthened from moment to general time instructions. Reported alpha reliabilities for the 
PANAS range from 0.89-0.90 for moment/today PA and from 0.80-0.87 for moment/today 
NA (Watson et ai, 1988b; Roberts & Gamble, 2001). 
Table 3.5: PANAS published means and standard deviations 
Values are means (standard deviations) 
Study Time Positive affect 
instructions 
Watson et al (1988b) 
Undergraduate & general 
population samples 
N=660 Moment 29.7 (7.9) 
N=657 Today 29.1 (8.3) 
Negative affect 
14.8 (5.4) 
16.3 (6.4) 
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Study Time Positive affect Negative affect 
instructions 
Lovejoy & Steuerwald (1995) 
N=19 undergraduates Today 24.2 (8.2) 14.3 (3.4) 
N= 16, intermittent depressive 21.7 (4.8) 19.4 (3.6) 
disorder 
N=12, cyclothymia 28.1 (3.1) 19.0 (4.0) 
Roberts & Gotlib (1997) 
N=92 undergraduates Moment 27.5 (7.3) 16.1 (4.9) 
Scott-Killgore (2000) 
N=302 undergraduates Moment 26.6 (8.6) 17.5 (7.2) 
Roberts & Gamble (2001) 
N=110 adolescents Moment 26.8 (9.6) 14.5 (5.1) 
Hopko et al (2003) 
N=14 mildly depressed Today 27.1 (5.5) 18.7 (4.4) 
N=23 undergraduates 32.7 (3.7) 15.8(4.4) 
3.4.6 Monitoring package selected for present study 
In summary, five measures were selected to monitor variability in bipolar disorders. 
Actigraphy objectively estimated biological variability of the sleep-wake cycle. Daily 
variability in social rhythms, self esteem and affect were assessed with self-report 
questionnaires: Social Rhythm Metric (SRM), Rosenberg Self Esteem Questionnaire 
(RSEQ), and the Positive And Negative Affect Schedule (PANAS), with additional 
'Depressed' and 'Elated' ratings included. The Behavioural Inhibition System and 
Behavioural Activation Systems (BISIBAS) Scales were rated once per week and provided 
a self report measure of behavioural activation. The characteristics of the self-report 
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questionnaires are outlined below (Table 3.6). An example print-out ofactigraph 
monitoring and copies of the four self-report measures are available in Appendices C to O. 
High internal consistency for the RSEQ, PANAS and BISIBAS Scales were demonstrated 
by the present study. 
Table 3.6: Characteristics ofself-report questionnaires 
Measure No. of Scale Score Co-efficient alpha 
items range for present study 
SRM 17 Time of 
-
Regularity score day 0-7 
-
Activity Level Index (ALI) 0-119 
-
Daily Activity Level Index (DALI) 0-17 
-
RSEQ 10 7-point 10-70 0.96 
Positive RSEQ subscale 5 5-35 
Negative RSEQ subscale 5 5-35 
PANAS 20 5-point -
PA subscale 10 10-50 0.93 
NA subscale 10 10-50 0.96 
'Depressed' mood rating 1 1-5 
-
'Elated' mood rating 1 1-5 
-
BIS/BAS Scales 20 4-point 
-
BIS subscale 7 7-28 0.85 
BAS subscales: 
Reward Responsiveness 5 5-20 0.88 
Drive 4 4-16 0.91 
Fun Seeking 4 4-16 0.67 
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3.5 Statistical Analysis 
Data were analysed using the Statistical Package for Social Sciences (SPSS version 9.0). 
Sleep variables were calculated with the actiwatch sleep analysis software (version 3.31), 
and then entered into SPSS for analysis. An overview of the data was conducted prior to 
statistical analyses. This overview included checking for any inconsistencies in the data, 
such as incorrectly entered values, which were corrected prior to analyses. Investigation of 
the extent of missing data was also conducted to inform the strategy for dealing with 
missing data. This strategy will be discussed next. 
3.5.1 Missing data strategy 
A disadvantage of longitudinal data collection is the increased likelihood of missing data. 
In the present study, missing data occurred from participants not completing all assessment 
items, removing the actigraphy-measuring device, and from participants dropping out ofthe 
study. List-wise deletion was applied to missing values that occurred when a participant 
did not complete a questionnaire or removed the actigraphy-measuring device over the 
monitoring period (see Streiner, 2002 for a discussion of missing data strategies). Since 
the analysis of data which excludes missing data may compromise the validity of results 
(Streiner, 2002), strategies to replace missing data were considered. For instance, Butler et 
al (1994) substituted missing data with the mean of the participant's score on the two 
adjacent days, although no more than two consecutive days of missing data in a series were 
allowed. However, most missing data for the current study were evident for bipolar 
disorder participants who were unwilling to complete some of the questionnaires daily. For 
example, some participants reported daily completion of the self esteem questionnaire was 
too distressing. It was concluded that replacing missing data in these instances would be 
misleading, as the main focus of the research was to investigate day-to-day variability. 
These participants continued to be monitored since at least one questionnaire was being 
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completed daily. Consequently, numbers varied between analyses as data were excluded 
list-wise. 
Questionnaire totals for the SRM, RSEQ, PANAS and BISIBAS were calculated by SPSS 
inputted formula. A questionnaire total was allocated a missing value if any item in the 
formula was missing (e.g. ifPA item 'interested' was missing for a specific day, the PA 
subtotal for that day would also be entered as a missing value. Questionnaire totals may 
mislead when questionnaire items are missing, leading to lower scores than would otherwise 
occur. Similarly, a weekly Activity Level Index (ALI) was recorded as a missing value, if 
any of the seven daily SRM questionnaires were not completed. 
Missing data also occurred when participants removed the actiwatch during the continuous 
monitoring period. For instance, a participant may have removed the actiwatch to have a 
bath in the evening, but then failed to replace the device on the wrist until the following 
morning. Participants recorded occasions when the actiwatch was not worn. In addition, 
visual inspection ofactigraph data identified missing data where no activity was recorded 
over prolonged time periods. Sleep variables were not calculated for nights when the 
actiwatch was not worn, with the exception of the time in bed variable which was provided 
by the SRM. Circadian rhythm variables were calculated from seven day consecutive 
actigraph monitoring periods. This seven day analysis period was shortened on occasions 
when the actiwatch had been removed (Section 4.2 provides more information on missing 
questionnaire and actigraph data in the current study). 
3.5.2 Computation of group mean and variability levels 
The mean level for each measure was calculated as the mean score for each participant 
across a 14 day monitoring period. Participants had completed varying monitoring periods 
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(bipolar disorder participants monitored for median 8 weeks, general population participants 
monitored for median 2 weeks). One possible limitation of aggregating data over different 
monitoring periods is that bipolar disorder participants may exhibit greater variability due to 
a longer monitoring period. Thus the first 14 day period when a participant completed the 
self-report questionnaires and underwent actigraph monitoring was selected. Groups' 
means and standard deviations were based on the mean of these individual scores; this 
method is an accepted way of obtaining group means from participants repeated measures 
(Bolger et aI, 2003). Indeed, aggregation of data measured repeatedly has been indicated 
to improve temporal reliability and may provide a stable level for a given variable (Epstein, 
1984). Similar methods for calculating group means from individual participants' means 
for the SRM, RSEQ and PANAS have been described in previous research using 
prospective daily monitoring (e.g. Lovejoy & Steuerwald, 1995; Kernis et aI, 1997; Monk 
et aI, 1997; Roberts & Gotlib, 1997). Variability in each measure was computed as within-
participant standard deviation scores across a 14 day monitoring period. This method was 
also consistent with previous research (e.g. Kernis et aI, 1997; Roberts & Gotlib, 1997; 
Gruber et aI, 2000). Variability for the group was computed as the mean of these standard 
deviations. 
3.5.3 Skewness and kurtosis of group mean and variability levels 
The distribution of mean and variability scores for participants was examined by calculating 
skewness and kurtosis for each variable. The signifIcance of skewness and kurtosis values 
was ascertained by calculating z scores. A skewness z score was calculated by dividing the 
skewness value by the standard error for skewness. Similarly, dividing the kurtosis value 
by the standard error for kurtosis provided a kurtosis z score. Skewness and kurtosis z 
scores outwith ± 1.96 indicate with 95% confidence that the distribution is not normal (Kerr 
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et aI, 2002). The findings from examination of the assumptions of a normal distribution for 
the participant sample are available in Section 4.9.2 and in Appendix I. 
3.5.4 Effect size, type I and type II errors and statistical power 
Effect size was calculated to indicate the extent of the difference between group mean and 
variability scores. This provides a useful method of interpreting any statistically significant 
differences between groups. Cohen's d (Cohen, 1988) was computed for the effect size of 
each dependent variable between-group comparison. The effect size measured the 
difference between the two participant group means (bipolar disorder group mean minus 
general population group mean), divided by the sample standard deviation. A d value of 
0.8 or greater is considered a large effect size (Cohen, 1988). 
Although the experimental hypothesis that greater variability in biological, behaviour, self 
esteem and affect measures would be evident in bipolar disorder compared to the general 
population could either be true or false, there were four possible interpretations of the 
results. These four interpretations are displayed in Figure 3.3. Two possible errors may 
occur when interpreting research findings: retaining the experimental hypothesis when it is 
false (Type I error) or rejecting the experimental hypothesis when it is true (Type II error). 
Consideration was given to minimise the risk of committing a type I or type II error in 
interpreting the research findings. Alpha (a) is the probability of a type I error occurring, 
and can only occur when the null hypothesis, no difference between groups, is true (Norman 
& Streiner, 2000; King & Minium, 2003). A 5% significance level (p<0.05) was selected 
for the current study, which is the usual level of alpha selected. This alpha level means 
there was a 5% chance that the present study would conclude that there a significant 
difference between groups, where no differences actually exist in the population. Beta (~) 
is the probability of a type II error occurring, and can only occur when the null hypothesis, 
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no difference between groups, is false (Norman & Streiner, 2000; King & Minium, 2003). 
Beta is the chance that the present study would conclude there was no difference between 
groups, when a difference did actually exist in the population. The likelihood that the 
present study committed a type I or type II error in interpretation of the research findings is 
discussed in Section 5.6. 
Figure 3.3: Four interpretations of a research hypothesis 
Experimental hypothesis 
Hypothesis is true Hypothesis is false 
Research Retain hypothesis True positive False positive 
decision (Type I error) 
Reject hypothesis False negative True negative 
(Type II error) 
Statistical power is the probability of concluding there was a significant difference between 
groups when a difference exists in the population (Norman & Streiner, 2000; King & 
Minium, 2003). Power is calculated by subtracting beta from one (power = 1-~). 
Therefore, a reduction of beta would increase statistical power and vice versa. The 
recommended 80% minimum level of statistical power was selected (Cohen, 1988) as the 
desired level of power. Accordingly, the current study would have had a 20% (~=0.20) 
chance of concluding there was no difference between groups, when a difference occurs in 
the population, if80% statistical power was achieved. A prospective power calculation to 
determine the required sample size for 80% power and alpha level 0.05 was not conducted 
as the current study was exploratory in nature. Furthermore, at the start of data collection, 
little published evidence on the variability of distribution and effect size for selected 
measures in bipolar disorder samples was available, which limited the ability to make a 
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realistic estimation of the required group sample size to detect differences between bipolar 
disorder and general population samples. The actual statistical power obtained for the 
current study compared to the required power of80% will be discussed in Section 5.6. 
3.5.5 Parametric comparisons between the bipolar disorder and general population 
groups 
Between-group analyses of participant mean scores for the level and variability of each 
measure were conducted between bipolar disorder and general population groups. The 
present study had one independent variable (participant group) and multiple dependent 
variables for biological, behaviour, self esteem and affect measures. Consideration was 
given to the selection ofthe appropriate analyses to investigate differences in the mean level 
and variability of measures between the bipolar disorder and general population groups. 
3.5.5.1 Parametric analyses rejected by current study 
Two parametric tests were considered before being rejected as inappropriate for the current 
study: an independent t test and a repeated measures analysis of variance (ANOVA). The t 
test is a relatively simple parametric analysis of differences between group means. 
However, since several dependent variables were being investigated, this analysis was 
considered unsuitable as the risk ofa Type I error is increased with multiple t tests (Cohen, 
2001; Kerr et aI, 2002). Repeated measures analysis of variance was the second type of 
analysis considered. However, a repeated measure ANOV A has limited applicability to 
time series that are the same length across participants, which do not include missing data 
and that hold to the compound symmetry assumption (Gibbons et aI, 1993; Collins & Sayer, 
2000). It was decided not to replace missing data in the present study (Section 3.5.1 
provides more information). Compound symmetry assumes that variances between data 
points across the time series are homogeneous. Compound symmetry may be more likely 
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with longitudinal data with large time intervals between measurements. However, it is 
likely that measures collected one day will be more correlated to measures collected on the 
next day, than to measures collected several days later. Thus, it was decided repeated 
measures analysis of variance was not suitable for analysing the data for the present study. 
3.5.5.2 Multivariate analysis of variance 
The third parametric analysis considered was multivariate analysis of variance (MANOVA). 
Multivariate analysis of variance can be used when two or more dependent variables are 
being analysed (Bryman & Cramer, 1997; Norman & Streiner, 2000). Multivariate analysis 
of variance investigates whether the mean level of several dependent variables differs 
between groups (Tabachnick & Fidell, 200 I). Although MANOV A can also be limited by 
missing data and varying time series across participants, it is suitable to analyse data when 
the compound symmetry assumption does not hold. Participant mean and variability levels 
for each variable were computed, and this removed the problem of missing data. Further, 
each participant now had a mean and variability score for each variable, which also removed 
the limitation of varying time series (Section 3.5.7 provides dctails of the time serics 
analyses conducted for each participant). It was therefore decided for the present study 
that MAN OVA analyses of mean and variability levels for biological, behaviour, self esteem 
and affect measures would be most appropriate for the between group analyses. 
Variables were conceptually grouped with correlations between variables hypothesised to be 
higher within each grouping. Multivariate analyses ofvariance to investigate group 
differences in the level or variability of measures were conducted to control for multiple 
comparisons. Multivariate analyses of variance (MANOVA) were conducted for the 
following measures: 
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• Mean scores of sleep variables (time in bed, sleep duration, night waking time, sleep 
efficiency, sleep latency, fragmentation index) 
• Day-to-day variability of sleep variables (time in bed, sleep duration, night waking time, 
sleep efficiency, sleep latency, fragmentation index) 
• Mean scores of social and circadian rhythm variables (social rhythm regularity, daily 
activity level index, night time activity level, day time activity level, relative amplitude, 
interdaily stability, intradaily variability) 
• Week-to-week variability of social and circadian rhythm variables (social rhythm 
regularity, daily activity level index, night time activity level, day time activity level, 
relative amplitude, interdaily stability, intradaily variability) 
• Mean scores of behavioural inhibition and activation (BIS, BAS reward responsiveness, 
BAS drive, BAS fun seeking) 
• Week-to-week variability of behavioural inhibition and activation (BIS, BAS reward 
responsiveness, BAS drive, BAS fun seeking) 
• Mean scores of self esteem and affect variables (self esteem, positive affect, negative 
affect, elated, depressed) 
• Day-to-day variability of self esteem and affect variables (self esteem, positive affect, 
negative affect, elated, depressed) 
• Mean scores and day-to-day variability of positive and negative self esteem subscales 
Although participants with bipolar disorder had completed varying lengths of prospective 
monitoring, both bipolar disorder and general population participants had their mean level 
and variability of measures calculated from a 14 day monitoring period. Ifdata were 
aggregated over longer monitoring periods for bipolar disorder participants, it could be 
argued that greater variability was merely an artefact of the longer time frame. Therefore, 
comparison of 14 day monitoring periods for bipolar disorder and general population 
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participants was considered a conservative investigation of group differences in variability. 
However, it was also possible that a longer prospective monitoring period would be 
necessary to obtain an accurate estimation of the mean level and variability of measures in 
bipolar disorder. To illustrate, previous studies have reported seven weeks of monitoring 
was required to identify social rhythm 'traits' in mood disorder samples although two weeks 
monitoring was adequate for general population samples. Consequently, MANOY A group 
comparisons were repeated using the full prospective monitoring period for each participant 
with bipolar disorder. 
3.5.5.3 Homogeneity tests for multivariate analyses 
Two tests for homogeneity were conducted with each MANDY A. Firstly, homogeneity of 
variance was examined with Box's M statistic. This homogeneity test examines the 
equivalence of the covariance matrices of the dependent variables across the groups. 
Tabachnick and Fidell's (2001) succinct guidelines for interpretation of Box's M suggest 
significance tests are robust to any deviations from homogeneity when sample sizes are 
equal and p associated with M is greater than 0.001. Secondly, Levene's homogeneity 
tests were conducted. Levene's tests are univariate analyses that examine the error 
variance of the dependent variables across the groups. If the p value associated with 
Levene's test is less than 0.05, the homogeneity of variance assumption is not met (Cohen, 
2001). An advantage of Levene's test is that it remains robust even when the assumption 
ofa normal distribution is not met (Petrie & Sabin, 2000). If the assumptions of the 
homogeneity tests are not met, the univariate analyses should be used instead of the 
multivariate analysis to indicate significance (Norman & Streiner, 2000). Whilst analysis of 
variance is relatively robust to departures from the normal distribution and to unequal 
sample sizes, it is not robust to unequal variances (Petrie & Sabin, 2000; Cohen, 2001). 
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3.5.5.4 Holm method for correction of alpha level 
Since univariate analyses involved mUltiple comparisons between the groups, it may be 
considered necessary to correct the alpha level. For instance, a multivariate analysis of six 
variables would produce six univariate comparisons between groups. Ifalpha was set at 
p<0.05, then six comparisons would increase the possibility of obtaining a significant result 
to approximately p<0.30. Therefore, there may be some risk of committing a Type I error 
in the current study if significant fmdings were not interpreted with consideration of the 
number of comparisons conducted. Thus, it was decided to correct the alpha level for the 
number of univariate comparisons conducted following each multivariate analysis. 
A typical post hoc comparison is the Bonferroni correction, where alpha (p<0.05) is divided 
by the number of comparisons. The Bonfcrroni correction is a conservative method to 
correct for multiple comparisons. However, this method was not selected for the present 
study as the Bonferroni correction may be considered as overly stringent (Norman & 
Streiner,2000). Instead, Holm's (1979) modification of the Bonferroni correction was 
applied to univariate analyses. The Holm method orders the probabilities obtained from 
smallest to largest; the smallest probability is then compared to alpha 0.05 divided by the 
number of comparisons. If the probability for that dependent variable is significant, the 
next smallest probability is compared to alpha 0.05 divided by the number of comparison 
minus one, and so on (Further description of the Holm method is available in Norman & 
Streiner, 2000). The Holm method to correct the alpha level was subsequently applied to 
univariate analyses to indicate which differences between bipolar disorder and general 
population groups remained when this more conservative alpha criteria was applied. 
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3.5.6 Non-parametric comparisons between the bipolar disorder and general 
population groups 
Although between group differences were initially investigated with parametric analyses, 
non-parametric comparisons were also utilised. Since parametric analyses are based on 
certain underlying assumptions regarding the parameters of the normal distribution, any 
violation of these assumptions impacts on the robustness ofthe analyses. The parametric 
homogeneity of variance assumption has already been outlined in Section 3.5.5.3. The 
normal distribution assumption was investigated by examination of the skewness and 
kurtosis for each dependent variable to ascertain whether the sample scores did approximate 
the normal distribution. A skewness or kurtosis score outwith ± 1.96 would indicate with 
95% confidence that the distribution was not normal (Kerr et ai, 2002). Non-parametric 
analyses may be more robust and powerful than parametric analyses when normal 
distribution assumptions are violated (King & Minium, 2003). Skewness and kurtosis 
scores for the dependent variables are provided in Appendix I. Therefore, when parametric 
assumptions of normally distributed data and homogeneity of variance were not met. non-
parametric analyses were selected as the preferred inferential test. The Mann-Whitney U 
test was selected as the non-parametric analysis to investigate between group differences in 
the mean level and variability of measures. Variables were retained in the same conceptual 
groups that they had been allocated for parametric analyses. Holm's correction was 
applied to the alpha level to control for multiple comparisons; significance was set at 
p<0.05. 
3.5.7 Time series analyses in bipolar disorder 
Data collected for the study was suitable for time series analyses since equal temporal 
spacing of measures had occurred (West & Hepworth, 1991; West et al. 2000). Time 
series analyses were conducted to investigate daily variability for participants with bipolar 
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disorder. Aggregation of data masks any order effects that may be present within a time 
series (Epstein, 1984). Furthermore, variability calculated as within-participant standard 
deviation scores provides average variability, but not any indication of the frequency of 
change (Larsen, 1987). Further investigation of the measures found to differ between the 
general population and bipolar disorder groups were thus subjected to time series analyses. 
Time series models provide estimates in either the time domain or frequency domain 
(Larsen, 1990; Shumway & Stoffer, 2000). The time domain approach models future 
values on current and past values and tends to be utilised as a forecasting tool (Shumway & 
Stoffer, 2000). The present study utilised the frequency domain approach since variability 
was the primary focus. Periodic or systematic variation was investigated. The time series 
for each measure was collapsed to remove days with missing data as time series analyses are 
unable to process missing data. Missing values were not replaced for reasons outlined in 
Section 3.5.1. A similar procedure of collapsing the time series to remove missing values 
was employed by Woyshville et al (1999). Since Woyshville et al (1999) reported 
statistically significant differences between participants with no missing data compared to 
participants with missing data, the impact of collapsing the time series on the findings were 
also conducted. All participants in the present study displayed missing data for one or 
more daily measures across the monitoring period. Thus, the participant's time series, 
collapsed to remove missing values, was compared to the longest time period across which 
the participant had no missing data for that variable. 
The variables subject to time series analyses were measures indicated to differ between the 
bipolar disorder and general population groups. Each participant's data for the measures 
were plotted across time, with the time series collapsed to remove any missing values. 
Firstly, autocorrelation analyses were conducted to assess whether an association existed 
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across days for each measure. Autocorrelation analyses are outlined in section 3.5.7.1. 
Secondly, cross-correlation analyses investigated associations across time between the 
measures. Cross-correlation analyses are outlined in section 3.5.7.2. 
3.5.7.1 Autocorrelation analyses 
The serial dependency of the data was investigated. A daily measurement may be more 
similar to the previous day's score than days further removed in time (West et aI, 2000). 
Evidence has suggested stronger associations within measures across time may exist in 
bipolar disorder, compared to the general population. For instance, slower affect recovery 
following life stress has been reported in mood disorders (Goplerud & Depue, 1985; Peeters 
et aI, 2003). These associations suggest stronger associations in the ratings of measures 
may be evident from day-to-day in bipolar disorder. Autocorrelation can detect whether 
data are serial dependent (Reis & Gable, 2000). For example, a lag one effect indicates 
dependency between adjacent days, a lag two effect indicates dependency between the data 
extends across two days. A partial autocorrelation function (PACF) was utilised in the 
present study. Partial autocorrelation provides a correlation coefficient for a time lag once 
the effects of smaller time lags have been removed (for instance, the time lag at day two has 
the effect of day one's time lag removed). Ifautocorrelation scores are within the 95% 
confidence limit, data can be regarded as independent. The PACF value is zero at all lags if 
there is no serial dependency in the time series (West & Hepworth, 1991). 
A one day difference transformation was applied to control for autocorrelation; most of the 
significant autocorrelations were displayed at the one day lag (autocorrelation findings are 
provided in Section 4.11). Partial autocorrelation analyses were repeated with the one day 
difference transformed time series to check for significant autocorrelations. It was 
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necessary to remove the effect of autocorrelation prior to cross-correlation analyses as 
autocorrelations in the data may otherwise impact on fmdings. 
3.5.7.2 Cross-correlation analyses 
Simple correlation between two time series treats data as if it were cross-sectional; findings 
may be misleading if trends, cycles or serial dependency exist in the data (West & 
Hepworth, 1991). The relationship between variables was investigated by computing 
cross-correlation functions. Cross-correlations also need to control for serial dependence, 
otherwise fmdings may be erroneous. The autocorrelation analyses conducted identified 
the extent of serial dependency in each participant's time series for the measures. A one 
day difference transformation was applied to remove serial dependency. Concurrent cross-
correlations were computed for each participant. Cross-correlation findings are outlined in 
Section 4.11. 
Theoretical postulation (e.g. psychobiosocial models of bipolar disorder; Scott, 2001) has 
suggested variation in biological vulnerability, behaviour and cognition, within an ever 
changing environment, may lead to variation in affect. If interactions occur from day-to-
day between these five systems, then associations across time may be measured to identify 
any direction of associations. Also, investigation of associations between measures across 
time could also indicate whether there a delayed or immediate interaction occurs between 
the systems. For instance, such analyses could suggest whether a decrease in self esteem 
had an immediate impact on affect levels or impacted over the following days. 
3.5.8 Comparisons within the bipolar disorder group 
The primary hypothesis of the current study was that greater variability would be observed 
in bipolar disorder compared to the general population. A second hypothesis was that 
121 
variability would also differ across participants with bipolar disorder. Participants with 
bipolar disorder who displayed greater variability were hypothesised to be more vulnerable 
to relapse. Inclusion criteria ensured participants were only included in the study if they 
had experienced a recent episode in the preceding two years. Most individuals with bipolar 
disorder remain vulnerable to relapse over time. It was not feasible to prospectively 
monitor participants until each individual had experienced an acute bipolar episode. 
Participants with bipolar disorder were relatively stable and regularly attended a lithium 
clinic during the study. However, evidence has reported relapse rates of 65% over two 
years (Silverstone et aI, 1998) and 82% over seven years (Coryell et aI, 1995). Thus most 
bipolar disorder participants were expected to subsequently experience relapse following 
study participation. A three year follow up was selected as a suitable time period to 
retrospectively assess each participant's vulnerability to relapse. 
Relapse in bipolar disorder can be defined by several outcomes, such as an individual's 
recall of the fll'st emergence of symptoms, clinician diagnosis, or hospitalisation. 
Furthermore, outcomes across a follow-up period could occur on numerous occasions. In 
particular, individuals with rapid cycling disorder by definition will experience several 
episodes across a year. Accordingly, first admission to hospital following study 
participation was selected as the follow-up outcome measure. The advantages of using 
fll'st admission as the outcome measure included it being a dichotomous, well-defmed 
measure, a marker of severity and provided a blind, independent measure of outcome. In 
April 2005, Forth Valley Primary Care NBS Trust Medical Records provided the date of 
fll'st admission following study participation for the individuals with bipolar disorder. The 
follow up period ranged from a minimum 38 months to a maximum of 44 months since 
participants had been recruited to the study over a six month period. 
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3.5.8.1 Fisher's exact test 
High and low variability group differences in admission to hospital were investigated with 
non-parametric analysis. Admission was analysed as a categorical variable with two values 
(admission to hospital; no admission). The hypothesis that greater vulnerability to 
admission would be observed in participants who displayed high variability was 
investigated. Contingency tables for admission and variability were produced, with 
participants divided into low and high variability subgroups for measures found to differ 
significantly between bipolar disorder and general population groups. A median split of 
variability scores divided participants into low and high variability groups. When sample 
size is less than 20 or when a cell in the 2x2 contingency table has an expected value less 
than five, it is recommended practice to use Fisher's exact test rather than the Chi-squared 
test (Norman & Streiner, 2000). Accordingly, Fisher's exact test investigated the 
difference in admissions over the follow up period in low and high variability subgroups of 
bipolar disorder participants. 
3.5.8.2 Exploratory Kaplan-Meier survival analysis 
Survival analysis investigated if tentative associations between variability measures and 
admission could be identified. Survival analyses may be considered exploratory due to the 
small sample size. Since participants had a variable length of follow-up, survival analysis 
may be a better method of analysing the patterns of admission between participant 
subgroups, than using contingency tables in isolation. Assumptions of survival analysis 
include identifiable start and end points. The date participants began daily monitoring was 
the selected start point; inclusion criteria meant participants with bipolar disorder were not 
experiencing an acute episode when they began study participation. The end point selected 
was first admission to hospital following each individual's start point. Since the exact date 
offrrst admission had been obtained from Medical Records, the Kaplan-Meier approach was 
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used instead of the actuarial approach which analyses survival over intervals oftime. 
Admission dates provided the opportunity to calculate the number of days until admission. 
Furthermore, when sample size is small (N<50), the Kaplan-Meier is the recommended 
technique (Norman & Streiner, 2000). The cumulative probability of survival (Le. not 
having an admission to hospital) across the follow up period was plotted in a survival curve. 
The Kaplan-Meier approach was then used to investigate differences in time to first 
admission in participants with bipolar disorder who displayed high variability compared to 
individuals who displayed low variability across the monitoring period. The Kaplan-Meier 
analyses investigated differences in the variability measures found to differ between bipolar 
disorder and general population groups. Variability in measures were analysed as 
continuous measures. Subsequently, a median split was applied to group participants into 
low and high variability subgroups. Kaplan-Meier analyses were repeated with the 
categorical variability measures. 
Admission to hospital was an outcome likely to differ across diagnostic subtypes. Clinical 
experience suggests individuals are more commonly admitted for mania than for depression, 
which would make individuals with bipolar I disorder more likely to have an admission 
compared to individuals with bipolar II disorder. Accordingly, further exploratory Kaplan-
Meier analyses included diagnosis as a strata variable. The strata levels for diagnosis were: 
bipolar I disorder, bipolar II disorder, and rapid cycling disorder. The Mantel-Cox log-
rank test investigated the equality of survival distributions for variability measures. The 
log-rank test is a non-parametric test that compares the occurrence of outcomes in each 
group across time. Ifno group differences exist, then at any time point, outcomes 
observed in each group (either variability or diagnosis) should be proportional to the 
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participants at risk ofadmission in each group. These subgroup analyses are provided in 
Appendix M. 
3.5.8.3 Exploratory Cox regression 
The current study prospectively monitored biological, behavioural, self esteem, and affect 
variability in bipolar disorder. Previous research has indicated several factors may interact 
to precipitate relapse in bipolar disorder. Accordingly, analyses of bipolar relapse may 
need to consider several variables in order to identify associations with relapse. Cox 
regression was thus used to investigate the effect of several variability measures in the 
prediction oftime to first admission in bipolar disorder participants. Two blocks were 
entered into the Cox regression and a forward stepwise (conditional LR) method was used 
to identify variables that were significant predictors oftime to admission. 
The first block of the Cox regression looked at gender, diagnosis and age. Gender (male, 
female) and diagnosis (Bipolar I Disorder, Bipolar II Disorder, Rapid Cycling Disorder) 
were analysed as categorical variables. Age was analysed as a continuous variable. A 
limited number of covariates were included in the block due to the small sample size. With 
a larger sample, length of history and number of previous episodes would have been useful 
to include as both may influence relapse in bipolar disorder (Goodwin & Jamison, 1990). 
The three demographic variables selected were included because of their known impact on 
bipolar relapse. Furthermore. these demographic variables have also been reported to 
impact on the measures used in the current study. For instance, sleep disturbances have 
been associated with both age and gender (Breslau et ai, 1996). Thus, it was important to 
control for the effect of these factors in order to identify if variability measures contributed 
any further predictive power. 
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Several covariates were included in the second block of the Cox regression. These 
covariates included variability in the four affect measures: positive affect variability; 
negative affect variability; elated variability; and depressed variability. In addition, the 
variability measures found to differ between bipolar disorder and general population groups 
were included as covariates. The covariates were analysed as continuous variables to 
identifY associations with admission in bipolar disorder. Indicator parameter coding was 
used to identifY whether high variability was associated with greater risk of admission. 
The second block of co variates were subsequently reanalysed as categorical variables. A 
median split was applied to each measure to divide participants into high and low variability 
subgroups. The main advantage of these supplementary analyses was to assess the impact 
of any outliers as with a small sample size, an extreme variability score could skew the 
results. Repeating the analyses with categorical covariates was thus used as a checking 
device. The overall group median, high variability median and low variability median were 
produced for each covariate. 
3.6 Summary of method 
The aim of the present study was to investigate variability in bipolar disorders. The 
average level and variability of diathesis vulnerability, behaviour, self esteem and affect 
measures in bipolar disorder were compared to the general population. Prospective daily 
monitoring provided the average level and variability of measures for each participant. 
Group differences in the average level and variability of measures were investigated. 
Measures observed to differ between groups were subsequently subject to time series 
analyses for participants with bipolar disorder. Finally, a three year follow-up assessed the 
clinical importance of variability in bipolar disorder. The association between variability 
and subsequent hospital admission in bipolar disorder was investigated. 
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Chapter 4 Comparison of bipolar disorder and general population groups 
The recruitment of bipolar disorder and general population participants and their respective 
demographic characteristics will be outlined briefly (Section 4.1). Secondly, the extent of 
missing data for each measure will be reported (Section 4.2). Thirdly, descriptive statistics 
for the mean level and variability of biological, behaviour, self esteem and affect measures 
will be provided for each participant group, with the inferential analyses that investigated 
group differences (Sections 4.3 to 4.10). Fourthly, time series analyses of variability within 
bipolar disorder participants will be produced (Section 4.11). Finally, associations between 
variability and subsequent hospital admission will be reported (Sections 4.12 to 4.14). The 
fmdings of the current study will then be summarised (Section 4.15). 
Figure 4.1: Flowchart of bipolar disorder participants recruited to study 
N= 55, possible participants 
I I 
N=45, consultant consent to N=4, consultant consent N=6, no episode in 
approach individual obtained not obtained past 2 years 
I 
I 
N=30, invited to N=lS, did not participate 
participate 
I 
N=24, recruited into N=6, refused consent 
study 
I 
N=20, daily questionnaires N=4, early dropouts with no 
completed questionnaires completed 
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4.1 Recruitment of bipolar disorder participants 
A total of 55 individuals with bipolar disorder were identified, although six had not relapsed 
in the previous two years, leaving 49 as suitable for inclusion. Consultant consent was 
obtained for 45 of these individuals (Figure 4.1). Fifteen individuals were unable to be 
asked to participate (Section 4.1.2 provides reasons for non-participation). Thirty 
individuals were invited to participate in the research project. Twenty-four individuals 
were recruited. Four early dropouts did not complete any questionnaires. The final 
sample comprised 20 participants with bipolar disorder (41 % of individuals identified as 
suitable for inclusion). 
4.1.1 Characteristics of bipolar disorder participants 
Twenty individuals with bipolar disorder participated in the research project. Demographic 
information is provided in the table below (Table 4.1). Participants had an age range from 
30 to 62 years and had a history of bipolar disorder ranging from one to 43 years. The 
number of previous episodes experienced ranged from two to IS episodes. Eight 
participants were prescribed lithium only, and five participants received another mood 
stabiliser. The remainder (N=7) were prescribed a combination of lithium and other mood 
stabilising drugs. Duration of illness and number of previous episodes was unclear in 
casenotes for three participants. The number of previous episodes was also unclear for 
another four participants. Illness duration and number of prior episodes were not reported 
in cases where the participant was a poor historian, the history was complicated, or 
casenotes were incomplete. Medication and illness history of participants with bipolar 
disorder are provided in Table 4.2. 
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Table 4.1: Demographic characteristics of bipolar disorder participants 
Values are numbers (percentages) of participants unless stated otherwise. 
Variable Participants Early Dropouts Refusers 
(N=2O) (N=4) (N=6) 
Mean (SD) age (years) 43 (11) 35 (8) 57 (6) 
Females 10 (50%) 3 (75%) 3 (50%) 
Type of bipolar illness: 
Bipolar I 8 (40%) 2 (50%) 3 (50%) 
Bipolar II 4 (20%) 2 (50%) 2 (33%) 
Rapid Cycling 8 (40%) 0 I (17%) 
Table 4.2: Medication and illness history of bipolar disorder participants 
Values are numbers (percentages) of participants unless stated otherwise. 
Variable Participants 
(N=2O) 
Prescribed lithium 15 (75%) 
Prescribed mood stabilising drugs 12 (60%) 
Median duration of illness, in years 10 (6-15)1 
(inter-quartile range) 
Median no. of bipolar episodes 7 (4-10l 
(inter-quartile range) 
I Median based on N= 17 out of 20 for duratIon of Illness 
2 Median based on N=13 out of20 for number of episodes 
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4.1.2 Characteristics of non-participants 
Six individuals with bipolar disorder refused to participate in the research project. Four 
early dropouts provided a signed consent form but did not complete any questionnaires. 
Demographic characteristics for these individuals (N=1 0) are provided in the table above 
(Table 4.1). Reasons for non-participation for the early dropouts included physical health 
problems (N=2); patient consent withdrawn (N=I); and work commitments (N=I). 
Reasons for refusal (N=6) were not provided. Fifteen individuals, identified as suitable for 
inclusion, were unable to be recruited for the study. Reasons for individuals not 
participating (N=15) included: time constraints of clinic, no time to ask for consent (N=11); 
inpatient (N=1); died (N=1); moved away from area (N=l); and physical illness (N=I). 
4.1.3 Characteristics of general population participants 
A control group was recruited from the general population. The general population 
participants had an age range from 26 to 59 years. The general population individuals were 
recruited by opportunity sampling from personal and occupational sources. Age and 
gender information for the general population participants are available in Table 4.3. An 
independent samples t test indicated the difference between bipolar disorder and general 
population participants in age was not significant (t= -0.401, df28, p=0.691). 
Table 4.3: Demographic characteristics of general population participants 
Values are numbers (percentages) of participants unless stated otherwise. 
Variable Participants (N=IO) 
Mean (SD) age (years) 41 (14) 
Females 5 (50%) 
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4.2 Missing data 
The range of completed daily questionnaires for the twenty participants with bipolar 
disorder was two to 24 weeks. The ten general population participants completed two to 
four weeks of daily monitoring. Although a high proportion of questionnaires were 
completed by participants, missing data did occur. In particular, not all participants with 
bipolar disorder were willing or able to complete all ofthe questionnaires as well as undergo 
actigraph monitoring. Five participants with bipolar disorder did not agree to wear an 
actiwatch. Similar to a recent UK study where RSEQ completion had a self-reported 
depressive impact (N=32 professional participants, N=21 service users or lay people; Blount 
et aI, 2002), two bipolar disorder participants were unwilling to complete the self esteem 
questionnaire as they reported completion was too distressing. Participants did not report 
any distress at completing the SRM, PANAS or BISfBAS questionnaires. 
Participant mean and variability scores were calculated for a 14 day monitoring period to 
compare the mean level and variability of measures between groups. The proportion of 
missing data that occurred within each group over these 14 day monitoring periods are 
provided in Table 4.4. Missing data also occurred with actigraph monitoring of the sleep-
wake cycle. For participants who underwent actigraph monitoring, missing sleep data were 
evident for 15 nights (8%) for the bipolar disorder group and eight nights (6%) for the 
general population group. A larger percentage of missing data were evident in the bipolar 
disorder group compared to the general population group for self completion ofSRM, 
RSEQ, and BISIBAS questionnaires and actigraph monitoring. 
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Table 4.4: Frequency of questionnaires not completed over 14 days of monitoring 
Values are numbers (percentages) of questionnaires not completed 
Questionnaires Bipolar Disorder General Population 
(N=20) (N=10) 
PANAS 16 (6%) 10 (7%) 
BISIBAS 11 (28%) 2 (10%) 
RSEQ 33 (12%) 8 (6%) 
SRM 2 (5%) 0(0%) 
4.3 Mean level and variability of diathesis vulnerability, behaviour, self esteem and 
affect measures 
The bipolar disorder and general population groups were compared on average level and 
variability of diathesis vulnerability, behaviour, self esteem and affect measures. The mean 
level and variability for each measure was calculated for each participant across a 14 day 
monitoring period (Section 3.5.2 provides further information on this methodology). 
Group means for each measure's level and variability were then calculated from these 
participant means. Multivariate analyses of variance were conducted to investigate 
between-group differences in the mean level and variability of measures: 
• Mean scores of sleep variables: time in bed, sleep duration, night waking time, sleep 
efficiency, sleep latency and fragmentation index 
• Day-to-day variability ofs\eep variables: time in bed, sleep duration, night waking time, 
sleep efficiency, sleep latency and fragmentation index 
• Mean scores of social and circadian rhythm variables: social rhythm regularity, daily 
activity level index (DALI), night time activity level (L5), day time activity level (M I 0), 
relative amplitude (RA), interdaily stability (IS) and intradaily variability (IV) 
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• Week-to-week variability of social and circadian rhythm variables: social rhythm 
regularity, DALI, L5, MIO, relative amplitude, IS and IV 
• Mean scores of behavioural inhibition and activation: BIS, BAS reward responsiveness, 
BAS drive and BAS fun seeking 
• Week-to-week variability of behavioural inhibition and activation: BIS, BAS reward 
responsiveness, BAS drive and BAS fun seeking 
• Mean scores of self esteem and affect variables: self esteem (SE), positive affect (PA), 
negative affect (NA), elated and depressed 
• Day-to-day variability of self esteem and affect variables: SE, PA, NA, elated and 
depressed 
• Mean scores and day-to-day variability of positive and negative self esteem subscalcs 
The following sections will outline the descriptive and inferential statistics for each group of 
variables. When parametric assumptions were not met for a group of variables, non-
parametric test results were selected as the preferred test for group differences. Inferential 
tests conducted but not presented in this chapter are provided in Appendix J. Analyses for 
sleep, social rhythms, and circadian rhythms, are provided in section 4.4 and behavioural 
activation/inhibition analyses are provided in section 4.5. The analyses for the self esteem 
and affect measures are provided in section 4.6. 
4.4 Level and variability of diathesis vulnerability and behaviour measures 
The circadian rhythm of the sleep-wake cycle and self-report assessment of behavioural 
activation/inhibition provided diathesis vulnerability measures for participants. Daily social 
rhythms were monitored to provide a measure of behaviour. The sleep-wake cycle was 
objectively estimated with actigraphy whilst self report completion of the Social Rhythm 
Metric (SRM) provided daily social rhythms. The average level and variability of sleep-
wake measures will be outlined first, and then the occurrence and regularity of social and 
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circadian rhythms will be reported (circadian rhythms obtained from actigraph sleep-wake 
analysis). Thirdly, average level and variability of behavioural activation and inhibition will 
be reported. 
4.4.1 Average levels of sleep measu res 
Time in bed was provided for most days of prospective monitoring since bed-time and get 
up times were recorded on the SRM questionnaire. The remaining five sleep variables 
(sleep duration; night waking time; sleep efficiency; sleep latency; and fragmentation index) 
were only available for nights when an actigraph device was worn by the participant. Table 
4.5 provides the mean sleep measures for the bipolar disorder and general population 
groups. Six participants with bipolar disorder did not undergo actigraph monitoring, so the 
bipolar disorder group means are based on the remaining fourteen participants. A 
MANOV A was conducted for the mean level of six sleep variables: time in bed, sleep 
duration, night waking time, sleep efficiency, sleep latency and fragmentation index. The 
sample sizes were unequal (N=14 bipolar disorder; N=IO general population), but the 
significance of Box's M was greater than 0.001 (Box's M 54.688, F=1.778, df21, 
1377.759 p=O.O 16). This suggests the MANOV A will be robust to any deviation from 
homogeneity of covariance. However, Levene's test was significant for sleep duration 
(F=4.351, dfl, 22, p=0.049) indicating the error variance of this dependent variable was 
not equal across the two groups. Furthermore, five of the six mean sleep variables were 
not normally distributed (Appendix I). Since two parametric assumptions were not met, 
the results of the multivariate test were discarded (F=2.319, df 6, 17, p=0.081). Mann-
Whitney test results for the mean level of six sleep variables are provided in Table 4.5. The 
rejected MANOVA results are provided in Appendix J. Large effect sizes were evident, 
with significant differences between groups observed for time in bed, night waking, sleep 
efficiency, and fragmentation index. Thus, differences in averaged sleep measures between 
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bipolar disorder and the general population over a 14 day period suggested sleep 
disturbances occur in bipolar disorder during inter-episode periods. 
4.4.2 Night-to-night variability of sleep measures 
A MANOV A was conducted for the variability of the six sleep variables. The sample sizes 
were unequal (N=14 bipolar disorder; N=I 0 general population), but the significance of 
Box's M was greater than 0.001 (Box's M 59.545, F=1.936, df21, 1377.759 p=0.007) 
which suggests the MANOVA will be robust to any deviation from homogeneity of 
covariance. Levene's test was significant for sleep efficiency variability (F=6.926, dfl, 22, 
p=0.015), sleep latency variability (F=S.203, dfl, 22, p=0.033) and fragmentation index 
variability (F=6.622, dfl, 22, p=O.O 17). This indicates the error variances of these three 
dependent variables were not equal across the groups. The six sleep variability variables 
were not normally distributed (Appendix I). Since two parametric assumptions were not 
met, the results of the multivariate test were discarded (F=1.515, df6, 17, p=0.232). 
Mann-Whitney test results for the variability of sleep variables are displayed in Table 4.6. 
The rejected MANOVA results are provided in Appendix J. There were four significant 
differences in the variability of sleep measures between the bipolar disorder and general 
population groups. Greater variability in sleep duration, night waking, sleep efficiency, and 
fragmentation index measures were evident in bipolar disorder. Greater night-to-night 
variability in sleep measures in bipolar disorder suggested disturbances in the sleep-wake 
cycle. 
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Table 4.5: Averaged sleep measures comparison between bipolar disorder and general population groups 
Sleep variable Bipolar Disorder General Population Effect U Significance 
M(sni 95%CI M (SD)2 95%CI Size* 
Time in bed (min.) 543 (61) 508-578 499 (45) 467-530 0.8* 35 0.040* 
Sleep duration (min.) 426 (84) 377-475 427 (33) 403-451 -0.01 65 0.770 
Night waking time (min.) 77 (37) 56-98 47 (24) 30-64 0.9* 30 0.019* 
Sleep efficiency (%) 78 (12) 71-84 86 (6) 82-90 -0.7 32 0.026* 
Sleep latency (min.) 36 (26) 21-51 21 (17) 9-32 0.7 45 0.143 
Fragmentation index 39 (17) 29-49 25 (11) 17-33 0.9* 28 0.014* 
I Based on participant mean scores over 14 days for N=14 bipolar disorder participants 
2 Based on participant mean scores over 14 days for N=1O general population participants 
* Indicates large effect size and/or statistically significant finding, p<O.05 
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Table 4.6: Sleep variability comparison between bipolar disorder and general population groups 
Sleep variable Bipolar Disorder General Population 
M (SD)I 9S%CI M(sni 
Time in bed variability (min.) 77 (34) 57-97 59 (22) 
Sleep duration variability (min.) 80 (37) 59-101 53 (21) 
Night waking variability (min.) 33 (21) 22-45 14 (8) 
Sleep efficiency variability (%) 9 (5) 6-12 4 (2) 
Sleep latency variability (min.) 34 (24) 21-48 18 (10) 
Fragmentation index variability 13 (6) 9-17 8 (2) 
I Based on participant mean scores over 14 days for N=14 bipolar disorder participants 
2 Based on participant mean scores over 14 days for N=lO general population participants 
• Indicates large effect size and/or statistically significant finding, p<O.05 
9S%CI 
43-75 
38-68 
9-19 
3-6 
10-25 
6-9 
Effect 
Size* 
0.6 
0.8* 
1.0* 
1.0* 
0.8* 
0.8* 
U Significance 
38 0.061 
30 0.019* 
15 0.001* 
20 0.003* 
42 0.101 
29 0.016* 
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4.4.3 Average levels ofsocial and circadian rhythm measures 
Daily completion of the SRM provided a habitual time for an activity over each weekly 
period. A weekly regularity score that indicated the variability of daily social rhythms from 
their habitual weekly time was calculated. In addition, the number of activities completed 
daily was calculated (DALI). Mean levels of SRM regularity and DALI are provided in 
Table 4.7 for each group. Circadian rhythm variables for the sleep-wake cycle were 
calculated for each week ofactigraph monitoring. In particular, interdaily stability and 
intradaily variability measures provide an indication of rest-activity regulation over time. 
Table 4.7 also provides the mean circadian rhythm scores for the bipolar disorder and 
general population groups. 
A MANOVA was conducted for the mean level of two social rhythm (regularity of social 
rhythms, number of daily activities performed) and five circadian rhythm variables (night 
time activity level, day time activity level, relative amplitude, interdaily stability, intradaily 
variability). The sample sizes were unequal (N=14 bipolar disorder; N=IO general 
population), but the significance of Box's M was greater than 0.001 (Box's M 74.451, 
F=I.670, df28, 1309.218, p=O.O 16) which suggests the MANOY A will be robust to any 
deviation from homogeneity of covariance. Levene's test did not indicate any significant 
fmdings, suggesting the error variance of the seven dependent variables was equal across 
the participant groups. Four of the mean social rhythm and circadian rhythm variables did 
not display a normal distribution of scores (Appendix I). Two out of three parametric 
assumptions were met, so the parametric analysis was considered the preferred test for 
group differences. The multivariate tests did not indicate any significant difference between 
groups for mean levels of social and circadian rhythm variables (F=1.938, df7, 16, 
p=0.129). 
138 
Table 4.7: Averaged social and circadian rhythm measures comparison between bipolar disorder and general population groups 
Social/circadian Bipolar Disorder General Population 
rhythm variables M (SD)I 95%CI M(SDi 95%CI 
Regularity score 4.00 (0.78) 3.55-4.45 3.88 (0.84) 3.28-4.47 
DALI 12 (2) 11-13 13 (1) 12-14 
L5 1533 (1353) 752-2314 754 (715) 243-1266 
MlO 20628 (16281) 11228-30028 17853 (7580) 12431-23275 
RA 0.85 (0.10) 0.79-0.90 0.91 (0.06) 0.87-0.96 
IS 0.50 (0.12) 0.43-0.57 0.52 (0.14) 0.42-0.62 
IV 0.81 (0.20) 0.69-0.92 0.88 (0.15) 0.78-0.99 
I Based on participant mean scores over 14 days for N=14 bipolar disorder participants 
2 Based on participant mean scores over 14 days for N=IO general population participants 
• Indicates large effect size and/or statistically significant finding, p<O.05 
Effect df F Significance 
Size* 
0.2 23 0.142 0.710 
-0.7 23 3.069 0.094 
0.7 23 2.742 0.112 
0.2 23 0.249 0.622 
-0.7 23 3.754 0.066 
-0.2 23 0.129 0.723 
-0.4 23 1.027 0.322 
Variables: DALI. Daily activity level index; L5. Night time activity level; MIO, Day time activity level; RA. Relative amplitude; IS, Interdaily stability; IV. lntradaily variability 
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Disruption may also be observed in the timing of circadian rhythms. Thus, mean onset 
times of night time and day time activity levels were also calculated for each group (Table 
4.8). Large skewness and kurtosis z scores (skewness 8.12, kurtosis 18.23) were evident 
for the distribution of scores for night time activity onset time suggesting non-parametric 
analysis would be appropriate. Mann-Whitney U analyses indicate no significant 
differences in onset times in either day time or night time activity levels. Circadian rhythm 
timing does therefore not appear to be disturbed in the bipolar disorder participants. 
Table 4.8: Mean onset times for lowest night time activity and highest day time 
activity levels 
Variable Bipolar Disorder General Population U p 
M (SD)\ 95%CI M (SD)1 95%CI 
L5 onset 2:27 (2:46) 0:51-4:04 1 :42 (0:35) 1: 16-2:07 66.5 0.841 
MI0 onset 9:47 (1 :57) 8:39-10:54 10:21 (1:33) 9:13-11:28 52.5 0.312 
I Based on participant mean scores over 14 days for N= 14 bipolar disorder participants 
2 Based on participant mean scores over 14 days for N=IO general population participants 
Variables: LS onset, Lowest five hour period of night time activity level onset time; MIO onset, Highest ten 
hour period of day time activity level onset time 
4.4.4 Variability of social and circadian rhythm measures 
Variability in social rhythm measures were investigated in terms of variability in the weekly 
regularity of social rhythms and in the number of daily activities. Variability in circadian 
rhythm measures was also investigated. Variability in social and circadian rhythm measures 
were calculated as the standard deviation across the 14 day period for each participant. 
Social and circadian rhythm variables were calculated for each seven day period; variability 
was therefore calculated from the two standard deviation values for the 14 day period. The 
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DALI was a daily measure of social rhythms, with the overall mean and standard deviation 
calculated across the 14 day period, as per the daily self-report questionnaires (Section 
3.5.2 provides more information about the computation of group mean and variability 
levels). A MANOVA was conducted for the variability of the seven social and circadian 
rhythm variables (daily activity level index, social rhythm regularity, night time activity level, 
day time activity level, relative amplitude, interdaily stability, intradaily variability). Box's 
M was significant (Box's M=99.909, F=2.157, df28, 1286.042, p=O.OOO) indicating the 
assumptions of homogeneity of covariance were not met. Unequal sample sizes (N=12 
bipolar disorder; N=l 0 general population) in combination with a significant Box's M 
suggests the MAN OVA results should be considered tentatively (Tabachnick & Fidcll, 
2001). Furthermore, Levene's test was significant for variability in three circadian rhythm 
variables: night time activity level (F=14.001, df 1,20, p=O.OOI), relative amplitude 
(F=6.323, df I, 20 p=0.021) and intradaily variability (F=5.269, df I, 20, p=0.033). 
Furthermore, five of the variability in social and circadian rhythm variables were not 
normally distributed (Appendix I). The multivariate analysis was discounted (F=2.217; df 
7, 14; p=0.097) since the parametric assumptions were not met. Mann-Whitney test results 
for variability of social and circadian rhythm variables are displayed in Table 4.9. The 
rejected MANOVA results are provided in Appendix J. Greater variability in relative 
amplitude in bipolar disorder was the only significant difference observed in the variability 
of social and circadian rhythms between groups. Variability in relative amplitude suggested 
individuals with bipolar disorder were less consistent in their waves ofrest and activity over 
the monitoring period. 
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Table 4.9: Social and circadian rhythm variability comparison between bipolar disorder and general population groups 
SociaUcircadian rhythm Bipolar Disorder General Population Effect U Significance 
variable M (SD)l 95%CI M (SD)2 95%CI Size * 
Regularity score variability 0.54 (0.47) 0.24-0.84 0.59 (0.33) 0.35-0.82 -0.2 85 0.645 
DALI variability 1.26 (0.45) 0.98-1.55 l.15 (0.27) 0.96-1.35 0.3 87 0.567 
L5 variability 382 (468) 84-679 102 (90) 38-167 0.8* 38 0.094 
M 1 0 variability 3872 (3433) 1691-6053 1752 (1632) 585-2920 0.7 40 0.121 
RA variability 0.04 (0.03) 0.01-0.06 0.01 (0.02) -0.001-0.02 1.0* 28.5 0.023* 
IS variability 0.06 (0.06) 0.02-0.10 0.05 (0.04) 0.02-0.08 0.2 61 0.804 
IV variability 0.09 (0.05) 0.05-0.12 0.19 (0.17) 0.06-0.31 -0.8* 43 0.172 
I Based on participant mean scores over 14 days for N=12 bipolar disorder participants 
2 Based on participant mean scores over 14 days for N=IO general population participants 
• Indicates large effect size and/or statistically significant finding, p<O.05 
Variables: DALI, Daily activity level index; L5, Night time activity level; MIO, Day time activity level; RA, Relative amplitude; IS, Interdaily stability; IV, Intradaily variability 
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4.5 Level and variability of behavioural activation/inhibition measures 
Each participant's level of behavioural activation/inhibition was monitored weekly with the 
self-report BISIBAS Scales. The variability of behavioural activation from week-to-week 
was of particular interest since bipolar disorder has been theoretically postulated to occur 
with behavioural activation dysregulation (Depue et aI, 1987). Mutual inhibition has also 
been proposed to exist between the behavioural activation and inhibition systems (Pickering 
et aI, 1999). Thus, level and variability of behavioural inhibition was also investigated. 
4.5.1 Average level of behavioural activation/inhibition levels 
Mean levels of behavioural activation and inhibition for the participant groups are available 
in Table 4.10. A MANOV A was conducted for the mean level of behavioural inhibition 
(BIS) and the three behavioural activation variables (BAS reward responsiveness, BAS 
drive, BAS fun seeking). The sample size was unequal between the groups (N=16 bipolar 
disorder; N=IO general population). Box's M results indicated the analysis would be 
robust to any deviation from homogeneity of covariance (Box's M=24.726, F=I.976, df 10, 
1689.922, p=O.032). Levene's test of equality of error variances indicated the error 
variance of BAS reward responsiveness (F=4.953, df 1,24, p=O.036) and BAS drive 
(F=4.124, df 1,24, p=O.053) was not equal across groups. The mean BAS fun seeking 
variable was not distributed normally (Appendix I). Thus, the multivariate analysis 
(F=2.024, df 4, 21, p=O.128) was discarded since two of the parametric assumptions were 
not met. Mann-Whitney test results are provided in Table 4.10. The rejected MANDV A 
results are provided in Appendix J. No significant differences between the groups for 
behavioural inhibition or any of the three behavioural activation subscales were observed. 
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Table 4.10: Averaged behavioural activation/inhibition measures comparison between bipolar disorder and general population groups 
BISIBAS Bipolar Disorder General Population Effect U Significance 
M (SD)1 95%CI M (SD)1 95%CI Size* 
BlS 23 (4) 20-25 20 (5) 16-23 0.7 49 0.101 
BAS reward 15 (3) 14-17 15 (2) 14-16 0.1 81.5 0.860 
responsiveness 
BAS drive 10 (4) 8-12 10 (2) 8-11 0.1 82 0.879 
BAS fun seeking 10 (2) 9-lJ 9 (1) 9-10 0.5 67 0.362 
1 Based on participant mean scores over 14 days for N=16 bipolar disorder participants 
2 Based on participant mean scores over 14 days for N= I 0 general population participants 
* Indicates large effect size and/or statistically significant finding, p<O.05 
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4.5.2 Week-to-week variability of behavioural activation/inhibition measures 
The variability of behavioural activation and inhibition over the 14 day period was also 
assessed since bipolar disorder is postulated to be characterised by dysregulation of the 
behavioural activation system. The results of Box's M test (Box's M=34.353, F=2.411, df 
10, 1033.845, p=0.008) and almost equal sample groups (N=9 bipolar disorder, N=8 
general population) indicated the analysis would be robust to any deviation from 
homogeneity of covariance. Smaller group sample size compared to the analysis of 
averaged behavioural activation/inhibition measures was due to fewer participants 
completing the BISIBAS measure on two occasions over the 14 day period. Levene's test 
indicated the error variance for the four dependent variables was equal across the groups. 
Three of the variability of behavioural activation/inhibition variables were not distributed 
normally (Appendix I). Since two of the parametric assumptions were satisfied, 
MANOV A was retained as the preferred inferential test to investigate group differences. 
The fmdings ofthe multivariate analysis indicated no significant difference in behavioural 
activation and inhibition variability between the groups (F=O.323, df 4, 12, p=O.857). 
Group means for behavioural inhibition and activation variability are displayed in Table 
4.11. 
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Table 4.11: Behavioural activationlinhibition variability comparison between bipolar disorder and general population groups 
BISIBAS Bipolar Disorder General Population Effect df F Significance 
M (SO)1 95%CI M(SO)l 95%CI Size* 
BIS variability 1.6 (1.2) 0.7-2.5 1.2 (1.0) 0.3-2.0 0.4 16 0.640 0.436 
BAS reward 1.4 (2.2) -0.3-3.1 1.1 (0.9) 0.3-1.8 0.2 16 0.173 0.684 
responsiveness 
variability 
i 
, 
BAS drive 0.9 (1.5) -0.2-2.1 0.8 (0.8) 0.1-1.5 0.1 16 0.059 0.812 
I 
variability 
BAS fun seeking 0.6 (0.6) 0.1-1.0 1.0 (1.1) 0.1-1.9 -0.4 16 1.057 0.320 
I 
variability 
I 
I Based on participant mean scores over 14 days for N=9 bipolar disorder participants 
2 Based on participant mean scores over 14 days for N=8 general population participants 
• Indicates large effect size and/or statistically significant finding, p<O.05 
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4.6 Level and variability of self esteem and affect measures 
Self esteem was monitored to provide a measure of cognition from day-to-day. The 
average level and variability of self esteem, as measured by the RSEQ, was calculated for 
each participant group. Positive and negative affect were measured to provide a general 
measure of affect, whilst measures of elation and depression were used to provide affect 
monitoring specific to bipolar disorder. Average levels and variability of the affect 
measures were also calculated for each participant group. 
4.6.1 Average level ofself esteem and affect measures 
Table 4.12 provides the group mean levels of self esteem and affect measures. The unequal 
sample sizes (N=18 bipolar disorder; N=1 0 general population) combined with a significant 
Box's M test (Box's M=116.419, F=2.719, df28, 1225.586, p=O.OOO) suggested the 
multivariate analysis should be considered tentatively. Levene's test was significant for the 
depressed rating (F=8.919, dfl, 26, p=O.006) and self esteem (F=8.850, dfl, 26, p=0.006), 
indicating that the error variance of these two dependent variables was not equal across the 
groups. Mean depression and negative affect variables were not distributed normally 
(Appendix I). Thus, with two parametric assumptions not being met, the results of the 
MANOVA were discounted (F=I.872; df7, 20; p=0.128). Mann-Whitney test results for 
mean self esteem and affect measures are provided in Table 4.12. The rejected MANDV A 
results are provided in Appendix J. Significantly lower positive affect, lower self esteem, 
higher negative affect, and higher depressed ratings were evident for the bipolar disorder 
group. Although this suggests reduced self esteem and affect levels occur in bipolar 
disorder across inter-episode periods, such attenuation may have been due to higher 
depression levels. However, analyses using depression ratings as a covariate were not 
conducted to investigate this possibility. 
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Table 4.12: Averaged self esteem and affect measures comparison between bipolar disorder and general population groups 
----_ ... _---- ----
---
Self esteem Bipolar Disorder General Population Effect U Significance 
and affect M (SD)l 95%CI M (SD)2 95%CI Size* 
SE 41 (16) 34-49 56 (8) 50-62 -1.0* 39 0.014* 
PA 21 (7) 17-24 29 (5) 25-33 -1.0* 27.5 0.001 * 
NA 17 (8) 13-21 13 (4) 10-16 0.6 45.5 0.016* 
Elated 1.7 (0.8) 1.3-2.1 2.3 (0.7) 1.8-2.8 -0.8* 60.5 0.081 
Depressed 2.1 (1.2) 1.5-2.7 1.2 (0.3) 0.9-1.4 0.9* 35.5 0.004* 
I Based on participant mean scores over 14 days for N=18 bipolar disorder participants 
2 Based on participant mean scores over 14 days for N= 1 0 general population participants 
• Indicates large effect size and/or statistically significant finding, p<O.05 
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4.6.2 Variability of self esteem and affect measures 
The variability of self esteem and affect across the 14 day monitoring period were then 
considered. Although sample sizes were unequal (N=18 bipolar disorder; N=lO general 
population), Box's M test was not significant (Box's M=42.296, F=0.988, df28, 1225.586, 
p=0.484), indicating multivariate analysis will be robust to any deviation from homogeneity 
of covariance. Levene's test was significant for SE variability (F=4.615, dfl, 26, p=0.041) 
suggesting the error variance of this dependent variable was not equal across groups. 
Variability in self esteem and negative affect variables were not distributed normally 
(Appendix I). The MANOVA results were discounted (F=2.278; df7, 20; p=O.070) as two 
of the parametric assumptions were not met. The Mann-Whitney test results for variability 
of SE and affect variables are displayed in Table 4.13. The rejected MANOVA results are 
provided in Appendix J. Significantly greater SE and NA variability was observed in the 
bipolar disorder group. 
4.6.3 Positive and negative self esteem subscales 
A robust fmding from the between group analyses was lower self esteem level and greater 
self esteem variability were observed in the bipolar disorder group. Self esteem, as 
assessed by the Rosenberg Self Esteem Questionnaire, provides positive and negative self 
esteem subscales which combine to form a total self esteem score. The average level and 
variability of the positive and negative self esteem subscales were also calculated (Table 
4.14). Further analysis was conducted for self esteem to investigate whether positive or 
negative self esteem played a specific role in differentiating bipolar disorder and the general 
population. 
Four self esteem dependent variables were entered into a multivariate analysis: positive SE 
level; negative SE level; positive SE variability; and negative SE variability. Unequal 
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sample sizes (N=18 bipolar disorder; N=l 0 general population) and a Box's M test greater 
than p=O.OOl suggests the multivariate analysis will be robust to any deviation from 
homogeneity of covariance (Box's M=35.320, F=2.844, df 10, 1606.780, p=0.002). 
Levene's test was significant for positive SE level (F=2I. 725, df 1, 26, p=O.OOO), positive 
SE variability (F=7.367, df 1,26, p=0.012) and negative SE variability (F=4.796, df 1,26, 
p=0.038). Significant results for Levene's test indicate the error variance of these three 
dependent variables was not equal across the groups. Positive self esteem variability was 
not distributed normally (Appendix I). The results of the multivariate analysis were 
discarded (F=3.087, df 4,23, p=0.036). The results of the Mann-Whitney tests for the self 
esteem subscales are provided in Table 4.14. Significant differences between groups for 
the four self esteem variables were observed. Lower positive and negative SE levels were 
observed in the bipolar disorder group; scores for positive SE items were reversed so that 
higher scores on either SE subscale indicate higher SE (Section 3.4.4.1 outlines scoring for 
the RSEQ). Furthermore, greater variability in positive and negative SE was observed in 
bipolar disorder compared to the general popUlation group. Thus, these results suggest 
both the level and variability of positive and negative self esteem, as measured by the 
RSEQ, differentiate bipolar disorder and the general population. 
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Table 4.13: Self esteem and affect variability comparison between bipolar disorder and general population groups 
Self esteem and affect Bipolar Disorder General Population Effect U Significance 
M (SD)1 95%CI M (SD)2 95%CI Size* 
SE variability 4.5 (2.6) 3.2-5.8 1.8 (0.8) 1.2-2.4 1.1 * 24 0.002* 
P A variability 4.2 (2.2) 3.1-5.3 5.1 (2.2) 3.5-6.6 -0.4 74 0.253 
NA variability 4.0 (2.7) 2.6-5.3 2.1 (2.3) 0.5-3.7 0.7 54 0.043* 
Elated variability 0.5 (0.4) 0.3-0.7 0.8 (0.4) 0.5-1.1 -0.8* 60.5 0.081 
Depressed variability 0.6 (0.5) 0.3-0.8 0.3 (0.3) 0.1-0.5 0.8* 58 0.061 
1 Based on participant mean scores over 14 days for N=18 bipolar disorder participants 
2 Based on participant mean scores over 14 days for N= I 0 general population participants 
• Indicates large effect size and/or statistically significant finding. p<O.05 
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Table 4.14: Average level and variability of positive and negative self esteem comparison between bipolar disorder and general population groups 
Self esteem Bipolar Disorder General Population Effect U Significance 
M(SDi 95%CI M (SD)z 95%CI Size· 
Positive SE level 23 (8) 19-27 30 (2) 28-31 -1.0* 45 0.031 * 
Negative SE level 19 (8) 15-23 26 (6) 22-31 -0.9* 40 0.017* 
Positive SE variability 2.3 (1.5) 1.6-3.1 0.7 (0.5) 0.3-1.1 1.1 * 18.5 0.001 * 
Negative SE variability 2.7 (1.5) 1.9-3.4 1.6 (0.8) 1.0-2.2 0.9* 46 0.035* 
I Based on participant mean scores over 14 days for N= 18 bipolar disorder participants 
2 Based on participant mean scores over 14 days for N= I 0 general population participants 
• Indicates large effect size and/or statistically significant finding, p<O.05 
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4.7 Holm correction for univariate between group analyses 
Across a 14 day period, the average level of eight variables (time in bed, night waking, sleep 
efficiency, fragmentation index, self esteem, positive affect, negative affect, depression) and 
the variability of seven variables (sleep duration, night waking, sleep efficiency, 
fragmentation index, relative amplitude, self esteem, negative affect) were observed to differ 
between bipolar disorder and general population groups. However, these significant 
fmdings may require interpretation with consideration ofthe impact of multiple univariate 
analysis comparisons. The Holm method was therefore applied to correct the alpha level to 
0.05 for the number of comparisons conducted for each conceptual group of variables. 
Following this correction of the alpha level, significant differences in the average level of 
four variables (self esteem, positive affect, negative affect, depression) and the variability of 
three variables (night waking, sleep efficiency, self esteem) remained between groups. 
Thus, lower self esteem and positive affect, higher negative affect and depressed ratings, 
and greater variability in night waking time, sleep efficiency and self esteem were observed 
in the bipolar disorder group with conservative interpretation of non-parametric analyses. 
4.8 Longer monitoring period for bipolar disorder participants 
The experimental hypothesis was that greater variability would be observed in bipolar 
disorder compared to the general population. Although participants had completed varying 
monitoring periods (median 8 weeks for bipolar disorder, median 2 weeks for general 
population), each participant had the mean level and variability of measures calculated from 
a 14 day monitoring period. If the data had been aggregated over longer periods for 
participants with bipolar disorder, greater variability exhibited in the bipolar disorder group 
could merely be due to the artefact of the longer time frame. Alternatively longer 
prospective monitoring may be necessary to give a more accurate estimation of the mean 
level and variability of measures in bipolar disorder. Previous findings have indicated 
153 
identification of social rhythm 'traits' required seven weeks of monitoring in mood disorder 
samples, whereas two weeks were adequate for general population samples (Monk et aI, 
1991; Ashman et aI, 1999). Parametric comparisons between groups were therefore 
repeated using the full prospective monitoring period of the participants with bipolar 
disorder. 
The mean level and variability of measures in bipolar disorder participants over their full 
prospective monitoring period were compared to the mean level and variability of measures 
in general population participants over their two week monitoring period (Analyses 
provided in Appendix K). In brief, these multivariate analyses of variance observed similar 
results to the comparison ofa 14 day monitoring period. Across a longer monitoring 
period for bipolar disorder, the average level of seven variables (night waking, sleep 
efficiency, fragmentation index, night time activity level, self esteem, positive affect, 
depression) and the variability of 11 variables (sleep duration, night waking, sleep efficiency, 
fragmentation index, daily activity level index, night time activity level, day time activity 
level, relative amplitude, self esteem, negative affect, depression) were observed to differ 
between bipolar disorder and general population groups. When alpha levels were corrected 
for mUltiple univariate comparisons, the average level of three variables (self esteem, 
positive affect, depression) and the variability of six variables (sleep efficiency, 
fragmentation index, relative amplitude. self esteem, negative affect, depression) remained 
significantly different between the groups. Lower self esteem. lower positive affect. higher 
depression and greater variability in sleep efficiency, fragmentation index, relative 
amplitude, self esteem, negative affect, and depression were evident in bipolar disorder. 
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4.9 Summary of group comparisons 
Comparison of diathesis vulnerability, behaviour, self esteem and affect measures suggested 
differences existed between bipolar disorder and the general population across the average 
level and variability of several measures used in the current study. Parametric group 
comparisons were conducted over 14 days and repeated over longer time periods for 
bipolar disorder participants. Non-parametric comparisons were conducted over 14 days 
to check the impact of violating parametric assumptions. Although significant differences 
between groups changed across these statistical comparisons, consistencies emerged in the 
disturbances observed in the average level and variability of certain measures. Group 
comparisons over longer time periods in bipolar disorder should be considered tentative 
since differences observed may have been an artefact of using different monitoring periods 
across participant groups. Non-parametric analyses were considered more reliable for 
variables with extreme skewness and kurtosis scores for the sample distribution (level of 
negative affect and depression, variability in night waking and sleep efficiency). Thus to 
summarise, the more robust group differences observed with parametric and non-parametric 
analyses over 14 days, corrected for multiple comparisons, were lower self esteem and 
positive affect, higher negative affect and depressed ratings, and greater variability in night 
waking, sleep efficiency and self esteem in bipolar disorder. 
4.10 Time series analyses of bipolar disorder participants 
Time series analyses were conducted to further investigate variability in bipolar disorder in 
terms of how measures changed across time. Variables found to significantly differ 
between the bipolar disorder and general population groups were subjected to time series 
analyses: sleep efficiency; night waking time; selfesteem; positive affect; negative affect; 
and depressed ratings. In addition, although elated ratings did not differ significantly 
between the groups over a 14 day period, it was considered important to investigate elated 
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ratings across time in a bipolar disorder sample. Time series analyses included plotting the 
data across time, conducting autocorrelation analyses and then cross-correlation analyses. 
Time series were collapsed to remove days with missing data; time series analyses cannot be 
conducted on series that have missing data points. 
Example plots for one bipolar disorder participant's actigraph estimation of night waking 
and sleep efficiency over 24 weeks (a collapsed time series of alternate 2 week periods that 
comprised a total 82 nights with 2 missing nights removed) and self esteem ratings over 24 
weeks (a collapsed time series of161 days with 7 days with missing data removed) are 
displayed in Figures 4.2, 4.3 and 4.4. Greater variability in night waking, sleep efficiency 
and self esteem had been observed in bipolar disorder compared to the general population. 
Time series plots of these measures suggested frequent variation across time. Associations 
between night waking and sleep efficiency can be clearly observed in Figures 4.2 and 4.3 
where this participant evidently had several days of disturbed sleep. 
Time series analyses were repeated for each participant's longest consecutive time series to 
check the impact of collapsing the data set. Autocorrelation analyses assessed the 
association of ratings from one day to the next for each measure; a partial autocorrelation 
function (PACF) was used, with effects of smaller time lags removed. Cross-correlation 
analyses investigated associations across time between the measures. Difference 
transformations were applied to remove the serial dependency of measure before cross-
correlations were computed. Further description of the time series analyses methodology is 
provided in section 3.5.7. The following sections provide the results of auto correlations 
and cross-correlations of sleep, self esteem and affect measures. 
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Figure 4.2: Time series plot of night-to-night actigraph estimation of night waking in 
a participant with rapid cycling disorder 
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Figure 4.3: Time series plot of night-to-night actig.'aph estimation of sleep efficiency 
in a participant with rapid cycling diso."der 
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Figure 4.4: Time series plot of day-to-day self esteem ratings in a participant with 
rapid cycling disorder 
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4.10.1 Autocorrelations of sleep measUI"es 
Partial autocorrelation plots for night-to-night sleep efficiency and night waking time were 
conducted for 15 participants with bipolar disorder; five remaining participants with bipolar 
disorder did not undergo actigraph monitoring of the sleep-wake cycle. The collapsed time 
series of these 15 participants was a median 27 days (range 7 to 82 days). The longest 
consecutive time series for sleep measures was a median 14 days (range 6 to 27 days). The 
PACF plots for sleep efficiency showed positive lags for six participants, three of these 
participants had also displayed positive lags for night waking time. Positive lags show 
dependency in the measure across days. For instance, a one day lag would suggest that 
night wakillg one night was influenced by night waking the previous night. When each 
participant's longest consecutive time series was subjected to PACF analysis, none of the 
participants displayed positive lags for sleep efficiency. The P ACF plots for night waking 
time showed positive lags for six participants; 60% of participants displayed no significant 
night-to-night association for night waking time. When the longest consecutive time series 
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for each participant was subjected to PACF analysis, only one participant displayed a 
significant one day lag for night waking time. Thus, partial autocorrelations for night 
waking time and sleep efficiency for participants with bipolar disorder show no consistent 
serial dependency from one night to the next night. In other words, the time spent awake 
and the sleep efficiency for a specific night did not appear to impact on night waking or 
sleep efficiency for any following nights in most of the participants with bipolar disorder. 
4.10.2 Autocorrelations ofself esteem and affect measures 
Partial autocorrelations were conducted for 19 participants for self esteem as one 
participant only completed the self esteem questionnaire on one occasion. The median 
collapsed time series was 30 days for self esteem (range 5 to 161 days). The longest 
consecutive time series for self esteem was a median 14 days (range 3 to 42 days). The self 
esteem PACF plots for the collapsed time series showed positive lags for five of the 
participants. An example of a participant's partial autocorrelation plot of self esteem is 
provided in Figure 4.5. A positive lag one effect was evident for one participant with a 42 
day consecutive time series for self esteem ratings. No consistent association for the 19 
participants was observed for self esteem ratings across days. 
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Figure 4.5: Partial autocorrelation function of self esteem in a participant with rapid 
cycling disorde.· 
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Partial auto correlations were conducted [or 20 participants [or positive aITect, negative 
affect, depressed, and elated ratings. The median collapsed time series was 35 days for 
affect (range 8 to 163 days). The longest consecutive time series [or affect measures was a 
median 14 days (range 2 to 28 days). The positive affect P ACF plots indicated nine 
participants had positive lags [or their collapsed time series; a positive lag one eITect was 
evident for one participant with a 70 day consecutive time series [or positive a1Tect ratings. 
The negative affect PACF plots [or the collapsed time series showed positive lags [or ten of 
the participants, whilst only two of these participants displayed a positive one day lag for 
the consecutive negative affect time series. Five participants had positive lags [or elated 
ratings, with three participants having significant positive lags over the consecutive elated 
time series. Finally, ten participants showed positive lags [or their collapsed time series [or 
depressed ratings. Four participants also had positive lags for the consecutive time series 
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for depressed ratings. No consistent associations for the 20 participants were observed for 
the four affect measures across days. 
In summary, most lags displayed in the PACF plots for self esteem and affect were within 
the 95% confidence limits. Although 25 to 50% of participants displayed significant partial 
autocorrelations, there was no consistent pattern to the autocorrelations observed. In 
particular, participants with longer time series did not appear any more likely to have 
positive lags across time. Since the majority of lags were within the 95% confidence limits 
for most participants, there did not appear to be any consistent serial dependency of self 
esteem or affect ratings from day-to-day. Stronger associations within measures across 
time had been hypothesised in bipolar disorder in line with previous findings. For instance, 
stronger associations of affect across days have been suggested by the observation of slower 
affect recovery following life stress in mood disorders (Goplerud & Depue, 1985; Peeters et 
al,2003). 
4.10.3 Cross-correlations of sleep and affect measures 
Although no consistent serial dependency was identified by the autocorrelation plots for any 
variable, the autocorrelation values did differ from zero. This indicated the data were not 
completely independent across time. As such, one day difference transformations were 
conducted to remove any underlying serial dependency. Differencing also makes a time 
series stationary, an essential component of cross-correlation analysis. Following these 
transformations, the partial autocorrelation analyses were repeated to check the impact of 
transforming the data. A one day difference transformation was effective in removing 
positive lags for each variable, which then enabled cross-correlations to be computed. 
161 
Fifteen participants with bipolar disorder had completed actigraph monitoring and had sleep 
data available. However, cross-correlations were only able to be conducted for measures 
that varied across time. Five participants had constantly rated elation as 'very slightly or 
not at all.' Although two participants had constantly rated depression as 'very slightly or 
not at all,' one ofthese participants did not have sleep data available either. Consequently, 
cross-correlations of sleep measures that included elated ratings were conducted for 10 
participants; cross-correlations that included depressed ratings were conducted for 14 
participants. 
Elated and depressed ratings were subject to cross-correlation analyses with night waking 
and sleep efficiency to investigate associations between these sleep measures and bipolar 
mood ratings. Associations between elation and sleep measures were not consistent across 
participants (N=I 0 participants with bipolar disorder). There was no significant cross-
correlation between night waking and elation for five participants; the remaining five 
participants displayed significant cross-correlations with no distinct pattern. Six 
participants had no significant cross-correlation between sleep efficiency and elation; there 
was no pattern identified for the four participants with significant correlations. Similarly, 
no consistent associations between depression and sleep measures were identified across 
participants (N=14 participants with bipolar disorder). Eight participants displayed no 
significant cross-correlation between night waking and depressed ratings. Six participants 
had significant cross-correlations with no consistent pattern. Nine participants had no 
significant cross-correlations between sleep efficiency and depressed ratings, while the 
remaining five participants had a range of significant cross-correlations that were 
inconsistent. Thus evidence in this small sample of participants with bipolar disorder 
suggests there were no consistent associations between sleep measures and elated or 
depressed ratings across inter-episode periods. 
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4.10.4 Cross-correlations ofself esteem and affect measures 
Elated and depressed ratings were subject to cross-correlation analyses with positive affect, 
negative affect and self esteem. Self esteem was then cross-correlated with positive and 
negative affect. Finally, cross-correlations of positive and negative affects were conducted 
for participants. As with cross-correlations of sleep and affect measures, one day 
difference transformations were conducted to remove any underlying serial dependency. 
Partial autocorrelation analyses were then repeated to check the impact of transforming the 
data. One day difference transformations were effective in removing positive lags for the 
variables. Cross-correlations were conducted, for each participant, on the transformed 
time series for each measure. Twenty participants had daily ratings of affect whilst 19 
participants had daily self esteem ratings. However, five participants had constantly rated 
elation as 'very slightly or not at all' and two participants had constantly rated depression as 
'very slightly or not at all.' Consequently, the number of participants in cross-correlations 
of self esteem and affect varied from 14 to 20 participants, depending on scores available. 
Associations between depression ratings and positive and negative affect were investigated 
with cross-correlation analyses (N= 18 participants with bipolar disorder). Ten participants 
(56%) displayed significant negative zero lag correlations between depression and positive 
affect. A significant zero lag cross-correlation indicates the level of one variable is 
associated with the level of the second variable on the same day. In addition, six 
participants showed depression/positive affect associations across time. Fifteen 
participants (83%) displayed significant positive zero lag correlations between depression 
and negative affect, with seven participants showing depression/negative affect associations 
across time. Over halfthe participants were observed to have depression ratings that were 
correlated with same day positive and negative affect ratings. Thus, whilst over halfofthe 
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participants rated depression and positive affect inversely on the same day, most participants 
rated same day depression and negative affect ratings consistently. 
Associations between elation ratings and positive and negative affect were investigated with 
cross-correlation analyses (N= 15 participants with bipolar disorder). Seven participants 
(47%) displayed significant positive zero lag correlations between elation and positive 
affect; five participants showed elation/positive affect associations across time. Three 
participants displayed significant positive zero lag correlations between elation and negative 
affect, whilst one participant displayed a significant negative zero lag correlation. Lastly, 
six participants showed varying associations between elation and negative affect across 
time. Accordingly, associations between elated ratings and positive and negative affect 
ratings across time were not consistent across participants. 
Daily positive and negative affects were cross-correlated concurrently to investigate their 
independence (N=20 participants with bipolar disorder). Research evidence has indicated 
conflicting positive affect-negative affect associations, with some reports indicating 
independence and others indicating a negative correlation. In the current study, eight 
participants (40%) displayed a significant negative zero lag correlation between PA and NA, 
whilst two participants (20%) displayed a significant positive zero lag correlation. 
Furthermore, six participants showed associations between NA and PA across time. Thus, 
whilst some participants showed PA-NA associations across the same day, no consistent 
association between positive and negative affect ratings was identified for the majority of 
participants. 
Finally, the association between self esteem and affect variables was investigated. Self 
esteem was cross-correlated with positive affect, negative affect, and elation and depression 
164 
ratings. An example of a participant's cross-correlation plot for self esteem and depression 
ratings is displayed in Figure 4.6. Eight participants (42%) displayed significant positive 
zero lag correlations between self esteem and positive affect. Nine participants showed 
associations between self esteem and positive affect across time. Seven participants (37%) 
displayed significant negative zero lag correlations between self esteem and negative affect, 
whilst five participants showed associations between self esteem and negative affect across 
time. Significant positive zero lag correlations between self esteem and elated ratings were 
evident for four participants; a further participant displayed a significant negative zero lag 
correlation. Six participants displayed negative zero lag correlations for self esteem and 
depressed ratings. These fmdings suggest self esteem on a given day was not consistently 
associated with elated/depressed ratings across participants with bipolar disorder. Thus, 
cross-correlation evidence indicated whilst some participants showed associations between 
self esteem and affect for a given day and over time, others displayed no significant 
association. Cross-correlation observations are summarised in Table 4.15. In line with 
mood-state hypotheses that posit stronger cognition-mood associations in mood disorders, 
(e.g. Teasdale, 1988) and previous reports of self esteem associations with mania and 
depression (e.g. Lyon et aI, 1999), self esteem-affect associations had been expected to 
occur across time in the current study. However, no consistent association between self 
esteem and affect was identified for a majority of participants with bipolar disorder. 
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Figure 4.6: Cross-correlation of self esteem and depressed ratings in a participant 
with rapid cycling disorder 
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Table 4.15: Summary of cross-correlations between measures in bipolar disorder 
Cross-correlation on same day % of participants Type of association 
SE-PA 42% Positive 
SE-NA 37% Negative 
Depression-SE 32% Negative 
Depression-P A 56% Negative 
Depression-NA 83% Positive 
Elation-SE 21 % Positive 
Elation-PA 47% Positive 
Elation-NA 20% Positive 
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4.10.5 Summary of time series analyses in bipolar disorder 
The daily scores for night waking, sleep efficiency, self esteem, positive affect, negative 
affect, elated, and depressed ratings were plotted across time for participants with bipolar 
disorder. Partial autocorrelations for each measure were conducted to identify associations 
across time. In particular, strong associations within measures across adjacent nights had 
been expected in line with theoretical postulation (e.g. Wehr, 1987) and previous 
observations of delayed affect recovery (e.g. Goplerud & Depue, 1987). Although some 
participants did display associations across time, no consistent serial dependency was 
observed across participants for the sleep, self esteem and affect measures. Furthermore, 
when measures were cross-correlated, few consistent associations were identified across 
most participants with bipolar disorder. Strong associations between affect and sleep and 
between affect and self esteem had been expected, in line with mood-state hypotheses (e.g. 
Teasdale, 1988). 
4.11 Variability comparison of bipolar disorder participants 
Variability may be considered a clinically useful measure if associated with vulnerability to 
relapse in bipolar disorder. The study hypothesis that greater variability would be 
associated with increased vulnerability to relapse was investigated through comparison of 
admission dates. The first admission dates following study participation of the twenty 
individuals with bipolar disorder were obtained in April 2005 from Forth Valley Primary 
Care NHS Trust Medical Records. The follow up period ranged from 38 to 44 months due 
to staggered start dates of study participation. Eight (40%) participants had a hospital 
admission across an approximate three year follow up period. The median time to first 
admission for these eight participants was 284 days (range 40 to 1240 days). Associations 
between admission and variability in measures that differed between the bipolar disorder and 
general population groups were investigated: variability in self esteem, night waking time 
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and sleep efficiency. Variability for each measure was calculated as the standard deviation 
of scores across the monitoring period for each participant. Low and high variability 
groups were categorised according to a median split ofvariabiIity scores; participants with 
variability scores below the median score were categorised as low variability; participants 
above the median score were categorised as high variability. 
Group differences in the number of admissions to hospital between high and low variability 
subgroups were investigated with non-parametric analyses (Appendix L). Nineteen 
participants were categorised into low SE and high SE groups; one participant with bipolar 
disorder had completed the self esteem questionnaire on only one occasion and thus had no 
SE variability data available. The difference in the number of admissions between SE 
variability groups was not statistically significant (p= 0.570, one tailed Fisher's exact test). 
Admission rates in high and low variability for night waking and sleep efficiency were then 
compared. Fifteen participants were categorised into low and high night waking or sleep 
efficiency groups according to a median split. Five participants with bipolar disorder had 
no sleep measures variability data available over their monitoring period. Differences in the 
number of admissions between low and high variability subgroups were not significant for 
night waking (p= 00405, one tailed Fisher's exact test) or for sleep efficiency (p= 0.214, one 
tailed Fisher's exact test). 
In summary, results suggested greater variability was not associated with increased 
vulnerability to relapse. The three measures (self esteem, night waking time, sleep 
efficiency) found to be significantly more variable in bipolar disorder compared to the 
general population were not associated with risk of subsequent admission to hospital. 
However, due to the small sample size and variable length of fOllow-up for bipolar disorder 
participants, contingency tables may not in themselves fully explore the significance of 
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variability in bipolar disorder. Instead of investigating the association between variability 
and the occurrence of relapse, it may be more clinically useful to investigate the association 
between variability and time to relapse in bipolar disorder. In order to address this issue, 
exploratory survival analysis was subsequently conducted for the present study. 
4.12 Exploratory Kaplan-Meier survival analysis of variability in bipolar disorder 
The Kaplan-Meier approach to survival analysis was used since the exact date of first 
admission to hospital over the follow up period was obtained from Medical Records for 
each participant. Eight ofthe twenty participants with bipolar disorder experienced an 
admission following study participation. The survival rate was calculated each time an 
admission occurred. Since participants were enrolled into the study across several months, 
participants had varying lengths of follow up. The follow up period for the twenty 
participants ranged from 1139 to 1319 days. There were four censored cases that occurred 
between the seventh admission at 1126 days and the last admission at 1240 days. The 
remaining eight participants were censored across 1258 to 1319 follow up days. A Kaplan-
Meier survival curve for admission to hospital was subsequently plotted in Figure 4.7 
(Cumulative survival rates for admission are provided in Appendix M). Censored cases 
were marked on the plot and were not included in the calculation of the cumulative survival 
rate. The observed 40% admission rate was lower than rates reported by previous research 
investigations of relapse rate in bipolar disorder. This suggests the sample of participants 
with bipolar disorder in the current study comprised individuals who experienced better 
outcome over a three year follow-up than outcomes more typically representative of this 
clinical population. 
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Figure 4.7: Kaplan-Meier survival curve for admission 
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Variability in bipolar disorder had been hypothesised to be associated with heightened risk 
for relapse. With consideration of the small sample size of bipolar disorder participants and 
the small number of outcomes (admissions) in the current study, it was decided not to 
investigate the association between outcome and the variability of each measure. Instead, 
the three measures (self esteem, night waking, and sleep efficiency) observed to vary to a 
greater extent in bipolar disorder across a 14 day period compared to the general population 
were selected. The significance of self esteem, night waking and sleep efficiency variability 
and subsequent admission to hospital were investigated with log-rank tests. The resulLs are 
displayed in Appendix M. The Mantel-Cox log-rank tests suggested continuous measures 
of variability in self esteem, night waking and sleep efficiency predicted admission. When 
diagnostic strata were considered, high self esteem variability predicted admission 
specifically in bipolar I disorder. Participants were then categorised into low and high 
variability subgroups for self esteem, night waking and sleep efficiency. Log-rank tests 
were repeated with these categorical groups. Results suggested no significant association 
between variability and subsequent admission. When diagnostic strata were considered, no 
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significant associations between diagnosis and categorical variability groups emerged for 
prediction of admission. The cumulative probabilities of survival for self esteem, night 
waking and sleep efficiency variability subgroups were calculated and plotted (Appendix 
M). All Kaplan-Meier fmdings should be considered tentative due to the small sample size, 
particularly when analysed by diagnostic strata. 
4.13 Exploratory Cox regression of variability in bipolar disorder 
Cox regression analyses investigated the effect of several variability measures upon the time 
to first admission in bipolar disorder. Gender, diagnosis and age were entered into the first 
block of the Cox regression model. Given the small number of participants with bipolar 
disorder, it was decided not to enter all variables that may impact on relapse. The 
continuous covariates in the second block of the Cox regression included variability in the 
four affect measures: positive affect variability; negative affect variability; elated variability; 
and depressed variability. Variability measures found to differ between bipolar disorder 
and general population groups were also included as covariates: self esteem variability; 
night waking time variability; and sleep efficiency variability. Fourteen participants were 
included in this analysis (N=6 admissions, N=8 censored). A forward stepwise (conditional 
LR) method identified age and sleep efficiency variability as significant predictors of 
subsequent admission in bipolar disorder; increasing age and high variability in sleep 
efficiency predicted earlier admission. These results are displayed in Table 4.16. 
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Table 4.16: Cox regression significant predictor variables 
95% CI for Exp(B) 
Predictor variable df Exp(B) Lower Upper p 
Age 1 1.320 1.068 1.631 0.010 
Sleep efficiency variability 1 1.385 1.038 1.849 0.027 
Subsequently, the Cox regression analysis was repeated using categorical high and low 
variability participant subgroups for seven covariates: self esteem, night waking, sleep 
efficiency, positive affect, negative affect, elated, and depressed. This supplementary 
analysis was to check ifany outliers had skewed the findings of the continuous covariate 
Cox regression. With Cox regression of categorical covariates, age was the only variable 
identified to predict admission in bipolar disorder (Exp(8) = 1.151, 95% CI 1.030-1.286, 
p=0.013). Cox regression analyses with such a small participant sample were exploratory, 
so inconsistent findings across continuous and categorical covariate analyses was perhaps 
not unexpected. A tentative fmding was variability in sleep efficiency, measured 
continuously, predicted first admission in bipolar disorder across a three year follow up. 
4.14 Summary of results for the present study 
The aims of the current study were to investigate the average level and variability of 
diathesis vulnerability, behaviour, self esteem and affect measures in general population and 
bipolar disorder participants and to assess the clinical importance of variability in bipolar 
disorder. When average level and variability of measures across a 14 day period were 
compared between bipolar disorder and general population groups, significant differences 
emerged. After controlling for multiple comparisons, lower positive affect, higher negative 
affect, higher depressed ratings, lower self esteem, and greater variability in night waking 
time, sleep efficiency and self esteem were observed in bipolar disorder compared to the 
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general population. Overall, fmdings suggested averaged self esteem and affect measures 
differed between bipolar disorder and general population groups whilst averaged biological 
and behaviour measures did not differ over a 14 day period. Variability in self esteem, 
night waking time and sleep efficiency also differed between groups whilst variability in the 
other biological, behaviour and affect measures did not differ. Time series analyses 
indicated self esteem and affect measures were correlated for some participants with bipolar 
disorder across the same day, but no associations across time between measures were 
identified. Finally, a three year follow-up suggested variability in self esteem and sleep 
efficiency may predict first admission to hospital for participants with bipolar disorder. 
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Chapter 5 Discussion 
The present study prospectively investigated whether an underlying dysregulation in 
diathesis vulnerability, behaviour, self esteem, and affect measures could be identified during 
inter-episode periods in bipolar disorder. Greater variability was hypothesised to occur in 
bipolar disorder, compared to general population participants, as variability was posited to 
reflect the underlying vulnerability of the disorder. Night waking, sleep efficiency and self 
esteem were observed to be more variable day-to-day in bipolar disorder across a 
prospective 14 day period. Furthermore, lower average levels of self esteem and positive 
affect, and higher average levels of negative affect and depressed ratings were observed in 
bipolar disorder across 14 days. These findings suggest that individuals with bipolar 
disorder differ from the general population across sleep, self esteem and affect measures, 
even during inter-episode periods. 
The association between the observed dysregulation during inter-episode periods in bipolar 
disorder and relapse was then investigated by follow up of subsequent admission to hospital. 
The observed 40% admission rate at an approximate three year follow up was lower than 
expected. Previous research evidence had reported rates of relapse in bipolar disorder at 
65% over two years (Silverstone et aI, 1998) and 73% over five years (Gitlin et aI, 1995). 
Reasons for this low admission rate in the current study may include the potential for early 
intervention with individuals who regularly attended a Lithium Clinic. Also, the admission 
rate in the current study does not take into account those individuals who experienced an 
acute episode that was managed without requiring admission. Variability in sleep efficiency 
and self esteem were suggested to predict earlier time to admission. Thus, a tentative 
conclusion from the current study's findings was that variability in bipolar disorder may play 
a role in determining relapse. 
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5.1 Average level and variability ofsleep measures 
The present study reported sleep disturbances occur in bipolar disorder during inter-episode 
periods. Consistent differences in the variability of sleep measures emerged between bipolar 
disorder and the general population. Trends towards sleep disturbance in bipolar disorder 
were suggested in terms of lower sleep efficiency, greater night waking and fragmented 
sleep. However, when multiple comparisons were considered, averaged sleep measures 
were not found to differ across a 14 day period or over longer monitoring periods for bipolar 
disorder. Differences between bipolar disorder and the general population in slcep 
variability, but not averaged sleep measures, may suggest chaotic dysregulation rather than 
an impoverished sleep-wake cycle in bipolar disorder. Sleep disturbance in bipolar disorder 
was suggested by the present study to involve greater variability from night-to-night rather 
than consistently poor sleep when compared to the general population. 
No differences in average levels of sleep measures between bipolar disorder and the general 
population was a rmding consistent with other research. Previous studies over five days 
using EEG measures (Knowles et ai, 1986) and actigraph sleep measures (Millar et ai, 2004) 
have also reported no differences in average sleep measures between individuals with bipolar 
disorder and the general population. Millar et al (2004) did report some trends towards 
lower sleep efficiency, greater sleep latency and sleep duration in bipolar disorder. Indeed, a 
more recent actigraph investigation over eight days reported increased time in bed and 
reduced sleep efficiency in bipolar disorder compared to the general population (Harvey et 
al,2005). Since samples recruited by the present study and other actigraph studies (Millar 
et ai, 2004; Harvey et ai, 2005) were relatively small, trends towards objective sleep 
disturbance in bipolar disorder during inter-episode periods, measured by actigraphy, may 
warrant further investigation. Thus to date, preliminary evidence suggests average slcep 
measures over brief time periods may differ between bipolar disorder and general population 
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samples. In the current study, however, more robust differences were observed in the 
variability of sleep measures across time. 
Greater night-to-night variability'S of night waking and sleep efficiency were observed in 
bipolar disorder participants across 14 days. This suggested that individuals with bipolar 
disorder displayed sleep disturbance when compared to individuals from the general 
population. Furthermore, since individuals with bipolar disorder were not experiencing an 
acute manic episode, this may suggest ongoing biological dysregulation across inter-episode 
periods in bipolar disorder. Participants with bipolar disorder had been included in the 
study if they were not currently experiencing mania. When variability in sleep was 
measured across each bipolar disorder participant's full monitoring period, greater 
variability in sleep efficiency and the fragmentation index were observed in bipolar disorder 
compared to the general population. Trends towards greater variability in night waking 
and sleep duration were also suggested in bipolar disorder across a longer monitoring 
period. The observed greater variability in sleep measures may suggest a general 
dysregulation or instability in the sleep-wake cycle in bipolar disorder. 
Greater night-to-night variability of night waking and sleep efficiency in bipolar disorder 
suggests sleep disturbance occurs during inter-episode periods as well as being symptomatic 
of acute bipolar episodes. Furthermore, the presence of ongoing sleep disturbance in 
bipolar disorder suggests a biologicaJly vulnerable sleep-wake cycle that may be less able to 
withstand further disruption compared to the more stable cycle displayed in the general 
population. This vulnerability may explain why sleep disturbance can have a clinically 
significant impact on mood in bipolar disorder (e.g. the precipitation of bipolar relapse by 
long distance flights; Jauhar & Weller, 1982). The presence of sleep disturbance during 
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inter-episode periods is consistent with the circadian rhythm disruption diathesis-stress 
model of bipolar disorder. 
Differences in the variability of sleep measures between bipolar disorder and the general 
population has also been suggested by previous research. A recent actigraph study over 
five days (Millar et aI, 2004) observed differences in sleep variability between bipolar 
disorder and the general population. Millar et al (2004) observed greater variability in 
actigraph and subjective estimates of sleep duration in bipolar disorder whilst actigraph 
measurement of night waking time variability and subjective sleep latency and sleep 
efficiency variability's were significantly greater in bipolar disorder participants (N=19 
bipolar disorder, in remission, N=19 general population; Millar et ai, 2004). Thus, 
evidence from the current study and Millar et al (2004) suggests sleep disturbance, as 
indicated by night-to-night variability, may be observed in individuals with bipolar disorder 
during inter-episode periods. A tentative conclusion is that this sleep disturbance may be 
symptomatic of possible chronic circadian rhythm dysregulation in bipolar disorder. 
The current study observed sleep disturbance was associated with subsequent relapse in 
bipolar disorder. Variability in sleep efficiency was suggested as a predictor of earlier time 
to admission. This is consistent with previous literature review findings that suggested 
sleep disturbance may be a risk factor for relapse in mood disorders (Gillin, 1998; Jackson 
et aI, 2003). A small prospective study reported increased sleep disturbance occurred prior 
to relapse in major depression; individuals who relapsed were compared with individuals 
who did not relapse, matched for age, gender and time from last relapse, (N=14; Perl is et aI, 
1 997). Further prospective investigation of the sleep-wake cycle and long term course may 
clarity which aspects of sleep disturbance may be associated with subsequent relapse in 
bipolar disorder. 
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5.2 Average level and variability of circadian and social rhythm measures 
The current study observed no differences in either the level or variability of circadian 
rhythm measures over 14 days between bipolar disorder and general population participants. 
A trend towards greater variability in relative amplitude was observed in bipolar disorder, 
but did not remain significant after controlling for multiple comparisons. In line with 
theoretical postulation that circadian rhythm disruption may cause relapse in mood disorders 
(e.g. Healy and Williams, 1988, 1989), the present study had hypothesised that an 
underlying biological vulnerability to bipolar disorder may be present during inter-episode 
periods; disturbances in circadian rhythms were proposed to indicate biological 
dysregulation. Reasons for the ongoing sleep disruption observed in bipolar disorder may 
have included homeostatic regulation problems or faulty circadian timing. Indeed, when 
participants with bipolar disorder were considered over their full monitoring periods, 
greater variability in the relative amplitude of the sleep-wake cycle was observed after 
controlling for multiple comparisons. Relative amplitude describes the wave of the sleep-
wake cycle across day and night in terms of activity levels. Greater variability may suggest 
that the waves ofrest and activity in individuals with bipolar disorder were more unstable. 
Thus, some disturbance in circadian rhythms may be tentatively suggested to occur over 
longer time periods in bipolar disorder. Evidence, however, suggested no underlying 
circadian rhythm disturbance across a brief 14 day period in bipolar disorder, as measured 
byactigraphy. 
There has been little actigraph research conducted to date that investigated circadian rhythm 
disruption in mood disorders. Two studies have observed circadian rhythm disturbances in 
seasonal affective disorder samples. A study by Teicher et al (1997) reported lower 
interdaily stability occurred over a three day period in seasonal affective disorder compared 
to the general population (N=25 unipolar or bipolar depression with seasonal pattern; N=20 
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general population). This suggests less regularity of the rest-activity rhythm to 
environmental zeitgebers from day-to-day in individuals with seasonal affective disorder. A 
more recent study (N=17 seasonal affective disorder, N=17 general population; Winkler et 
ai, 2005) reported a lower level of relative amplitude in seasonal affective disorder; no 
differences were observed in either interdaily stability or intradaily variability between 
seasonal affective disorder and general population samples. Actigraph research has also 
observed circadian rhythm disruption in Alzheimer's disease; lower interdaily stability and 
higher intradaily variability occurred in individuals with Alzheimer's disease compared to 
general population individuals (Witting et ai, 1990). Similar disturbances were expected to 
be observed in the current study. Actigraphy is a valid measure of circadian rhythms, so 
possible reasons for non-significant fmdings in the current study include the sample size and 
length of monitoring period, particularly since relative amplitude disturbance, but not 
attenuation, showed trends towards greater variability across 14 days whilst this greater 
variability was evident across a longer time period in bipolar disorder. It also remains 
possible that circadian rhythm disturbance of the rest-activity rhythm does not occur during 
inter-episode periods in bipolar disorder. 
The timing of circadian rhythms may be maintained by several environmental and social 
zeitgebers, including light and social rhythm regularity. Disturbances in these zeitgebers 
may thus lead to disruption in circadian rhythms; zeitgeber disturbance may be an incipient 
indicator of future circadian rhythm disturbance. In the present study, the level and 
variability of circadian rhythm measures over 14 days were not observed to differ between 
bipolar disorder and the general population. The zeitgeber monitored in the present study 
was daily social rhythms. When the level and variability of social rhythm measures were 
compared, similar to circadian rhythm findings, no differences emerged between participant 
groups over a 14 day period. No evidence of social rhythm disruption was evident across 
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longer monitoring periods in bipolar disorder either, after controlling for multiple 
comparisons. Thus, the current study observed no disturbances in social rhythms during 
inter-episode periods in bipolar disorder. 
Previous research evidence, with a similar sample size to the current study, has shown social 
rhythm disturbances in mood disorder samples over longer monitoring periods. A research 
study with a remitted depression sample suggested seven weeks of monitoring was required 
to obtain a representative estimate of an individual's level of social rhythm regularity, 
although two weeks monitoring was adequate for a general population sample (N=20 
unipolar depression, N=15 general population; Monk et ai, 1991). Although no 
disturbances in social rhythm regularity were evident across longer monitoring periods in 
bipolar disorder, ten of the twenty participants had completed less than seven weeks of 
social rhythms monitoring. This may have impacted on the results obtained. Therefore, 
perhaps longer monitoring periods across all participants would have provided a more 
accurate indication of whether social rhythm disturbance occurs in bipolar disorder over 
inter-episode periods. 
Social rhythm regularity was not found to differ between bipolar disorder and the general 
population in the present study. Although research evidence has suggested lower social 
rhythm regularity in acute depression (Szuba et ai, 1992; Brown et aI, 1996), regularity has 
not been reported to significantly differ from the general popUlation when depression is in 
remission (Monk et ai, 1991). Since participants with bipolar disorder in the present study 
were monitored over a 14 day period during which no acute episodes occurred, it was 
consistent with these earlier fmdings that no group differences emerged. However, Ashman 
et al (1999) reported lower social rhythm regularity in rapid cycling bipolar disorder 
compared to the general population. Furthermore, Ashman et al found no variation in social 
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rhythm regularity for bipolar disorder participants across elated and depressed states 
suggesting lower regularity was not due to mood state. Thus, it remains unclear to what 
extent, if any, that social rhythms may change across euthymic, depressed and elated states in 
individuals with bipolar disorder. Findings from the present study add to the evidence that 
social rhythm regularity during inter-episode periods in mood disorders may not differ from 
the general population. 
Similar regularity in social rhythms across bipolar disorder and general population groups 
suggested the participants with bipolar disorder maintained regular lifestyles. This was an 
interesting finding since bipolar disorder has been previously associated with reduced 
occupational functioning (Coryell et aI, 1993; MacQueen et aI, 2001). As work can be 
considered a regular zeitgeber, reduced occupational functioning could be expected to 
impact on social rhythm regularity in bipolar disorder. The Social Rhythm Metric recorded 
the activity time to 'start work, school, housework, volunteer activities, child or family care,' 
but no specific information on occupation activity was collected. However, only six (30%) 
of the bipolar disorder participants were known to be employed compared to eight (80%) of 
the general population participants. Moreover, some of the participants with bipolar 
disorder regularly attended structured group activities such as gardening and art classes at 
the Lithium Clinic. It is possible that this attendance had a positive effect on the regularity 
of social rhythms. This should be considered tentatively with further investigation necessary 
to investigate the potentially beneficial effect of attending structured activities at a Lithium 
Clinic on social rhythm regularity. 
Greater variability of social rhythm regularity had been expected to occur in the bipolar 
disorder group. A previous study by Monk et al (1991) had reported greater variability in 
weekly social rhythm regularity in remitted depression compared to the general population. 
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In contrast, the present study found no differences in the variability of social rhythm 
regularity between bipolar disorder and the general population. Sample sizes from the 
current study and Monk et ai's (1991) research were relatively small, suggesting more 
investigations into variability of social rhythms in mood disorders may be necessary to 
identify whether greater variability occurs across inter-episode periods, in comparison to the 
general population. Indeed, variability during inter-episode periods may differ between 
unipolar and bipolar disorders. 
Investigation ofthe level and variability of daily activities suggested no group differences; 
number of daily activities completed was not found to differ between bipolar disorder and 
the general population in the present study. Previous research comparisons between 
general population and mood disorder samples have observed lower numbers of weekly 
activities performed in currently depressed (Brown et ai, 1996) and rapid cycling bipolar 
disorder individuals (Ashman et ai, 1999) but no differences in acutely depressed (Szuba et 
ai, 1992) or remitted depressed individuals (Monk et ai, 1991). Although the present study 
found no evidence that the number of daily activities completed differed between bipolar 
disorder and the general population, since ten participants with bipolar disorder had 
completed less than the seven weeks necessary to identify social rhythm 'traits' (Monk et ai, 
1991), longer monitoring periods across all participants may have been more effective in 
determining whether social rhythm disturbances exist during inter-episode periods in bipolar 
disorder. 
5.3 Average level and variability of behavioural activation/inhibition measures 
Although behavioural activation dysregulation theories (e.g. Depue et ai, 1987) suggest the 
emotion systems of behavioural activation and inhibition would differ in bipolar disorder 
compared to the general population, no significant differences in either level or variability 
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were evident in the present study. Although behavioural activation and inhibition are 
posited to be biological systems, the systems were measured with a self report questionnaire 
about behaviour. The behavioural inhibition system (81S) level and three behavioural 
activation system (BAS) subscale (reward responsiveness, drive, fun seeking) levels or their 
respective variability's across 14 days were not observed to differ between bipolar disorder 
and general population groups. Further investigation of behavioural activation and 
inhibition across longer monitoring periods in bipolar disorder also suggested the level and 
variability of these measures does not differ between bipolar disorder and the general 
population. 
Earlier research evidence had suggested differences in behavioural activation and inhibition 
levels between mood disorder and general population individuals may exist. A study by 
Meyer et al (2001) reported higher cross-sectional levels of behavioural inhibition, BAS 
drive and BAS fun seeking in bipolar disorder participants compared to the general 
population; no significant group differences were observed in BAS reward responsiveness. 
However, it is possible that methodological factors, including the impact of cultural 
differences, may have contributed to the group differences reported; Meyer et al (200 I) 
compared 59 American individuals with bipolar disorder with 729 Australians recruited 
from the general population by another study (Jorm et aI, 1999). Furthermore, behaviour 
activation/inhibition measures were self-reported in individuals with bipolar disorder across 
a range of euthymic, depressive, mixed and manic states. The impact of grouping this 
spectrum of mood states on the level of behavioural activation/inhibition is uncertain. The 
directions of behavioural activation levels in mood disorders compared to the general 
population were contrary between Meyer et al (200 I) and a more recent study (Kasch et ai, 
2002). Similarly to Meyer et al (2001), a study by Kasch et al (2002) observed higher 
cross-sectional levels ofBIS in currently depressed participants compared to the general 
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population. In contrast, Kasch et al (2002) reported lower BAS reward responsiveness, 
BAS drive and BAS fun seeking. Thus, although preliminary cross-sectional evidence 
suggested differences in behavioural activation and inhibition may exist between mood 
disorders and the general population, direction of differences may be influenced by current 
mood symptoms. Indeed, the level of behavioural activation has been theoretically 
postulated to vary across mood states in bipolar disorder; high behavioural activation during 
mania and low behavioural activation during depression (Depue & Zald, 1993). 
Three previous research studies addressed the associations between behavioural activation 
and inhibition with manic and depressive symptoms in mood disorder samples (Meyer et aI, 
1999, 2001; Kasch et aI, 2002). Meyer et aI's (1999) cross-sectional study reported the 
three BAS subscales were positively correlated with manic symptoms whilst negatively 
correlated with depressive symptoms in individuals at risk of developing a mood disorder. 
The BIS was also significantly correlated with depressive symptoms, but not manic 
symptoms. Meyer et al (2001) observed no significant cross-sectional correlations between 
BAS subscales and depressive/ manic symptom severity in bipolar disorder participants. 
However, a significant positive correlation was observed between BIS and depressive 
symptom severity; BIS level did not correlate significantly with manic symptom severity. 
Finally, Kasch et al (2002) reported significant negative cross-sectional correlations 
between depressive symptom severity and BAS subscale levels for the depressed 
participants; BIS level did not correlate significantly with depressive severity. Thus, 
evidence to date suggests higher behavioural activation may be associated with elation, 
lower behavioural activation with depression and higher behavioural inhibition with 
depression. However, findings across studies were not entirely consistent and 
generalisation may be limited by the diverse samples recruited. 
184 
Ifbehavioural activation or inhibition does vary across different mood states in bipolar 
disorder, then greater variability would be evident in BIS and BAS across time. Variability 
across a 14 day period in behavioural activation or inhibition was not found to differ 
between bipolar disorder and general population groups in the present study. Two studies 
with mood disorder samples have also investigated associations between BISIBAS and 
symptoms across time. Firstly, Kasch et al (2002) reported BIS and BAS were stable 
across initial and eight month follow up ratings in individuals with current major depression; 
changes in BISIBAS ratings were not found to be associated with changes in depression 
severity. Secondly, Meyer et aI's (2001) investigation of longitudinal associations between 
BISIBAS and elation/depression observed no associations between behavioural activation 
and elation/depression across time. The level of behavioural inhibition was found to vary 
with depression, but not with mania. Thus, research to date has not provided compelling 
evidence that dysregulated behavioural activation exists in bipolar disorder. 
If behavioural activation dysregulation does exist in bipolar disorder, then a possible 
methodological explanation for the lack of variability observed by research studies may be 
the measurement of behavioural activation. Since the BISIBAS Scales is a trait measure 
that individuals rate how they feel generally and not for a specific time period, then it is 
perhaps unsurprising that variability across time has not been indicated. Furthermore, a 
recent theoretical proposal by Johnson et al suggested that it may not be the level of 
behavioural activation that differs over time but the occurrence of incentive cues that vary 
leading to symptoms of mania in bipolar disorder (Johnson et aI, 2003). In particular, 
Johnson et aI's (2000c) study observed increased symptoms of mania following goal 
attainment life events, which may be considered as reward responsiveness cues. Although 
a strong theoretical base led the hypothesised association between behavioural activation 
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and elation/depression in bipolar disorder, the present study did not provide any evidence to 
support the theory of behavioural activation system dysregulation in bipolar disorder. 
5.4 Average level and variability ofself esteem measu res 
The present study observed differences in the level and variability of self esteem between 
individuals with bipolar disorder during inter-episode periods and the general population. 
Participants with bipolar disorder reported lower levels of self esteem with higher day-to-
day variability across a prospective 14 day period. These differences remained between 
groups when the level and variability of self esteem were considered for participants with 
bipolar disorder over their full prospective monitoring periods. Furthermore, when positive 
and negative self esteem subscales were investigated, both level and variability of the 
subscales differed between bipolar disorder and general population groups. This would 
suggest that general self esteem, rather than a specific dimension, differed in bipolar 
disorder during inter-episode periods compared to the general population. 
The current fmding of lower self esteem in bipolar disorder compared to the general 
population was consistent with previous research studies. Most investigations have 
reported lower self esteem levels in bipolar disorder, during inter-episode periods, 
compared to the general population (Shapira et aI, 1999; Blairy et ai, 2004; Serretti et ai, 
1999, 2005). A different level of self esteem in remitted bipolar disorder compared to the 
general population may suggest self esteem as an enduring cognitive vulnerability factor, 
with reduced self esteem associated with relapse in the disorder. A recent review reported 
the interaction between low self esteem and onset of depressive symptoms or episodes was 
not robust (Roberts & Monroe, 1999). However, since studies reviewed mainly comprised 
general population samples such findings may not necessarily reflect associations in clinical 
samples. A more recent study with a bipolar disorder sample, reported low self esteem 
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level was associated with onset of bipolar depression but not related to mania (Johnson et 
al,2000b). Furthermore, preliminary evidence has suggested differences exist in self 
esteem levels across individuals categorised by bipolar mood state; self esteem was lowest 
in bipolar depression, highest in remission, whilst in hypomania, self esteem level occurred 
between the levels of depressed and remitted states (N=77 bipolar disorder; Scott & Pope, 
2003). Thus, although low self esteem may occur across inter-episode periods in bipolar 
disorder, with few investigations of diathesis-stress associations, the clinical significance of 
low self esteem with regard to relapse in bipolar disorder is as yet unclear. 
Research evidence has suggested that low self esteem may be a relative term which actually 
reflected intermediate responding. For instance, Baumeister et al (1989) reviewed self 
esteem sample distributions from 23 research studies with general population samples and 
observed a higher self esteem sample midpoint than the conceptual midpoint. Intermediate 
responding has also been observed in remitted bipolar disorder samples with higher mean 
self esteem levels than conceptual midpoints (Johnson et ai, 2000b; Blairy ct aI, 2004; 
Serretti et ai, 2005). The current study also observed an average self esteem level in 
bipolar disorder that was higher than the conceptual midpoint of Rosenberg's self esteem 
questionnaire. Self esteem levels higher than the conceptual midpoint suggest that 
although individuals do not have a high opinion of themselves, they do not necessarily have 
a negative view of themselves. When Likert response self esteem ratings were plotted for 
bipolar disorder and general population groups, descriptive differences between groups 
emerged. General population participants tended to 'agree' with positive self esteem 
statements and 'disagree' with negative self esteem statements. In contrast, participants 
with bipolar disorder had a wide range of responses to positive and negative selfesteem 
statements, with no particular mode response (Appendix F provides distribution of rating 
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responses to self esteem. These findings may be usefully applied to targeted psychological 
interventions to improve self esteem levels, which may then reduce risk of relapse. 
The current study observed group differences in both the level and variability ofpositive and 
negative self esteem measures. Lower levels of positive and negative self esteem were 
evident in bipolar disorder (higher scores indicated higher self esteem for both subscales due 
to application of reverse scoring). Moreover, higher variability'S of positive and negative 
self esteem were evident in bipolar disorder. These findings suggested that general self 
esteem, rather than a specific dimension, was disturbed across inter-episode periods in 
bipolar disorder, compared to the general population. This was consistent with recent 
research that reported the Rosenberg self esteem questionnaire to be unidimensional with 
general population samples (Gray-Little et aI, 1997; Greenberger et ai, 2003). In 
particular, Greenberger et al (2003) reported the two-factor structure of the questionnaire 
was an artefact of positive and negative wording. Evidence from the current study may 
suggest that negative and positive self esteem may both be considered as cognitive 
vulnerability factors in bipolar disorder. 
Greater variability in self esteem was observed in bipolar disorder compared to general 
population participants. Disturbances in self esteem occur during acute bipolar episodes, 
but this finding suggests that disturbances in self esteem may also exist during inter-episode 
periods in bipolar disorder. Greater variability in self esteem may be considered a cognitive 
vulnerability factor in the course of bipolar disorder, particularly if this instability could be 
associated with the course of the disorder. Indeed, self esteem variability across time was 
suggested to be of clinical importance in the current study. Greater self esteem variability 
predicted earlier admission in the subgroup of bipolar I disorder participants. Therefore, 
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tentative analyses suggest greater self esteem variability was associated with poorer 
outcome in bipolar disorder. 
The current fmding ofgreater self esteem variability in bipolar disorder compared to the 
general population is in line with previous research fmdings. Studies have reported self 
esteem variability as a predictor of depressive symptoms in general population samples 
(Roberts & Monroe, 1992; Kemis et aI, 1998). Little research has been conducted into self 
esteem variability in bipolar disorder. The current study's fmdings that variability in self 
esteem was heightened in bipolar disorder and possibly associated with earlier relapse has 
indicated the importance of further investigations with clinical samples will be necessary to 
test the robustness ofthese fmdings. 
5.5 Average level and variability of affect measures 
The average affect levels of individuals from bipolar disorder across inter-episode periods 
differed from the general population. Lower positive affect and higher negative affect and 
depressed levels were evident in bipolar disorder across a 14 day period; elated levels were 
not found to differ. When participants with bipolar disorder were considered over their full 
monitoring period, group differences between positive affect and depression levels remained. 
Differences in the level of positive affect between bipolar disorder and the general population 
was consistent with the theoretical model of behavioural activation dysregulation in bipolar 
disorder. Behavioural activation has been theoretically related to positive and negative 
affects. Although behavioural activation disturbances were not evident in the current study. 
it is posited that the observed disturbances in affect may reflect chronic disturbance in an 
underlying affect regulation system. 
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Some investigations have suggested differences in affect between the working week and the 
weekend. Positive affect has been reported to be higher and negative affect lower, on 
weekends than weekdays (Stone et ai, 1985; Clark & Watson, 1988; Kennedy-Moore et aI, 
1992). Observation of different levels of affect between groups in the present study may 
thus be limited if participant groups had different proportions of midweek days and 
weekend days. However, in the present study, when days of the week were considered, 
71 % of monitoring days were midweek days (Monday to Friday) and 29% were weekend 
days (Saturday and Sunday) for both bipolar disorder and general population groups. 
Consequently, a day of week effect was not responsible for the observation of different 
affect levels between groups. 
The current study observed lower average levels of positive affect and higher levels of 
negative affect in bipolar disorder. A discrepancy with the findings ofa prior prospective 
investigation of affect levels was noted. An experience sampling method study observed 
lower positive affect in bipolar disorder during inter-episode periods, but no difference in 
negative affect, compared to the general population (N=38 bipolar disorder. N=49 general 
population; Myin-Germeys et aI, 2003). The inconsistency in observed negative affect level 
across the two studies would suggest further investigation is necessary to supplement this 
preliminary evidence. In particular, investigation of affect levels with consideration of 
bipolar mood state may provide a more comprehensive understanding. To date, evidence is 
beginning to accumulate to suggest that affect levels across inter-episode periods in bipolar 
disorder remain disturbed compared to the general popUlation. The direction of these 
disturbances in positive and negative affects may require consideration of the presence of 
concurrent bipolar mood symptoms. 
190 
Higher levels of depression were evident in bipolar disorder across inter-episode periods 
compared to the general population. This finding suggests that individuals with bipolar 
disorder were experiencing ongoing bipolar mood disturbance. The observed lower levels 
of positive affect and higher negative levels may also suggest the presence of depressive 
affect. Higher depressed affect during inter-episode periods was consistent with a previous 
investigation by Millar et al (2004) who reported higher average depressed ratings over five 
nights in bipolar disorder compared to general population individuals. Furthermore, 
longitudinal studies (Judd et aI, 2002, 2003b; Joffe et aI, 2004) have reported subsyndromal 
symptoms commonly occur during inter-episode periods in bipolar disorder. 
Mood variability was not suggested to differ between bipolar disorder and the general 
population in the current study. No differences in the variability of positive, negative, 
depressed or elated affect ratings over 14 days were observed between participant groups. 
However, when participants with bipolar disorder were monitored over longer time periods, 
greater variability in negative affect and depressed ratings emerged. Current findings were 
in conflict with the hypothesised greater variability in affect expected to occur in bipolar 
disorder. In particular, high intraindividual variability in affect had been posited to provide 
support for the diathesis-stress model of behavioural activation dysregulation. Therefore, 
results suggested that although dysregulation in affect, in terms of variability, did not occur 
in the present bipolar disorder sample, disturbances were evident in terms of affect levels. 
Evidence has been inconsistent as to whether greater mood variability occurs in mood 
disorders compared to the general population. A recent study by Millar et al (2004) found 
no difference in mood variability, measured by a visual analogue scale ranging from most 
depressed to most manic, over five days between bipolar disorder and general population 
groups. In contrast, Lovejoy and Steuerwald (1995) reported greater positive and negative 
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affect variability's across 28 days in individuals with cyclothymia compared to the general 
population. Furthermore, high positive and negative affect variability across 30 days have 
been associated with depressive symptoms in a general population sample (McConville & 
Cooper, 1996). The combination of few studies that used different lengths of monitoring 
with small sample sizes of clinical and non-clinical participants limits generalisations. Since 
studies reporting differences in affect variability used longer monitoring periods, uncertainty 
remains as to whether observation of greater affect variability in mood disorders required a 
longer monitoring period than the 14 days used in the present study. To date, evidence 
from the current study and Millar et al (2004) suggested no disturbance in affect variability 
in bipolar disorder across relatively brief inter-episode periods. 
S.6 Limitations of current study 
The present study had several limitations that may have had an impact on the findings 
obtained. The sample size recruited, power of study, statistical analyses with small sample 
sizes, different sample sizes across groups, groups not matched, diagnostic interview not 
used to screen participants, the mixed diagnostic bipolar disorder sample, daily monitoring, 
no measurement of complexity, no measurement of ongoing clinical symptoms, correlation 
of Rosenberg self esteem questionnaire with depressive symptoms, and admission as an 
outcome measure were identified as possible methodological limitations. The limitations 
identified suggest that Type II errors, rather than Type I errors, may have been more likely 
to occur. Each limitation identified will be briefly discussed in tum. 
The first limitation of the study was the sample size of participants with bipolar disorder 
recruited was smaller than anticipated. The small sample size had an impact on the 
obtained power ofthe study. Although 55 individuals with bipolar disorder had been 
initially identified for the study, only 20 individuals were recruited and successfully 
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completed a period of prospective daily monitoring. Recruitment from a Lithium Clinic 
depended on a staff psychiatrist discussing the project with potential participants before 
introducing the researcher (Alison Jackson) to those individuals interested in participating in 
the project. Time constraints of the clinic meant 11 potential participants had not been 
approached during the recruitment phase of the project. Multivariate analysis of six 
dependent variables with an estimated moderate effect size (d=0.75), a 0.05, p 0.20 and 
desired level of 80% statistical power would require a sample of at least 50 participants. 
Thus, limited power may have led to underestimation of differences in average level and 
variability of measures between general population and bipolar disorder groups. 
The small sample recruited also had an impact on the robustness of conducting statistical 
analyses with smaller subgroups of the sample. When investigating the significance of 
variability in bipolar disorder, the small clinical sample was divided into smaller subgroups 
according to diagnostic subtype or variability type for exploratory survival analyses. The 
results of survival analyses must be considered extremely tentative due to the very small 
numbers in the subgroups. The effect size in survival analysis is calculated as the ratio of 
events at a given time-point (Norman & Streiner, 2000), which in the current study was the 
ratio of admissions at an approximate three year follow-up (range of follow-up from 38 to 
44 months). To test differences in survival between low and high variability subgroups 
with a two tailed test using a level 0.05, p level 0.20 and with a large effect size of2.0, then 
N=33 admissions per group would have been required for the desired 80% power. With 
the observed 40% admission rate, the required sample size should have been approximately 
83 participants in each group, comprising a total of 166 participants with bipolar disorder. 
Compared to the actual sample of20 participants with bipolar disorder recruited and 
followed-up at three years, survival analyses with such small sample numbers may not have 
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been appropriate. Therefore, limited power in the exploratory bipolar disorder subgroup 
comparisons must be noted. 
The comparisons between bipolar disorder and general population groups may have been 
limited since groups were not matched. Firstly, matching groups on factors that may 
impact on the mean level and variability of measures would have been beneficial. Factors 
that may have been used to match participants across groups include gender, age, 
occupation, and alcohol/drug use. The equal gender proportion of 50% males and 50% 
females was the same in both participant groups and there was no significant difference in 
age between bipolar disorder and general population groups (Section 4.1.3 provides more 
information). No specific information on occupation was collected, although this could 
have had an impact on most ofthe measures. For instance, employment may influence the 
regularity of social rhythms and the sleep-wake cycle. Finally, alcohol and substance use 
could have influenced measures in the current study. Prescribed medications in bipolar 
disorder participants were recorded, although adherence to medication (e.g. by blood 
lithium levels) was not monitored. It was not recorded if any general population 
participants were taking prescribed medication. In addition to prescription medicine, 
alcohol and substance use may both impact on social and circadian rhythms, including the 
sleep-wake cycle. By not matching groups in the current study, it remains unclear if the 
groups differed due to the presence of bipolar disorder or due to other factors. 
The comparisons between bipolar disorder and general population groups may also have 
been limited since different sample sizes were recruited across groups. Initially, the current 
study intended to replicate and extend a previous investigation by Ashman et al (1999). 
When a participant with bipolar disorder had completed a minimum eight week period of 
monitoring, an age and gender matched participant from the general population was 
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recruited (Section 3.2.2 provides further information). Between-group comparisons were 
intended to compare a two week period in general population participants compared to the 
full monitoring period in bipolar disorder participants (full bipolar disorder monitoring 
period comparisons provided in Section 4.8 and Appendix K). However, following 
statistician advice, between-group comparisons were altered to compare the same time 
period length. Since this decision was taken after data collection had been completed, 
further participants from the general population were unable to be recruited. Between-
group comparisons subsequently analysed differences in twenty participants with bipolar 
disorder compared to ten participants from the general population; group sample sizes 
differed between analyses as participants were excluded if missing data occurred. 
Therefore, unequal sample sizes may have impacted on the robustness of the analyses. 
A diagnostic interview was not used to screen participants for the research study. Inclusion 
criteria specified that participants with bipolar disorder had to meet DSM-IV criteria for 
bipolar lor bipolar II disorders. A staff psychiatrist confirmed case diagnosis from the 
casenotes of individuals who participated. Using the Structured Clinical Interview for 
DSM-IV (First et aI, 1997) for diagnostic classification would have been more rigorous. 
Furthermore, using this structured clinical interview to screen participants from the general 
population for mental health disorders would also have been beneficial. The use of a 
diagnostic interview would have required additional training for the research assistant 
(Alison Jackson) but would have been an improvement on the methodology applied for the 
current study. 
A further methodological limitation was analysis ofa mixed diagnostic bipolar disorder 
sample. The present study recruited a mixed bipolar disorder sample that comprised 
individuals with bipolar I, bipolar II and rapid cycling disorders. Bipolar disorder subtypes 
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by definition differ in the expression of symptom intensity and frequency. It is therefore 
quite possible that variability across inter-episode periods may also differ between bipolar 
disorder sUbtypes. Since research into inter-episode variability in bipolar disorders is 
preliminary, future investigations may benefit from considering each subtype of bipolar 
disorder separately. Indeed, survival analyses in the present study suggested high self 
esteem variability specifically predicted admission in bipolar I disorder, but not in bipolar II 
or rapid cycling disorders. Thus, if variability differs across diagnostic subtypes, then 
recruitment ofa relatively small bipolar disorder sample with three subtypes may have 
obscured differences between level and variability of measures across bipolar disorder and 
general popUlation groups. 
Another possible methodological limitation of the current study was the use of daily 
monitoring to measure affect. Self esteem was rated for the present moment, whilst end of 
day completion for the social rhythm has already been indicated as reliable (Monk et aI, 
1990). In contrast, participants completed daily self report affect ratings at the end of each 
day. This method was reliant on participants' accurate recall of the day to provide a 
generalised rating for the day that was not distorted. Both mood duration and intensity 
throughout the day requires consideration for a representative daily average mood (Hedges 
et aI, 1985). Furthermore, there may also be recency effects where more recent mood 
states may be remembered better (Parkinson et aI, 1995). Future research should perhaps 
consider momentary assessment of affect. Momentary sampling within days to provide 
daily mood may be useful, although using a single momentary measure for each day may not 
provide accurate representation of daily mood (Hedges et aI, 1985). However, limitations 
of frequent momentary assessment include potential reactive effects as well as becoming an 
increasingly intrusive procedure in the participant's daily life as frequency of monitoring 
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increases (Parkinson et aI, 1995). Investigation of daily versus momentary assessments of 
affect in clinical samples may elucidate which methodology would be most useful to apply. 
The present study did not consider the role of self-complexity or affect complexity in 
influencing variability in self esteem and affect. Research with general population samples 
has reported associations between complexity and variability. Greater self-complexity has 
been associated with less variability in both cognition (Rhodewalt et aI, 1998) and affect 
(Campbell et aI, 1991; Brown & Mankowski, 1993), whilst greater affect complexity has 
been associated with less variability in affect (Wessman & Ricks, 1966; Larsen & Cutler, 
1996). Future investigations may benefit from exploration of self- or affect complexity in 
clinical and general popUlation samples, as it is thus possible that complexity may influence 
the extent of day-to-day variability. Differences in self-complexity and affect complexity 
between mood disorders and the general population are unclear. Cognitive vulnerability 
has been reported in bipolar disorder, in terms of poor problem solving and over-general 
memory (Scott et aI, 2000). Such evidence leads the suggestion that self-complexity 
disturbances may be more likely to occur in bipolar disorder. Ifvariability in self esteem is 
a robust difference between bipolar disorder and the general population, then consideration 
of self-complexity may provide a more comprehensive understanding of the role of self 
esteem variability in the course of bipolar disorder. 
Although the current study aimed to investigate a clinical sample until relapse, no 
measurement of ongoing clinical symptoms was conducted during the daily prospective 
monitoring period. The PANAS had been altered to include ratings of elated and 
depressed affect, but these ratings did not provide a clinical rating of bipolar mood. Using 
an ordinal five point rating scale from not at all to extremely for bipolar mood was limited 
since it was unclear if the items measured the same intensity of elation and depression 
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across bipolar disorder and general population samples. It is possible that individuals with 
bipolar disorder may have responded differently to these items; prior experience of acute 
manic and depressive episodes may impact on the completion of daily elated and depressed 
ratings. Furthermore, recent evidence indicates that individuals with bipolar disorder 
commonly experience varying levels of symptomatology outwith acute episodes (Judd et aI, 
2002, 2003b; Joffe et aI, 2004). Use ofc1inician ratings (e.g. Hamilton Depression Rating 
Scale, Hamilton, 1960; Young Mania Rating Scale, Young et aI, 1978) or self-report scales 
(e.g. Internal State Scale, Bauer et aI, 1991) may have provided more robust indications of 
ongoing bipolar mood symptoms. Thus, the current study would have benefited from using 
a clinical measure of ongoing symptoms for the participants with bipolar disorder. 
The current study observed lower self esteem in bipolar disorder compared to general 
population participants. This was consistent with previous cross-sectional investigations of 
self esteem across inter-episode periods in bipolar disorder in the absence ofsubsyndromal 
symptoms (Serretti et aI, 1999; Shapira et aI, 1999; Blairy et aI, 2004). However, self 
esteem level has been reported to predict depressive symptoms in bipolar disorder (Johnson 
et aI, 2000b) and mood disorder (Roberts et aI, 1999) samples. In particular, the 
Rosenberg self esteem questionnaire has been observed to correlate with depressive 
symptoms, with lower self esteem associated with higher levels of depression. The current 
study observed higher depressed ratings in bipolar disorder compared to general population 
participants. It is therefore possible that the observed difference in self esteem level 
between groups could have been due to the difference in self-rated depressed affect. 
First admission to hospital following study participation was selected as the follow-up 
outcome measure for bipolar disorder participants. The advantage of using the first 
admission date was that it was a well-defined, dichotomous marker of severity. One 
198 
possible limitation was that the episode polarity for admission was not known. Evidence 
has accumulated to suggest variables that impact on mania do not have the same importance 
for bipolar depression and vice versa. For example, self esteem may playa role in 
precipitating bipolar depression (Johnson et ai, 2000b), whilst behavioural activation, 
particularly reward responsiveness, may be more important in precipitating mania (Meyer et 
al,2001). Thus, by not obtaining admissions for manic and depressive relapses separately, 
it was possible that some associations may have been obscured. In any case, the small 
sample size recruited in the current study limited the extent of potential subgroup analyses. 
A further limitation of using first admission as an outcome measure was that no information 
was gathered for acute episodes managed without admission to hospital. The potential to 
manage episodes in the community may differ across mania and depression; clinician 
knowledge suggests individuals tend to be more likely admitted for mania than for 
depression. Therefore, further research should endeavour to monitor the occurrence of 
episodes where admission does not occur as well as episode polarity. 
5.7 Implications 
The present study highlighted the importance that length of prospective monitoring may play 
in determining differences between groups. Three group differences (self esteem, night 
waking, and sleep efficiency) were observed between bipolar disorder and the general 
population when the variability of measures over a 14 day period was compared. When 
participants with bipolar disorder were measured over a longer monitoring period, greater 
variability emerged in six measures for bipolar disorder (sleep efficiency, fragmentation 
index, relative amplitude, self esteem, negative affect and depressed ratings). Participants 
with bipolar disorder were monitored for up to six months in contrast to the) 4 day 
monitoring period for general population participants. This longer time period could have 
led to a sampling error whereby greater variability in bipolar disorder occurred merely due to 
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differences in monitoring periods. Although this error is possible, it is also as likely that as 
the length of the monitoring period increases, each participant's ratings would provide a 
more accurate 'trait' level and variability for each measure. 
As individuals with bipolar disorder commonly experience inter-episode symptoms of 
varying intensity, perhaps a longer sampling period may be necessary to provide a reliable 
average level and variability of a prospective measure. Previous investigations have already 
highlighted that a longer time period is necessary for social rhythm 'traits' to be identified in 
mood disorders than in the general population (Monk et aI, 1991; Ashman et aI, 1999). A 
methodological implication from the current study was that if future investigations monitored 
variability over a longer time period (e.g. eight weeks) in both clinical and general population 
samples this could provide more reliable estimations of the level and variability of diathesis 
vulnerability, behavioural, self esteem and affect measures over time. 
Disturbances in the average level and variability of several measures, such as self esteem, 
were identified in bipolar disorder relative to the general population in the current study. 
Future investigations over longer time periods will be necessary to further clarify 
associations between the level and variability of measures and relapse in bipolar disorder. 
Furthermore, although considerably more time consuming than cross-sectional 
investigations, it would be methodologically important for future studies to prospectively 
assess the level and variability of measures. Previous investigations have identified that 
individuals do not accurately report their average level and variability for a specified 
measure. For instance, weak associations have been reported between self-report general 
self esteem levels and self esteem average levels (Kernis et ai, 1992; Greenier et aI, 1999) 
and between self- report measures of self esteem variability and prospectively measured self 
esteem variability (Kern is, 1993; Kernis et ai, 1989, 1992). Prospective assessment may 
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also provide further opportunities to investigate associations from day-to-day with time 
series analyses. The present study did not provide any consistent evidence of associations 
between measures across time in bipolar disorder. However, larger samples following 
participants across euthymic and acute periods may provide clarification of both inter-and 
intra-individual associations between diathesis vulnerability, behaviour, self esteem and 
affect measures from day-to-day. Thus, to obtain accurate estimations of the average level 
and variability of measures over time, prospective assessment is essential. 
The level and variability of self esteem was disturbed in bipolar disorder. Reduced self 
esteem levels during inter-episode periods in bipolar disorder were evident compared to the 
general population. Cross-sectional studies, with large samples have also observed low self 
esteem in remitted bipolar disorder (Shapira et aI, 1999; Blairy et aI, 2004; Serretti et aI, 
1999, 2005). Greater variability in self esteem was also evident in the current study, 
suggesting a general dysregulation in self esteem may occur in bipolar disorder. Survival 
analyses tentatively associated self esteem variability with earlier admission to hospital for 
bipolar I disorder in the current study. Low self esteem has been reported to predict higher 
levels of depression, with no observed impact on mania (N=31 bipolar I disorder; Johnson et 
al,2000b). Furthermore, a previous investigation with a sample that comprised individuals 
with seasonal affective disorder suggested low self esteem was associated with earlier 
relapse (N=45 seasonal affective disorder; McCarthy et aI, 2002). Bipolar disorder although 
routinely treated with pharmacotherapy, has been recognised to benefit from adjunctive 
psychological interventions (Scott & Todd, 2002). As such, self esteem disturbances in 
bipolar disorder may be considered as a potential focus for psychological interventions that 
may improve outcome for the disorder. 
201 
Night-to-night variability in night waking and sleep efficiency across inter-episode periods in 
bipolar disorder was disturbed relative to variability observed in the general population over 
a brief 14 day prospective monitoring period. Furthermore, variability in sleep efficiency 
was tentatively associated with earlier admission in bipolar disorder. These fmdings have 
important clinical implications for prognosis in bipolar disorders. Sleep disturbance may be 
considered as a potentially modifiable variable, whilst other risks of relapse are not 
susceptible to change. Indeed, two case studies suggested the course of rapid cycling 
disorder was stabilised by regulating timing and duration of sleep (Wehr et aI, 1998; Wirz-
Justice et aI, 1999). The present study has provided further evidence of the clinical 
importance of sleep in the course of bipolar disorder. 
Identification of sleep disturbance as a predictor of relapse may be of clinical importance for 
bipolar disorder. Sleep disturbance, unlike other risk factors for relapse, could be amenable 
to change. Psychological therapies already promote the advantages ofa good sleep-wake 
cycle (e.g. interpersonal and social rhythm therapy; Frank et aI, 1999). Actigraphy. in 
addition to being a research tool, could theoretically be applied in routine care as an early 
symptom monitoring tool to prevent relapse in bipolar disorder. Early symptom monitoring 
has been identified to be an effective strategy to prevent manic relapse in bipolar disorder 
(Perry et aI, 1999). Furthermore, a systematic review of bipolar prodromes identified sleep 
disturbance was reported as an early symptom of mania by 77% of individuals and as an 
early symptom of bipolar depression by 24% of individuals (Jackson et aI, 2003). However, 
one potential limitation of using actigraphy as an early monitoring strategy is that 
concordance from a significant proportion of individuals with bipolar disorder may not be 
obtained. In the current study, 25% (N=5/20 bipolar disorder participants) did not agree to 
wear an actiwatch, which is similar to the 30% observed in a previous study (N:;;:6/20 bipolar 
disorder participants; Harvey et aI, 2005). The application ofactigraph monitoring in 
202 
clinical practice may be a useful strategy to modify sleep disturbance during inter-episode 
periods and reduce risk of relapse in bipolar disorder. 
Self monitoring may be usefully applied to prevent relapse in bipolar disorder. A core 
strategy in recent psychological interventions for bipolar disorder has been the identification 
and monitoring of early symptoms of relapse (e.g. Perry et aI, 1999). Individuals with 
bipolar disorder have been indicated to be willing to engage in self monitoring strategies to 
prevent relapse, within routine care as well as during research studies. Furthermore, 
voluntary organisations such as the Manic Depression Fellowship also promote identification 
and self-management of early symptoms. Paper and pencil monitoring systems have been 
usefully applied, but electronic monitoring has started to gain prominence. The current 
study observed the utility ofactigraph monitoring as well as paper systems of monitoring 
changes in behaviour, selfesteem and affect. More recent prospective monitoring studies 
have applied electronic systems. For instance, Bauer et al (2004) reported high acceptance 
ofChronorecord, a home computer-based system of self-report ratings. Eighty-three per 
cent of Bauer et aI's (2004) sample completed three months of daily mood, sleep, menstrual 
cycle, medication and life events monitoring (N=96 bipolar disorder). Therefore, evidence 
suggests both electronic and paper systems of monitoring early symptoms of relapse in 
bipolar disorder may be usefully applied in future research investigations as well as routine 
care. 
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5.8 Conclusions 
The reported differences in average level and variability of certain diathesis vulnerability, 
self esteem and affect measures between general population and bipolar disorder 
participants was consistent with recent studies using bipolar disorder samples. Three 
prospective, longitudinal studies over average follow-up periods of three years (N=138 
bipolar disorder; Joffe et aI, 2004) and thirteen years (N=146 bipolar I disorder, Judd et aI, 
2002; N= 86 bipolar II disorder, Judd et aI, 2003b) reported individuals with bipolar 
disorder spend approximately half oftheir time euthymic. Consequently, the remaining half 
of their time is spent experiencing varying subsyndromal to acute symptomatic mood states. 
Thus, evidence is accumulating that bipolar disorder has a chronic, pervading presence 
consisting of ongoing dysregulation during inter-episode periods as well as recurrent acute 
episodes. 
The current study observed individuals with bipolar disorder display disturbances in affect, 
self esteem and sleep measures during inter-episode periods. In comparison to the general 
population, lower positive affect, lower self esteem, higher negative affect, and highcr 
depression levels were reported for participants with bipolar disorder. Greater variability in 
sleep efficiency, night waking and self esteem measures were also reported in bipolar 
disorder. High intraindividual variability was consistent with theoretical diathesis-stress 
models that posit weak regulation in underlying systems characterise bipolar disorder. 
These fmdings suggest underlying dysregulation across affect, self estecm and sleep occurs 
during inter-episode periods in bipolar disorder. 
Variability in bipolar disorder across inter-episode periods was identified to have clinical 
importance. Variability in sleep efficiency was associated with earlier admission in bipolar 
disorder across a three year follow up. Furthermore, there was some suggestion that self 
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esteem variability specifically predicted admission in bipolar I disorder. Findings from 
survival analyses must be considered as exploratory due to small sample sizes. However, 
observations occurred in the expected directions, with greater variability associated with 
increased vulnerability to relapse. These fmdings were of clinical importance since sleep 
and self esteem disturbances may both be considered as potentially modifiable in reducing 
risk of relapse in bipolar disorder. Therefore, to conclude, the current study provided 
evidence that heightened variability in bipolar disorders across inter-episode periods may 
represent an underlying dysregulation. 
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Appendix A. Ethics of Research Committee and management approval 
The research protocol was submitted to the Forth Valley Primary Care NHS Trust Ethics 
Committee in April 200 I. A letter from the Ethics Committee, dated 1st May 200 I, 
granted ethical approval to the study. Subsequently, it was necessary to obtain 
management approval from the Clinical Director and Chief Executive of Forth Valley 
Primary Care NHS Trust. Management approval was provided by the Chief Executive on 
the 5th June 2001 and from the Clinical Director on the 20th June 2001. 
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~ORTH VAll~Y H~Al TH BOARD 
AJHlkshl09 8 8 ta 
IS' May 2001 
Ms Alison Tait 
Research Assistant 
Department of Psychological Medicine 
University of Glasgow 
Gartnavel Hospital 
1055 Great Western Road 
GLASGOW 0120XH 
Dear Ms Tait 
RE: A study of psychoblosoclol functioning In bipolar disorders 
Thank you for your application for the above study which was reviewed by Forth Valley 
Ethics of Research Committee at the meeting on 26th April 2001. 
I am pleased to inform you that the FVERC grants ethical approval to the study. 
The Committee asked why 40 people were chosen for the study and commented that there 
were a large number of forms for participants to complete - is there any way these could be 
reduced without detriment, to the study? 
The project must be started within three years of obtaining notification of ethical approval. 
You should follow the protocol agreed and advise this committee of any changes made. An) 
alterations or amendments to the study protocol will require prior approval from Forth Valle) 
Ethics of Research Committee. You should also provide the committee with an annual 
progress report each year on the anniversary of approval of your project 
Please ensure that the Committee are advised when the study has been completed. with II 
appropriate. any notification for publication of results. 
33 Spiltal Street. Stirlillll. FK8 / DX 
Telepho"e: 01786 -45725/ 
Facsimile .. 01786·451474 
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You will no doubt realise that whilst the Committee has given approval for your project on 
ethical grounds, it is still necessary for you to obtain management approval, if you have not 
already done so, from the relevant Clinical Director and/or Chief Executives of the Trusts in 
which the work will be carned out. 
Yours sincerely 
Dr A J Holliday 
Secretary to Ethics of Research Committee 
33 Spittal Slrtn. Stirling. FK8 J DX 
Ttlltlplwn.: 01786 -4S72SI 
Facsimiltl: 01786 ·451474 
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05 June 2001 
EAH/FEK 
Alison Tait 
Research Assistant 
Department of Psychological Medicine 
University of Glasgow 
Academic Centre 
Gartnavel Royal Hospital 
1055 Great Westem Road 
GLASGOW 
G120XH 
 
A Study of Psychoblosoclal FunctionIng In Bipolar Disorders 
Thank you tor your letter of 25 May 2001 regarding the proposed study to be undertaken 
collaboratively between the Department of Psychological Medicine at the University of 
Glasgow and Or McCabe of Westbank Day Unit I am happy to approve your request for this 
study and look forward to hearing the outcome In due course. 
Yours sincerely 
 
E Anne Hawkins 
Chl.f Executive 
c.c. Dr Elaine McCabe, Westbank Day Unit 
Porth VaUey Primary Care NHS Trust 
Old Denny Road., Larbert. PKS 4SD 
Teleohone : 01324 570 700 Fnc'Iimile: n 1,24 5ti2 1ti7 
2SS 
GJD/ed 
20 June, 200 1 
Ms Alison Tait 
Department of Psychological Medicine 
University of Glasgow 
Academic Centre, Gurtnavel Royal Hospital 
1055 Great Western Road 
GLASGOW 
0120XH 
Dear Ms Tait 
Project Title: A study of psycbobiosocial functioning in bipolar disorders 
TIuUlk you for writing to me giving details of your excellent research proposal. I an 
pleased that you have considered asking my permission. r am delighted to grant it a 
look forward to the outcome of your work. 
Kind regards. 
cc: Professor Jan Scott. Head of Psychiatry, University of Glasgow 
Dr Elaine McCabe. Staff Psychiatrist, FVPCT 
Forth Vulley Primary Care NBS Trust 
Old Denny Road. Larbert. FKS 4SD 
Telenhone : 01324570 700 FlIcsimilp.~ 01 ~24 !itl2 ltl7 
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Appendix B. Information sheets and consent forms 
A staff psychiatrist identified individuals with bipolar disorder who attended a Lithium 
Clinic. Approval to approach each individual to participate was requested from the treating 
consultant psychiatrist. A consultant information sheet describing the research project was 
provided. Consultant approval was recorded for each individual on a consultant consent 
form. Individuals with bipolar disorder were approached to participate in the study by a 
staff psychiatrist, during routine appointments at a Lithium Clinic. Individuals received a 
patient information sheet, which outlined the purpose of the study and described what 
participating would involve. A patient consent form was completed by individuals who 
agreed to participate and a copy was provided for their own records. 
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Joan Searle Legacy Research Project: Information Sheet 
Research Project: A study of psychobiosocial functioning in bipolar disorders 
This research project aims to investigate the factors which may cause individuals with bipolar disorder to 
relapse. Ultimately, the research aims to investigate the antecedents, concomitants and consequences of 
relapse in bipolar disorder/manic depression. Goodwin and Jamison's (1990) three inter-related pathways 
to relapse in bipolar disorder (medication non-adherence, stressful life events, sleep disruption) will be 
monitored in combination with relevant personality vulnerability factors. 
Individuals who have bipolar disorder, and have experienced a recent episode in the past two years are 
being asked to participate. 
Inclusion criteria 
1. Clinical diagnosis of Bipolar I or Bipolar II disorder 
2. Currently in contact with general adult psychiatry services 
3. Willingness to provide informed consent 
4. Informed consent from the individual's consultant psychiatrist 
Exclusion criteria 
1. Unable to give written informed consent 
2. Current or recent involvement in other research projects 
Research Team 
Professor Jan Scott, Head of Psychiatry 
Ms Alison Tait, Research Assistant 
Dr Elaine McCabe, StatTPsychiatrist 
For further information, please contact Alison Tait, Research Assistant on (0141) 211 3933, or in writing: 
Joan Searle Legacy Research Project, Department of Psychological Medicine, Garnavel Royal Hospital, 
1055 Great Western Road, Glasgow G12 OXH. 
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Joan Searle Legacy Research Project: Consultant Psychiatrist Consent Form 
I have received a copy of the information sheet regarding the research project in addition to a copy of the 
patient information sheet. 
I have had an opportunity to discuss the research project with the research assistant and to address any 
concerns regarding the project. 
I provide my consent for the individual named below to participate in the project. 
Confidentiality regarding all information collected for this research project is assured. Access to the data 
will only be provided to individuals working on the project. 
Name of patient (in capitals): .................................................................... . 
Name of consultant psychiatrist (in capitals): .............................................. " .. 
Signature: ... t •• ,.o.t •• , t" ,t ••.•• I'. t •••••• ,. , •• t. I. t •• , It •••••• t , •••• If.' •• t ••• " •••• ,. It •• '.' •• , rtl 
Date: ....................... , ............. , ... , ...... , .... ,, .. , .. " ..... , ..... "., ................ , ... , 
259 
Joan Searle Legacy Research Project: Patient Information Sheet 
Research project title: Symptoms of relapse in bipolar disorder 
You are being invited to participate in a research project. It is important for you to understand the purpose 
of the research, and what participating will involve. Please read the following information carefully, and 
take time to decide whether or not you would like to take part. 
What is the purpose of the study? 
This research project aims to investigate the factors which may cause individuals who suffer from mood 
episodes to relapse. Research has indicated that, in addition to taking medication, individuals may be able 
to help prevent relapse by detecting early symptoms. Individuals may become vulnerable to relapse when 
their daily routine is disrupted or when a stressful life event occurs. If the factors which can cause 
individuals to relapse can be identified, it may be possible to prevent relapse occurring in some instances. 
Why have I been chosen? 
Individuals with a manic depressive disorder, who have experienced a recent episode, of either mania or 
depression, in the past two years are being asked to participate. The aim is to ask about 40 individuals to 
participate in the project. 
Do I have to take part? 
If you do decide to take part in the project, you will be given this information sheet to keep, and will be 
asked to sign a consent form. You will also receive a signed consent form to keep. 
It is your decision to take part in the research, and if you change your mind at any point. you are free to 
withdraw, and you do not have to give any reason why you want to withdraw. 
If you decide to withdraw from the research. your usual treatment will not be affected in any way. 
Similarly, if you are not interested in initially consenting to participate in the research. your usual treatment 
will remain unaffected. 
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What will happen to me if I take part? 
Whether you agree or not to take part in the research, the project will not interfere with your usual 
treatment. At the start of the research project, you will meet with the research assistant for an initial 
interview which will involve completing some questionnaires. Completion of questionnaires will take 
around one hour. Ifindividuals do not like completing any of the questionnaires or individual items in an 
assessment, they need not do so. 
We hope to meet every 8 weeks to discuss how the project is progressing for an individual and to address 
any questions or problems. At this appointment, we would also ask for some questionnaires to be completed. 
Individuals who do not like completing all questionnaires or individual items in the assessment need not do 
so. The length of this interview is estimated to be around one hour, which includes the completion of 
questionnaires. 
What do I have to do? 
Individuals are asked to provide daily information on how their day has been in the form ofa daily 
monitoring package which is completed at the end of each day. Individuals, if they prefer, do not have to 
answer all the proposed questions. This daily package is estimated to take around 10 to 20 minutes to 
complete, and should take less time once an individual is familiar with the layout of the daily package. 
Individuals are also being asked to wear a act i-watch to monitor their sleep-wake cycle. This device is 
around the same size as an average wristwatch, and it is hoped that individuals will not find the device 
intrusive. The daily package and act i-watch will be collected at the end of each week by the research 
assistant, at a time convenient for the individual. 
Each individual will be asked to participate in the research for] 2 months. At the end of participating in 
the research, if you are interested, you can be provided with information regarding the questionnaires you 
completed. Some individuals might find it useful to view how certain factors vary over time and what 
effect this might have on manic depression. 
We would also appreciate feedback on the research, and any suggestions which you feel could make 
monitoring easier. 
Will taking part in the study help me? 
The research aims to find out more about why individuals relapse, which may help us learn more about 
preventing relapse. 
Will taking part in the study cost me anything? 
There will be no cost to individuals taking part in the study. Any travelling expenses that are Incurred will 
be reimbursed. 
261 
Will my taking part in the study be kept confidential? 
The professionals involved in your care, including your GP, will be informed if you decide to take part. 
Your consultant psychiatrist will also be asked if the research will be beneficial for you. 
It is your decision whether you tell family and friends about your involvement in the research. 
All information which is collected about you during the course of the research will be kept strictly 
confidential, and will be kept secure at Gartnaval Royal Hospital. Only the individuals working on the 
project will have access to the information. Any information about you which leaves the hospital will have 
your name and address removed so that you cannot be recognised from it. 
What will happen to the results of the resea rch study? 
The results are likely to be published approximately 1 year after the end of the project. Individuals who 
participate in the project will not be identified in any report or publication. 
Who is organising and funding the research? 
The Joan Searle Legacy is funding the research project. The funds are administered through the University 
of Glasgow. 
Who has reviewed the study? 
Greater Glasgow Primary Care NBS Trust Ethics Committee and Forth Valley Ethics of Research 
Committee have reviewed the study. 
What if I have any questions 
Any questions regarding the research project can be answered by Alison Tait, who is the Research Assistant 
on the project. Alison can be contacted by telephone on (0141) 211 3933. 
If you prefer, you can also write to the following address: Joan Searle Legacy Research Project, Department 
of Psychological Medicine, Gartnavel Royal Hospital, 1055 Great Western Road, GlasgowGI2 OXH. 
What happens now? 
If you are interested in taking part in the research project, please sign the following consent form. 
The next stage will be to arrange a convenient time for the initial interview, where any further questions you 
may have can be addressed. 
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Joan Searle Legacy Research Project: Consent Form 
Research Project copy of consent 
Title of project: Symptoms of relapse in bipolar disorder 
Name of researcher: 
I have read and understood the information sheet, dated April 2001 (version lj and have received a copy of 
the information sheet to keep. 
I have had an opportunity to discuss the research project with the research assistant and to ask questions. 
I understand that my participation is voluntary and I am aware that I am free to withdraw from the research 
at any time, without having to give a reason. J understand that my care and treatment will not be affected 
in any way. 
Confidentiality regarding all information collected for this research project is assured. Access to the data 
will only be provided to individuals working on the project. 
I agree to take part in the above study 
Name (in capitals): ................................................. . Date: , ....... , ... , ..... ,',., ....... , 
Signature: . II tt ••• , '" t, It •••• '"' If., •• It ,.,1 It. II •••••• t",., •• r. II. II 
Name of person taking consent (if different from researcher): 
Name (in capitals): ................................................ .. Date: ............................. .. 
Signature: ........................................................... .. 
Researcher: 
Name (in capitals): ................................................. . Date: .............................. . 
Signature: ........................................................... .. 
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Appendix C. Actigraph monitoring 
Sleep variables were calculated for each night of actiwatch monitoring. Bedtime and Get 
up time were manually inputted according to the SRM daily time. The "Actiwatch 
software" (Cambridge Neurotechnology Ltd.) uses a sleep-wake scoring algorithm to then 
calculate a large number of variables. 
Non-parametric circadian rhythm analyses were calculated for each week of actigraph 
monitoring. A seven day analysis period provided mean values for circadian rhythm 
variables across that given week. 
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SLEEP WATC H 
Dai ly Sleep printout 
User identification CONTROL 1 
Start date 20·Feb·2002 
Subject age 00 
Day number 2 
Actogram Scale 6961 
Thu 21·Feb-2002 
Start time 12:30 
Subject sex F Epoch length 1.0 (Mins) 
Sensitivity : MED 
Fn 22·Feb-2002 
I , 
6961 
23.00 00.00 
I~;~I;',,' ;! = 
23.00 
Analysis start 
0100 02:00 03.00 
II 
04 .00 05 '00 06.00 07.00 
" 1/ I I 
08:00 
Analysis end 
0800 
Bedtime 00:35 
Sleep start 00:35 
Get up time 
Sleep end 
07:20 
07:18 
Time in bed 06:45 
Assumed sleep 06:43 
Sleep efficiency 91 .1 % Sleep latency 00:00 mins 
ActLlal sleep time 
No of sleep bouts 
No of wake bouts 
06:09 (91 .6 %) 
14 
14 
No of mins moving 28.0 (6.9 %) 
No of immobile phases 20 
Immobility phases of 1 min 
Total activity score 
Mean activity score 
Mean score In active periods 
Movement & fragmentation index 
Wake movement 
5290 
13,13 
188.93 
11 .9 
310.9 
Watch SIN V622282 
Actual Wake time 00:34 (8 .4 %J 
Mean length of sleep bouts 00:26:21 
Mean length of wake bouts 00:02:26 
No of mins Immobile 
Mean length of immobility 
(5 .0%) 
Date File 26·Msr ·2002 
375 .0 (93.1 %) 
18.8 
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Non parametric circadian rhythm analysis 
Identity: control 1 Age: 56 
Data start date: 20-Feb-2002 (Wed) 
Data start time: 12:30 
Analysis start: Wed 20-Feb-2002 00:00 
Analysis length: 7days 
Intradaily stability: 0.744 
Intradaily variability : 0.921 
Lowest 5 hour count: 354 
Max 10 hour count: 22055 
Amplitude (M10-L5): 21701 
L5 Onset: 01 :00 
M10 Onset: 07:00 
Relative amp: 0.968 
00 0600 1200 16:00 00'00 06'00 
Watch SIN:V622262 Date File:26-Mar·2002 
Sex: F 
12.00 16.00 
Cambridge Neurotechnology 
266 
Appendix D. Behavioural Inhibition System and Behavioural Activation Systems 
Scales 
The Behavioural Inhibition System and Behavioural Activation Systems (BIS/BAS) Scales 
was developed by Carver and White (1994). The BISIBAS Scales consists of one BIS 
subsea Ie and three BAS subscales. The. symbol denotes the seven BIS subscale items. 
The £ symbol denotes the five BAS Reward Responsiveness subsea Ie items. The. symbol 
denotes the four BAS Drive subscale items and the" symbol denotes the four BAS Fun 
Seeking subscale items. Items were rated on a four point Likert scale (l =strong 
agreement, 4=strong disagreement). Scores for the two items phrased positively for the 
BIS subscale were reversed (items five and seven). 
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BISIBAS scales 
This scale lists different statements concerned with individual's feelings and behaviour. 
Please read each statement carefully and indicate how much you agree with what it says by 
placing a cross (X) under the appropriate column. 
Statement strong agreement disagreement strong 
agreement disagreement 
I. If I think something 
unpleasant is going to 
happen J usually get pretty 
"worked up." • 
2. I worry about making 
mistakes .• 
3. Criticism or scolding 
hurts me quite a bit. • 
4. I feel pretty worried or 
upset when I think or 
know somebody is angry at 
me .• 
5. Even if something bad is 
about to happen to me, I 
rarely experience fear or 
nervousness .• 
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Statement strong agreement disagreement strong 
agreement disagreement 
6. I feel worried when I 
think I have done poorly at 
something. + 
7. I have very few fears 
compared to my friends. + 
8. When I get something I 
want, I feel excited and 
energised .• 
9. When I'm doing well at 
something, I love to keep 
at it .... 
10. When good things 
happen to me, it affects me 
strongly .• 
11. It would excite me to 
win a contest. • 
12. When I see an 
opportunity for something 
I like, I get excited right 
away .• 
13. When I want 
something, I usually go all-
out to get it .• 
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Statement strong agreement disagreement strong 
agreement d isagreemen t 
14. I go out of my way to 
get things I want. • 
15. If! see a chance to get 
something I want, I move 
on it right away .• 
16. When I go after 
something I use a "no 
holds barred" approach .• 
17. I will often do things 
for no other reason than 
that they might be fun. 
\' 
18. I crave excitement and 
new sensations. \' 
19. I'm always willing to 
try something new if I 
think it will be fun. \' 
20. I often act on the spur 
ofthe moment. \' 
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Appendix E. Social Rhythm Metric 
The Social Rhythm Metric (SRM) was developed by Monk et al (1990, 1991). The SRM 
consists of 17 daily activities, of which 15 are specified and two are idiosyncratic to the 
individual. The SRM requires the individual to record the time at which an activity occurs 
and the number of people present. The SRM yields several variables calculated with an 
outlier elimination algorithm provided by Monk et al (1991). A Microsoft Excel (version 
1997) spreadsheet was developed to facilitate algorithm calculations. An example 
algorithm calculation is provided for the activity 'get out of bed. ' 
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Social Rhythm Metric 
This diary-like sheet consists of a number of events and activities that individuals are likely to carry out on 
most days. Please complete the sheet at the end of the day, indicating the exact time at which the event was 
done (if done on that day) and with whom it was done (if done in the presence of another person). 
Please use Activity A and Activity B to indicate activities that you carry out on most days (e.g. walking a 
dog, reading, having a bath) 
Activity Cross if did not Time Cross to indicate the number of people 
do activity present when activity was done 
0 J 2 3 or more people 
1. Get out of bed 
2. First contact (in person or 
by phone) with another 
person 
3. Have morning beverage 
4. Have breakfast 
5. Go outside for the first time 
6. Start work, school, 
housework, volunteer activities, 
child or family care 
7. Have lunch 
8. Take an afternoon nap 
9. Have dinner 
10. Physical exercise 
11. Have an evening 
snack/drink 
12. Watch evening TV news 
program 
13. Watch another TV program 
14. Activity A: 
15. Activity B: 
16. Return home (last time) 
17. Go to bed 
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Algorithm for calculating scores on the Social Rhythm Metric 
1. Compute the average time and standard deviation each activity was performed over the 
week. 
2. Compute the minimum and maximum time range to determine outliers (Outliers are 
activity times that fall outside of 1.5 SO from the mean). 
Formulas are: MINTIME = AVERAGE TIME - (1.5 '" SO) 
MAXTIME = AVERAGE TIME + (1.5 "'SD) 
Therefore, non-outlier data fall within this range: MINTIME < TIME < MAXTIME 
3. Re-compute the mean using only non-outlier data; this is the habitual time. 
4. Recombine the non-outlier data and the outlier data to determine "hits." A "hit" is an 
activity time that occurs within 45 minutes of the habitual time. 
Formulas are: MINIMUM TIME FOR HIT = NEW MEAN - 45 MIN 
MAXIMUM TIME FOR HIT = NEW MEAN + 45 MIN 
Therefore, a time is considered a "hit" if it falls between this range: MINHIT < TIME < 
MAXI·UT 
5. Using all the 17 activities, select activities that occurred at least 3 times per week. 
6. Calculate the number of activities occurring at least 3 times per week and the total 
number of hits for those activities. 
7. Calculate SRM score = total number of hits for activities that occurred 3 or more times 
per week I number of activities occurring at least 3 times per week. 
8. Calculate Activity Level Index (ALI) = total of all activities which occur over week 
Calculate Daily Activity Level Index (DALI) = total of all activities which occur that day 
9. Calculate solitude ratio = total number of activities done alone I total number of all 
activities performed that week 
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Example Social Rhythm Metric get out of bed algorithm calculation 
~-
--
~--.----.-
- -
SRM: Get out of Bed 
Date Time Results Non Outlier Range, N=6 days Hit Times 
19/09/01 07:45 Mean 07:45 07:45 Habitual time 08:07 07:45 
20/09/01 07:50 SD 1:10 07:50 07:50 
21109/01 07:50 07:50 07:50 
22/09/01 09:30 09:30 
23/09/01 07:55 07:55 07:55 
24/09/01 07:55 Min 05:30 07:55 Min Hit 07:22 07:55 No orHits 5 
25109/01 05:30 Max 09:30 Max Hit 08:52 No of Misses 2 
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Appendix F. Rosenberg Self Esteem Questionnaire 
The Rosenberg Self Esteem Questionnaire (RSEQ) was developed by Rosenberg (1965). 
The RSEQ consists often items, with five negatively worded and five positively worded 
items to measure negative and positive self esteem subscales. The total score for both 
subscales measures global self esteem. Items were rated on a seven point Likert scale 
(l =strongly agree, 7=strongly disagree). The scoring for the five positively worded items 
was reversed. The + symbol denotes positive self esteem items. 
Likert response ratings for positive and negative self esteem statements were plotted for 
bipolar disorder and general population groups. General population participants tended to 
'agree' with positive self esteem statements and 'disagree' with negative self esteem 
statements. Participants with bipolar disorder had a wide range of responses to positive 
and negative selfesteem statements, with no particular mode of response. 
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Rosenberg Self Esteem Questionnaire 
This is a short questionnaire to measure thoughts about yourself. 
Please indicate whether you strongly agree, disagree, or strongly disagree with each 
statement at the present moment, by placing a cross (X) in the appropriate box. 
Statement strongly agree agree neutral disagree disagree 
agree slightly slightly 
1. On the whole 
I am satisfied 
with myself. + 
2. At times I 
think I am no 
good at all. 
3. I feel I have a 
number of good 
qualities. + 
4. I am able to 
do things as well 
as most people. 
+ 
5. I feel I do not 
have much to be 
proud of. 
6. I certainly 
feel useless at 
times. 
strongly 
disagree 
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Statement strongly agree agree neutral disagree disagree strongly 
agree slightly slightly disagree 
7.IfeelIama 
person of worth, 
at least equal to 
others. + 
8. I wish I could 
have more 
respect for 
myself. 
9. All in all, I 
am inclined to 
feel I am a 
failure. 
10. I take a 
positive attitude 
towards myself. 
+ 
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Figure F.1: Positive Self Esteem Ratings 
across 14 days 
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Likert Rating 
(16.3% of ratings were missing for bipolar disorder and 0% missing for general population groups) 
Figure F.2: Negative Self Esteem Ratings 
across 14 days 
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a. 
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o Bipolar disorder 
General Population 
(10.6% of ratings were missing for bipolar disorder and 5.9% missing for general population groups) 
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Appendix G. Positive And Negative Affect Schedule 
The Positive And Negative Affect Schedule (PANAS) was developed by Watson et al 
(1988). The PANAS comprises a ten item positive affect scale and a ten item negative affect 
scale. The + symbol denotes positive affect items. Two additional items were included in 
the PANAS list to measure current mood state relevant to bipolar disorder: 'elated' and 
'depressed.' Items were rated on a five point Likert scale (1 =very slightly or not at all, 
5=extremely). 
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PANAS 
This scale consists of a number of words that describe different feelings and emotions. Read 
each item and then mark the appropriate answer in the space next to that word. Indicate to 
what extent you have felt this way today by placing a cross (X) in the appropriate column. 
Use the following scale to record your answers. 
Word very slightly a little moderately quite a bit extremely 
or not at all 
1. interested + 
2. distressed 
3. excited + 
4. upset 
5. strong + 
6. guilty 
7. scared 
8. hostile 
9. enthusiastic + 
10. proud + 
11. elated 
12. irritable 
13. alert + 
14. ashamed 
15. inspired + 
16. nervous 
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Word very slightly a little moderately quite a bit extremely 
or not at all 
1 7. determined + 
18. attentive + 
19. jittery 
20. active + 
21. afraid 
22. depressed 
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Appendix H. Publications 
H.I A systematic review of manic and depressive prodromes article 
A systematic literature review of manic and depressive prodromes was conducted in 
December 2000. An article was drafted for publication with Dr Jonathan Cavanagh and 
Professor Jan Scott. The article was accepted by the Journal of Affective Disorders in July 
2002 and was published in 2003. 
H.2 Variability in bipolar disorders poster 
A poster reporting differences in variability between bipolar disorder and general 
population participants was presented at the West of Scotland Research and Development 
conference, held in October 2004. 
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EL."EVIER 
Review 
A systematic review of manic and depressive prodromes 
Alison Jackson A, Jonathan Cavanagh ft , Jan Scottb ,. 
'{)''l~'rl/ll''111 (If 1'.~n·lt"''':~lI'al M.,Jldn." Un!l"'l'slly (If" (;fa",,'''w, Gllrln<lI'Id R"~',,, /fospillll, GIII.'gil .... UK 
~DM.'I"" '1r P.\wh"fllg/mf AlI'did,rt', //1.\1/1/11" of 1'.'.1'.11/(11/)', PO. BtlI' 'N>. Df Cr"''''igllY P"rk, D''IInlllrk iliff. LOI,.flln S£,f SAF, UK 
"hstra'" 
Bm·kl!.rOlllld: This p\ll'~r ~'xph'rl'~ w h~ll1l'r individuals wilh II 010(11.1 Jisoni.:r ,'un hlt.'nlify Ih~ nalUl'C IInJ Juralion (If 
lkprV"isivl: and mani,' I'rn<.lrom~s. ,\/,'III"d,\; SI:\\'nlY·lhr~,· I'uhli"illilllls of pnlJrnnwl ~ymplnm~ in hiplliur lllld uO\I'0I:lr 
dbord.:/'\\ wwe: idl'nlifkJ hy Clll1lpUI~r ",,'m,'hv's of s,'''.:n lbll\hasc~ (indudinll MF.DlINIl unJ I'sycln') sUl'pknll.'nl,'d hy hand 
scurdll's of jllumah. S"\'I.mll'cn sludies (InIal samplc = I I Iii SUhjl'CIS) met crih:ria liJr inclusion in 11 sysh:nllltic I\'vicw. 
/((',\/111.,; AI kasl Nf¥!. \11' imliviJu .. ls wilh II nllxld Ji.,,,rJ.'f I:iln iJ~nllfy une or /linn: pn ... lroillal symploills. llwn: ar\,! limil,'J 
J .. la ul'lllul unip"I'lr dborJ,'rs. In hll'"I"r Jisnrd ... rs, carly ~>'ll1ph'mS "I' munia ar ... iJ.'nlilil'J nlllr~ Ir",yul.'nlly Ih;m c"rly 
symplul1l~ ur dl.'l'I'Ch.ioll. The: m"~1 robusl eMly symplolH Ill' Illullin is ~kcp Jislurhlml'c (m.:dian prcv"II:Il(,'-: 77~'.I. 1:'1I1y 
symplllills (If J,·pn.'~si"n ill'C inr(\n~i'I,·nl. Th~ IllC,IIl knglh Ill' Illllnil.' pl'lldronwlI ( > 20 day~) was consbll'lllly r'·p"rt ... d Itl he 
IOllger Ihun J.'pr,·ssivc I'n'Jrnnw~ ( < I') diIYS). \lowO:\'I.'r, d,'pl\'ssi\'c I'rndl'llmc~ shl1wcd j?1\,.I1,·r inl':l'·individulll vilriulillil 
(nlllgilli:! from 2 \0 :l6$ du)'s) in ,Jul1Ilinn Ih'lIl m"ni~ pfllJflll1ll'S (I 120 Jays). I.illlil(//iolll: Few prusp,'ctivc studiv's .. I' 
hi"olur, .md parlicularly unipolar di~"rdl.'rs haw ~e:n rl'p"rlcd. COlld/l.\"ioll.\: rarly symploms of rd,lp,,; in IIn~·,·liv .. 
disurd,'rs ,',Ill I .... ' iJl'nllh" ... I. Explanations "I' Ih\'! apl',I1'1~/ll dincn:n,'\,!s in til ... l"'l'o!,lnlljnn IIml knglh of !,l'"drulll"s hd\H~n 
mania and hip"lar ,kpr~s~ion nro c.~plol'l'd. Furlh .. r fl's,'im:h un duration, s"4u\,!nl'c "I' ~yml'hlill Ilpl' ... arill1l·c and 
I.'haral'lcri>li..:s {If rm.lrnm ... s is wUl'nlOh:d III c111rify Ill\,! dioi,'ul USl.'lillll~~s Ill' early SYIlll'IIllll Illunilorint;. 
(:) 200.1 Elscvkr Sl·j,'nl:l.' B. V. All rit;hh r,',,,,,,\,,:o.I. 
I, Introduction 
(lrtldrllOles lire d.:oscribed as cognitive. affective, 
o1l1d bch'l\'iouml curly symptoms of II disorder that 
appcilf bdlm: .1Il epi!>odc of dcprc:-;sion or mimia 
·('urr~~I"'lhlin~ IIl1th,'r. 
/;'·nklll ",{,Jr.'" .. : j.s~"I"" i"I'·kcl ... ~.uk (.I. S.'"lI). 
(Altman ct a!., Jl)1)2; Keitner ~~t 111., "No), fuvu und 
Kellner's (II)()I ) review sMed tllilt the duratioll of u 
prodrome is defined tiS the intervHI from th..: lime that 
the fir~t symptom is rc,:ogniscd to Ihe time whell th..: 
symptoms of' <I\l epi:-;ode n:ach lllilxilllUm severity, 
Detection of eHrly l>ymptlltlls e(luld filei\il"tc c<lrly 
itllervcntioll 10 rre\,\:nt or reduce the illlpud of 
relapse on the indiviJU:tl (Joyce, Il)S5; Molnar et 111.. 
()1(,5·()~27/f)~ S .. ','e fr'lf11 mall,'r if' 2(HJ~ I]".,jcr s..·j~n"" I1.V. :\111'1~hl' rc""ncd, 
",.j: 1O.IUlb·S(lI(,~·().\27(02)(")1h6.~ 
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19RR: Smith and Tarrier, I (J92; Perry ct (II., 1995; 
Basco and Rush. 19%; Lam et 111.. Il)l)<». 
Recent research on psychological interventions for 
recurrent unipolar and bipoltlr disordl.·rs has utilised 
the identiflcillion and early mmwgernent of prod-
romes as a core ~trategy (Scott, 19l)5, 2(1) I: Perry et 
al.. I <)<)9; Lam et .. I.. 200 I; Katon et .11 .• 200 I). 
Likcwbe. user groups such liS the ~hll1ic Dcprcssion 
Fello\\'ship in the UK lIrc trying to tCHch indiviuUlIIs 
to identify prollro1llcs in Ofuer to employ self-man-
lIgl'ment techniques. 
A systcmatic I iter-Iture se;Irch was condU<:led to 
identify wlwt early symplOl11s of ,kpression and 
mania have bl'ell dc~crjbed; to determine prodrome 
dUnJtion and any differences in duration hctween 
lh:prcssion ,lIld n1(lOi,,: and tll explore which carly 
w<H'ning symptoms arc most commonly il.!entifh:d. 
2. Merhod .. 
A systi.'lllatie literature reykw was conullct,,·u. All 
~nldles investigating early symploms of relap~e in 
bipolar or unipolar disorueT were eligible for inchl-
)"ion. ('ompllteri~ed lIataba~es se.m;hed were: MEl). 
LINE ( 19(16 to December 2000); Be~1 Eviul~nec (1991 
to present): PSYCUT (1967 to IINO, 1991 to 11)1)9): 
('IN"H!. (1982 to 11)95, 19% to December 2(00): 
f.MII.\SE (191<0 10 Dceellllwr 2()()O); Cochrane Dal<l-
base of Systenwtie Reviews (i~slle 4. 20(0): PRIl-
MJ:I)LlSI! (Januury I Q. 20D I ). 
The senTch u~eu the subject Iwadings [BIPOLAR 
DISORDER] or [DEPRESSIVE DISORDERS) with: 
[PRODROMAL] or [PRODROMES1 or [PROD-
ROME] or [EARLY WARNING SIGN] or [EARLY 
SIGNS) or [EARLY SYMPTOMSI. "nl.! the term 
[MANIC DEPRESSION] linked 10 the subject he;Id-
ing (BIPOLAR DISORDER]. On-line UbStr.1Ct~ were 
reviewed nnd reprints of potentially eligible urtlcles 
were obtained. A h,mu search of 1111 references of 
incllllleu journal nrtieles identifieu further relevllnt 
articles. Re~eill'chers with llll intercst in prodromes 
were "Iso con"Ieted for advke ,1I1U uewils of lIny 
other articks. 
2.1. J>ata (~r/,,(/clioll 
Two rcyicwcrs inlkpenucntly (\S~CS~cu the articles. 
A structured proforma recorded eligibility and rel-
evant utlla such as dhlgno:;is, elldy syl11plOIll~ iden-
tilkd. <lnt! prodroll1e duration. Exclusion enleri" 
were: ( I) curly symptollls of first onset of illness; (2) 
cllrly symptoms of r,,'lapse or slibsyndwlllul ~ylllp­
tOIllS as~oeiat~d with ~ub-ol'timal lithium levels or 
dbcontil1lmlion: (3) no dat". prcliminary uala. or 
qualitative data; (4) residuul "ymptllllls; (5) case 
rcports; anu 16) mixcl.! diagnostic s<lmpks. which 
included schizophrenia or other diw('uers. 
Fig. I illllstr.lles the article sek~'li()n proccss for 
the rcview. Ekctwllic ~carches idcntifieu 40 rcl~v"llt 
references ~I11U 1\ hanu search identified a further 3.1 
Nferences. Of Ihc~c, nine aJ1icles w~'I'c excludcu as a 
Anicles identified by. manual tcarth ofrcfc:rcnce 
lists and Kreened for rctri,:vBI (n"" 33) 
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s\x~ondary description of rcscardl findings (Sclarc 
and Cre~'d. I ()R7; MalHkr and Loudon. 11)88; Mik-
111witl el al.. 19)0\8; Roper, 19)0\1); Bad,lI. I ()t)2: Perry 
et al.. 11)95; Cutes et "I.. 19(1'); Nolen, 1999; L.am ct 
al.. 200 I). Another 41 llnicles mel other exclusion 
criteria (Tuble 1). Seventeen sludies, published be-
tween 1964 and 200 I, lIlet incJu~i()n crit~'riil. 
T"hlc I 
Sludic, "hi"h nWl ,,\du~i.m criteria 
b~lusion criten" 
b,rly ')'1111''''0\' 
uf fi~l un'toi\,·' ttl' 
ill'K'SS 
I:.lIrl)' _ymrluills "I' rd:lp'c 
"r ",I"ynolr"l1ml ~ymrl"I1'" 
a ....... illlcd ",ilh 'lIh-.'plimal 
lilhiulll t.,'wls "r Ji-conlinllatiun 
No J:lIa. prchminao)' d:"". Of 
'lutllolnliw.h,la 
Sump'" II\dud~d ,",'hi""I'lwllin 
"r olher .II s, 'r,I.-rs 
211 
3. R('slIlts 
Demographic ,lIla for the 17 inclmlcd nrlicks is 
provided in Table 2. Five ~ludks prospectively 
monitored early sympt(lmS (Post 1.'1 ,11.. 1981; Altrn.lIl 
et .11., 19()2: Perlis et Ill., 1997; Perry et ul., t 9')(); 
K;rton et "I., 20(1). Eleven stullies investigated elll'ly 
ll"pkIlN'n / 1%.') 
Ilupkin""n ( I I)6S, 
\\'iowkur (\')7(,) 
{n,~'1\!1 ct [II. {1<)'sOt 
MU'l'hy el ui. (1")\')1 
Drynllll\ and Ealon ( I')') 1 ) 
I'm'. ,~ al. / 1'~'~1 
E;o'''n ,-I 01. (1'1"5) 
Strakow.~i cl ~I, \ 1'1"'51 
Fah'n ~I ;,1. 11,,1)71 
,11Il1.! ell'\. (11)\)7) 
RU~lcr <.!I al. (1'1')<) 
[:~~\;lIlJ ~I nl. (2U(H)1 
MlII1,k'r (l 'NO) 
Fn\,lt \ 1'1(12) 
Klein ,., al (i'l') 1 I 
Klcin ~t ,,1. 11 (\112 I 
Kl'licr CI al. (If/I)~) 
Ba,l,1 t 1 'l(.~) 
Ja~,'hs('n (I')(,S\ 
Kd-cy (11,(,7) 
1.('Ch Alld 1.0..1, (1()t;7, 
t.-I:oj col a1. (1')1)1) 
11:111,,11:0' ,ot 01. ( 1'1<17 I 
M"hncl1 ,,-I :II. (\ ')1l7\ 
FMI,\'dh cl al. (l'IS(" 
F nnt el OIl. \ I ')I).j. 1'/.)(" \INS I 
I' .. y~el clld. (1')'15) 
SI, ... U,rd ct al. (1'171, 
Wnl,'rs (1')7'1) 
W,-hr ('1 Ill. t 1').~7J 
W"hr (\')1)1) 
'1'.:1':'" (1')1),1) 
K"ndlcr 1111.1 lIay~ (FIN,\) 
J'nV:1 I)' Ill. (\ ')XIi) 
Su\>nlilik Imd Nwdu,-rh,in (1 11l'N) 
R,'p"r ( I 'U,~) 
BIf\'hw!'lo" cl al. (1'11'1)) 
H'·;'"r ~I Ill. (I'}l/J) 
Murphy :mJ Moll"r (I'l%) 
lIo.:hd,,1 r ,-\ Ill. ( 1 iNN) 
N,wo"'"k 110.1 Rusk," 11')""''' 
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'!',hlc 2 
l>\!n1fl~rarhi. inl"nllati,," !;'r stu,li," inch .. bJ in s>'lH~m"ti~ rl!vi,'w 
IlIJ,olur 
,Ii",'nkrs 
M'Hltn 
unly 
lJmp,"nr un.! 
bll'''~'r Ji.un.!..'''' 
UIlII'"I .. r 
,1i,.., ... !\!1'>' 
(lnly 
Artiek' 
Altman c'l al. (I')'IZI 
M"'nar .'1 al. (I')XX) 
Smith an.! Tarri"r (II)<)~) 
Lam and W.>nll (19<)7) 
J"Y"c (I')X5) 
I'¢IT)' ct al. (1'1'/1)) 
K"itn~r "t al. ()I)%) 
1\"" ~t .. I. (I')XI) 
Sdurc an.! [Nc,1 (1')1)0) 
I'r:mcis nn,! G:"P,Ir(' (11)1)4) 
W""Al mhll.am (l'I'l')) 
Y,'\ll1y un,1 (irllbkr (I')IIS) 
1'1!11i, ~I HI. (1'1'J7) 
ranI cl Ill. (1')<)01 
Y"lInl.l ct al. 11'1')1) 
II1lYs 11l}(.4) 
I\nl,," vI III (2(HII) 
~ylllptolllS of rehlpse in bipolar di ~ordcr (joycc. 
11)1'15; Molnar el tiL, 19R1(; Altman et ul.. 1992: Smith 
11Illl Tarrier. 11)92; Kcitncr et nl.. 1 <)t)6; LUI1l unu 
Wong. 1997; Perl)' ct 1I1., )999) of which four 
investigated nll1nic early symptoms only (Post ct al., 
I ()X I: Sclnre :tnd Creed, 11)<)0; Fnme!s (lild Gasparo, 
1994; Wong nnd Lmn. lIN!). Young lind Gnlbler 
( I 9X5) invcstil:latcd eilrly symptoms of rclap~e ill 1\ 
mixell sUnlple of subj.'cts with unipolar mId hipohlr 
disorders. Five studil.'s inwstigat.'d I.'(lfly symptoms 
of rclaJl~e in unipohlr dcprc)'sion (lhlY", 1964: f.wu 
et Ill.. I ')<)0; Young cl 1I1.. 19'>1; Perlis ct 111.. \l)()7; 
Katon cl al.. 20t)) ). 
3./. ftlr(I' .~rl/lp'()l//s IIf /llIIpoltll· depI'(',n'ion 
Fanl cl al.·s (1990) small-scale stlllly (1/ = 15) 
rcpol1ed IOO'?·;' of illdi\'iduuls could itlentity carly 
~ymptol\\s of unipol<H rel"psc. Sleep disniptillll W,iS 
frequently elt.;:d ,IS nn carly sYl11ptOI11. bul no preval-
ence lhltil arc reported (Young unu Umbler. I !)!(S: 
Fav" et al.. 1 ()I)O; Young et (11., 1')1) I; Perlis el al.. 
191)7). favu ct al.·s ( II)!)()) stuuy identifiell thill the 
two most c()rlll110n .\yrnptums of unipol"" depression 
N(I. M./ln ~~C' ,,~ ~I;,I\! 
I~ .24 50S 
20 ~s 4~ 
20 44 4S 
40 44 42 
~() JS 44 
(,I) 45 32 
74 42 47 
Q 
-'7 44 
24 41 47 
11>0 ~H H 
20(, 44 40 
II nll!,J",n .\6 
.\7 
14 .\x 1<) 
I~ 4~ (~I 
~.1 .1/, 26 
!II 4); ~I 
JI\(o 46 21> 
rctrospl'etively identified wcre !,Iefll'raliscd Ilnx icty 
(!:mu) (lnd ilTitability (60%). 
The uunttion llf the prollroflHlI periull for nmjur 
depression wus 7-13.1 days. In II mixcd sampl.;: of 
lInipohlr and bipolar disorllcrs. the mi.'dian duration 
of II di.'prcssive prollrome was 21< days (Young unu 
Gmbler, 191(5). Data frolll other ~tud ies is ,Ii mcltl t to 
interpret us the samples wcre sub-di\'ii.kd II I'rinri 
according to elinic,,1 charact,'ri!ttii.'s (e.g. Ilays. 
1(4). 
3.2. Eu,,~1' .~I'I/IJl'II/,,~ q{ hipo/ar (/cp/'c,\'.\illll 
Eight studies rcpol'teu the cxisteni.'C of e.lrly 
symptoms of bipol .. r depressive relapse (Joyce, 
19R5: Young and Gmbler. 191'15; Molnar ct al.. 19l<H: 
Altman ct .11.. 11)')2; Smith ,lnd TmTier. \')92; Kcitncr 
ct ul.. 11)()6: Lam and Wong. 11}1j7: Perl)' el al .• 
Il)l)l}). The majority of inilivilllwis (70-1 ()()'~/o: me-
i1i,1Il X2%) can identify curly symptoms of bipolar 
llepl'I.'ssioll. Three !ttudic~ ri.'porteu percenHlgcs (If 
illllividulIls retrospectively reporting speeitle early 
symptoms (~1tllnar et ul.. I ()K~: Smith Ilnll Tllrrii.'f'. 
I IN:!: LUll and \Vong.. 19(7). The medl<ln prevalence 
of early );ymptorns Wi"; mooll change (4K'\.), p~y-
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choll1otor c1wngc (41 %). increased anxiety (36'!1o), 
appetite chtlnge (36% I. suicidlliity (2()%). slecp 
disturbance (24%). and other symptoms (22%1. 
However, no symptoll1 was c()llsi~tcntly identified 
(T,lble 3). 
The duration of the prodromal period for bipolar 
dl.!pressioll in hetc:rogencolls sampks showed consi-
dcmble variution. ranging bet\\wn 2 and 365 days 
(Young and Grabler. \9R5; Molnar et 111.. \ ()R!!; 
Altman et III., \992: Smith and Tarrier, 1(92). In 
~nldies comprising only bipolar SUbjects ('Llble 4). 
the mean ulIl1Ition of a dcpres~i ve prodrome was 
T:.nk·3 
l:arly ")'mp'"nlS id~nlifi~d in bif'"llIr di",mlN 
Early 
sympl.·ms 
Mo .... ,'han!!~ 
p,ych.m) 'I. 'r syml'l\ '11\~ 
In"r<·a.,~d ,In 'I~t)' 
Apf'C"I~ chan!!~ 
SlII"ldal id~'I': IItI,'nl 
S"'~I' di"Ult'anc~ 
()Ih,-r 
Manlll SI."I' di,'urhnnce 
P'ydh1tic symp"'m. 
M",x) chun!!~ 
I'sy,hlln1<.,or ,>mploms 
Oth"r 
Apf":ti'c chnn!!~ 
11-19 days (Mohl<ll' el aI., 19S5: Smith ,II1U Tarrier. 
1 Ql)2). 
3.3. Ea/'~v 8ymp/O/ll,\ of mal/ia 
Eleven studies reported the existence of a prod-
rumul period for m .. nia (Post ct aI., \91\ I: Joyce, 
19K5; Molnar et Ill.. Il)XK; Sclarc lind Creed. I ()I)O: 
Altman et al.. 191}2; Smith and Tanier. 1(1)2; Francis 
and Oaspuro. 1994; Keitner et 111., \ ()1)6; Lam and 
Wong. 11)97; Perry el ul.. It)!)\); Wong and Lam. 
ll)()'l). Seventy-five to 100% (median 93 IX.) of 
R~n~~ "I' ": ••• ,1' inJI\,d\Ull~ j,k.'lllil)-ing fI.\,·dian 
"111111'1,' si:r~ ,hi. carly ~)'mp"'m (0;.) 
20 40 III x.~ 41\ 
211 .jl) 1U l\(1 41 
211 .jll 11\5'1 ,'II 
20 -Ill It) ~,' .\6 
20 2'1 6-1 ~I) 
2(1 40 17 57 2-1 
20 1-1 21) 22 
20 20(. S,\ I)() 77 
2U 2UI> 7XO -17 
2U20(i 14 100 4.1 
20 20(, 10- WI) 34 
211 211 .15 311 
2U 2()(, 12 1>7 20 
In.:Illt1~~" "nxi~ty 2040 II 20 16 
Dn'a fl1l1ll M"lnar <I' ai_ (I·'XI'i). SclnN nn,1 ('rccd (I'~)(). Smllh nnd Tarrier (1()I)2). I.am and "'.lIll.l (1"'171, Wonl.l and Lam (11)1)'», 
Tanlll 4 
Es,imn'cd dura,i.,n "r f'1\"ln·m~~ r.,r bif'olnr ,lcl'''~'''''\ln And mania 
Mallia 
S,".), 
M""~lr II' ,,). I )lINK) 
Smi,h nnd Turri"r 11'}I)2) 
Y""nlllln.1 (;rl\"l~r (1(IIlS) 
I'mnd, an.ll;n,pnrco ( 1'~)4) 
Sd"r~ lind nv~d 111)1)\)) 
f\I"hw ~t .. 1.11')~!l1 
Smllh Rnd TIIITi"r ( ")lj2) 
N." 
In 
20 
II 
lOll 
24 
20 
20 
Dural ion of 
prllc.imnw (<iuys) 
2 ~I 
l )(,; 
7 I.U 
2 III 
2 l.::!fI 
I X.l 
I 1(4 
~h'an l~n~lh "f 
rnKln'nl<.' ,(111)') 
10-% 
I!I,R 
m".Ii:1I1 ~~. 
2,1 
m~'~lu,n 22 
20,S 
211') 
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individuals were IIble to identify one llr more "'Irly 
symptom of mania (Molnar et al., 19l<K; Selare and 
Creed, I (NO; Smith and Tarrier. 11)()2: Keilner et ul.. 
I (Nfl: Lmn und Wong. 191}7; Perry et al.. I <)<)I}). Five 
studies identitkd the percentage ()f individualli re-
trospectively reporting ellch specific early ~ymptom. 
As shown in T'lble 3, Ihe majority identified sleep 
disturbuncc as ,III indicator of m'llIic prodromes. The 
median prevalence of carly symptoll1~ WllS: slc,",p 
disIUlt)iln'~c (77%), p~yehotie symptoms (47%1. 
mood c1mnge (4J%). psychomotor chungc (J4%). 
other symptoms (30% I. nppctite change (20%). and 
increased :lnx iety ( I o'},,). 
The duration (11' the manie prodrome ranged from 
I to 120 dilYs (Pllst et 111., 11)81; Molmlr et <II.. 19~K: 
Schlre lind Creed. Ill,)O; Smith nnd T.mier. 19\)2: 
Francis <lnd Gasp<lfo. 11)(>41. As shown in Table 4, in 
studies rcporting mean and mellian durations, manic 
prodromes 1.lsted fOl': 21-29 days (Molml\, et al.. 
I Y8K; Sc1are and Creed. IIj(JO; Fr:lncis and Gasparo. 
1994: Smith und T"rrier. 191)2). 
4. [)j~etlssion 
Thcre lire tlm'e key jssm~s tIm 1 Misc from thi~ 
,ystcmatie review: the limitutions of the current 
research on affective prodromes. the findings on thc 
nature of manic and depressive prodromes. and the 
implications for c1inic,,1 practice and future research. 
4.1. l.illlilillillll\· (?f currellt I'£'.\·I'(/I'ch 
Less than one in a 1000 papers on the clinical 
features of am~cti\'c disorders .. duresscs prollromcs. 
Although th\! sample reviewed exceeded 1100 sub-
ject!!. the dat" on prodromes ill unipolar disorder is 
inildequllte. There is 111arginully man: d<lIU llll bip(lhtr 
di~ordcrs. but Ilndings from these !-tllLlies arc limited 
by thl' heterogeneity of the ~all1ples and nwthlllh,lo-
gics. Although many studies used recognised stan-
dar(h~ed interview schcdules to c(tJk~et symptom 
d'lt", mo~t retrospectively investigated cllrly symp-
tOI\1S of relapse. which may involve bia~l'd or 
,Ii~torted rccnll (Fava lind Kellner. Il)l) I). MlIny 
~tlldies had small s,lIllpic sizes that <llso Ii III it the 
gencmlisnrion of flndings (medilln V'" 40). 
4.2. rile jillllillg\' 
Four out of five individuals with unipolar or 
bipolar disorders clm identify one or more early 
symptoms bcf(lre a full relapse. In bipolur di~ordcrs, 
enrly symptollls of munin were reported by II higher 
percentage of individuals in comparison to carly 
symptoms of bipol:lr depression (llledhll1 97% for 
rmlllin vs. H2% for bipo!;tr depression). Greater 
di""~ity hu!! also been found to exist in the symp-
roms of depressive in compnrison to manic prod-
rOllles (Lmn !lnd Wong. 11)(>7: Gillin. Jl)l}!(). The 
most robUst early symptom of maniil W,IS sleep 
disturb<lllee. A phenomenon nlso r.·ported by Wchr .,t 
nl. (Il)R7). The most prominent cilrly symptom of 
bipolar dcpre~si()n WllS mood c1mnge. However, the 
hitler was identified by Jess than sn'% of individu(lls. 
This review suggests tlmt Ihe meitll dllnltion of 1\ 
mallie prodromc (mcnll > 20 days) is longer than 
th'lt of bipo!:lr depression (mean < 19 days). How-
ever. comparison of the ntllgc of dllnllioll i mlicatl's 
great.'r inter-individual \'nriation in the fllf'lller (bipo-
hlr dcpres~ion 2-365 d"ys; ll1"nin 1-120 days). This 
r.llses the pOiislbility that. unlike mania. duration of 
depressive prodromes is 110t normally diMributed 
statistically (Fnltlcis and G<l~pllr(), Jl)(J4). 
The dilTerencc in mean dumtion of manic as 
compared to depressive prodromes may relate to 
different biological processes. or it mlly be 1111 
artefact be,~ausc e<lrly symptoms. of mania arc readily 
idelltifi<lble. Scott (20() I) noted that early fCilturej; of 
mania are more distinctive IlS the symptoms dilrer 
qualitatively from the individtmls' d"y-to-d(IY ex-
periences. Early symptoms of bipoJ<lr deprcssion 
lll<ly represent !~ t..:lIS overt qumltitativc shift in afr~"t 
or hehaviour. particularly in individuals with re,idual 
deprcssivc sYlllptoms I Scott ct ill.. 2000; Fuva. 
I l)1}l)). Such subtle changes in t\lIlctioning may not . 
be rcc~lgtliscd as MIming signals M lkprcs~ivc 
rclap~c un Ii I th,'y IX'come more ~cvcre or pcrsist~'lIt 
or they lII'e accorJIp"nied by more memol1lhlc symp-
toms. Thi s wuulu givc an i\llpn:~sion of II bril'f .. 'r 
prodrome. This notion is !ntpportcd by F.wu et III. 
(I QI)(). JIll) II who reported nl lea~t nile early ~yrnp· 
rOIll of rchlpsc W:lS evident prior to the onset of 
deprcssed mood, yet mood cllilllge WilS the subjectivc 
expcrience Illost frcquently recalled. 
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./.3. Jl/lllfjC'aIi(II/.~ fur clinical p/"(lC'lin' al/d lillI//'(' 
rt'\'('(//,ell 
Monitoring lind inlervening when early sYlllptom~ 
<lrise has been deemed effective in preventing or 
minil1li~jng the imp'Jet of rd'lp~c in atTcctivc dis-
orders (Kupfer el ill., Il)!N; M,lI1der, ll)!)(); Scott, 
I \)95; Perry ct at.. 1 \)I)l). The usc of prompts. such 
as Smith and Turricr's (191)2) 4()-itclll emly ~ymp­
torn ehecl.;li~t muy lbcilitah.: identil1cillion. Individ-
\1,1110 lire only likely to benefit from monitoring early 
~ymptoms if this arpro,lch is used in eombimltion 
wilh effective coping stnttegics. Lam's work (Lllm 
und Wong. 191)7; tum ellll.. 20(1) d,'monlttnllelt tlml 
effective self-management stmtegies for the e,lrly 
symptoms of Jl\illlIa lind depreltsion ure llssodated 
with better clinical (Ind sociul outcomes. 
Evidence thut manic prodromes arc longer and 
l'w,icr 10 identify than Ihe bipohu' lkrres~ive prod. 
rlm1eS suggei'ts e:lrly intervention by the mental 
heulth services is more feasible for mania thilll for 
depression. Perry et ill. ( 19()l) found early symptom 
rl!cognition and intervention in patients with bipolar 
disorders !'ignifkantly reduced 1ll:llllC but not dqm!s. 
sive rcl<lpltes. They also noted that. once wlIming 
sigmlls were recognisl'd, it was cusicl' 10 inlroduee 
etTeeti"e phamlaeological treatments till' unite !nllnia 
th<l11 fhr bipolar (kpression. Katon I.'t Ill.·s CWO I) 
rc1ap~e prcvention program similarly reporteu uif· 
ficultics in Tl'ducing d,'pre~sivc relapses (although 
there were other benefits). The implication of Ihis 
review is that curly recognition lind treiltment of 
bipollir depre~sion is the greater cllllllenge. This is 
unfortunate as evidence suggests that outcome~ nre 
ulso worse: clinical rell1is~ion is significantly less 
likely to be achicved in bipolar depression than in 
maniu (59% \'S. 100%) <1111.1, even When achk'ved, it 
occurs siglllficnnlly less mpidly (11I,lswla et ul., 
1 ()\)7). 
FUlure reselll'Ch !ihould involve prosp,'ctive moni-
toring of eurly symptoms to provide more detailed 
de~criptiol1s of the dur.ltion und specific symptom~ 
IIssoeiated with pr()dromes of mtlnill, birolur depres-
siun. lind unipolar lkpressinn. II1\'esrigatioll of prod. 
rllml! lIumlion will determine whether mtlnic prod· 
romes <Ire truly longer than depressive prodromes 
and nwy determine the clinielll usefulness of eilfly 
~ymptllm Illllnitori ng. CUlllparison of the prodrol1le~ 
of bipolur dcpre~sion und unipolur depre:>sion may 
pruvide insights into the similarities and differlmce~ 
between these disorders. 
AeknowledgcllI('llts 
Professor Scott's rcsetlrch on bipoliIT disorder i~ 
supported by u Leg:ley from the Seurle Found .. lion. 
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·Wonll. C; .. I.am, 1> .. J 1)1)1). lne d.:wl'l'III,'nlllnJ "nlidation "r Ih~ 
cnpinl1 inwntnry t<'r !,rollr<'m~. of mania. J. A n,,~t. Di,,:>rd. 5.l. 
57 (,5. 
·YuUIlt!. M.;\ .• (int"I..·r. ('., lilll5. Hut'ldily 111' symptom on,cl III 
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Variability in bipolar disorders 
Jackson , A. ' McCabe, E . .! Espie, C. ' & Scott, J. J 
1 Section of PsYCllologica l M edicine. Universi ty of Glasgow, 2 Forth Valley Primary Care NHS Trust, 
3 D,v,s,on of Psycho logica l Medicine. Insti tllte o f Psychiatry. London 
00 l_ndl.v~du~ls W!th bipolar disorder display greater day-to-day 
vanab.fI,y In bIological, behaviour, s@1f esteem and affect 
mea~ures during Inter -episode perlod~, In comparl~on to 
IndiViduals from the genera l population? 
, .. 
Bipo lcor Oi ,oreler i, chardcteri ,eel by "cuto opi,ode, of meonia 
rHl(j (h ~pre!>"'lon . Sympto m" Include CIl (Hlgc~ Irl m ooel, cognitio n 
;:' Ind b d l a VIOUr. The prirTlclry tn~ at rlH ~nt Of bl polrlr cll ':>Or(h ~r ,'\ 
ptldrIlWCOtller" py, a ltl laugh even witl l propllyldctic treatment. 
n "k or n'! I ' lp~H rUlnain 'l high. AI)out 65% of ind ividual', With 
olpol;,r d' .... o rcler h;w e been o l)~crvl!cl to r£ ~ l f-I p'-.(~ over the course 
of 2 yuars (Sllver!>lOne el a i, 1998) . 
Int '-~ r-npl ,,>ocl l ! ... ym ptorn .... <U I ~ common in b ipolar (1J'~ord ( ~r i-Illel 
ccln incrcfl'se rhk o f n ~ I (-,p~f ~. A r (!c( ~nt n Wif !W identified " ' Cf !P 
d l'lturb;'H1Ct1 ... ~ " robu'\t Hrlrly ... ym ptolll o f rni-mi i-l , dlthOllg ll no 
consi"lt{-! nt t-! i lr ly "ymplom o f bipo lar cI~~ prH~"I IOn Wr l~ ,~v l(fent 
(J "lck"lon Po l rll , 2003). Inlnr - f!pl"IOd c "Iymptom ., . 1"1 we ll . \ ~ 
blOloglCil!. p' ycI1o log le;l l iln(/ SOCIi'l l filCtors m"y influenCQ tllP 
long term cour", of bipol" r d"order. limltecl re'enrell to date 
l1a, been conducteel 0 11 day-lo -clay p>ycl1obio>ocicil fUllction ing 
in bipo lar d isorclers . 
• • 
PclftlClprlnt" w llh blpolc-lr I or II (lI ~orcler~ welt! r~ crlJltcct From a 
l ,ti l iulll C IIIlIC a l lCl lI1dividua ls Fro m tile geller c.1I POPUI c.ltlOIl were 
",crultBei througll OpportUlllty " ,mpling. P;'lrt ielp""t' eompl" t[KI 
pro'peel/vl! ,,, ,I report quc!>llo lln; lIre~ to m" " Slire soeiil l rhythm, . 
be'owlour,, ' ilctlVi ltian/ lnhllJl t lon, ,,,II e'tcl~m ,lnd "flcct. Se l( 
"'port mO;l " " e' inc luded: Socl;,1 Rhythm MetriC. BellavioLira l 
Inhibit ion Sy,t,,,n /Beh;,vioura l Activa ti on Sy' tel11 Sub.cale,. 
Ro, enlJerg Sel( E' teel11 Que, lIonn;> i,,", Po, itive ;rnd Negative 
A(fect Scl1cdu lc anel elution and depressi on rat ings. Contlnuolls 
ad igra ph mo nitori ng over 14 dilY' providocl ,'In o bjec tivp 
["timation of the sleep-wake cycle. 
Twenty p rtlclpants with bipolar dlsoreler (mcan age 43. sci 11 ) 
ancl ten part icipants from tile genera l population (mean age 
41 . " , 14) com plelecl prospective monitoring for a minimulIl 14 
clay . 
Further d emogr f1ph ic Chil r rlc teri .... t ics fo r bipo la r disorder 
piJrticipclfltS arB di:,playecl in Ta ble 1. 
Tobie I : 
M(!fl ll i-md vr-lrI<-)bility !)Cores wen! ca /clilatrxi for f~ i"lc ll vari db lc 
acro~" ... 14 d rl)' pu lod for edch p .. lIt lCipclnl to produce group 
:-.core~. V{-Ina bh.~ '" W'{-!I P. g roupHcI into bi o lo g ic, ll / beh;wlo urrll rillc! 
\{-! If e .... t e (~m/d ff{-!cti vo rllei l SUre'l " IIlCH corn~ I (-I t i o ll '" I)etwnen 
w\r i rl l) Ii ~~ wm c hypott1o~ l.,ed to be higl1er IN ltlll11 (!rICh gro llpll1g. 
MLiit iv,lr ime nn;, Iy'''' of v" n " nep. (MAN O VA) wore conducted to 
IIw"'tlg<ltH group clifference, In avemgp. Invel " nel v<lr i<lbility of 
mCflSlIrcs. HOI/Jever, Clssumption" o f hornogcnc ity of vflr innccs 
il ncl normal eli str ibutio llS were not met for mOSl Ille .. sures. 
, uggest ing tent;, tive intPrprptmion of tl1P MANOVA ,1n;' l)",p,. 
According ly. non-rammetric M 1lln-WllItnpy U allil ly"" were 
collducteel to Investigate between group ellflcrences. using Holm\ 
correction for Inultiple comparisons. 
Non-pilrametrlc ana lyses Inelicared seven Of tile depenclent 
variables diff reel significantly between tI1e bipolilr disorder and 
gpner 01 1 popul,ltioll group'. R""ult, for til"'''' v,lri"bl,,, .lre 
di~pl aYL'CI in Table 2 , Lovvc r ~l f U~L!l! In. lowel" po~iti vu d fft."Ct. 
Iligh" r negative affect. higher depre, soel rating'. and greCl tl'r 
variability In n ight waking time. sl eep officlency and self esteem 
were evident 111 bipo lar dl screler Pilrtl clpanb compared to genera l 
popul'::'ltion pa rticipants. acro~~ ~ I 14 d.=.IY period. 
r :ihl(' 2 
Nig/lt waKing wnc 33 (21) 14 (8) 1.0 15 0.001 
var lab lllry (in minutes) 
Steep efficiency 9 (5) 4 (2) 1.0 20 0.003 
varlabHlly I") 
POSICIVO i1 rYo ct 10'10/ 21 (7) 29 (5) -1 .0 27.5 0 .001 
N ogarlvo afTOct lovel 17(8) 13 (4) 0 .6 45.5 0.016 
DcpmsslOfl love' 2. 1 1 .2 0.9 35.5 0 .004 
(1 .2 / (0 .3) 
So lf osroom love' 41 (16) 56 (8) -1.0 39 0.014 
Sa" e5(oom vm ic:'lbillty 4 . 5 1 .8 1. 1 24 0 .002 
(2. 6 / (0 .8) 
Power analysis suggested a larger sample size (N - 50) would 
be necH"'''y to detect madero'll . effect , IZp. between group 
ellfferences. 
• 
Greoler vilriabilily in sleep fficlency, nig ht Wilking time ilncl self 
c~IC(~m were ob~crvcd III IndIVldu ... l~ w illl b ipolar dl",order dUring 
intor-episoele porioel> compdrod to individudls from the general 
popu latio n. Findin gs are co n, istent with otl w r roporb 0 1 a 
di stur bed slec p -welke cyclo ill CUtilYllli c bi po lm dlsord"r 
compared to the gonerCl I population (Mi llar et ill, 2004) ' "ld 
self esteem variation acro~~ 1110 0d 'tates in bipOlar clisorder (Scott 
& Pope, 2003). 
::::: ~~::;~~,~&}~~ . J. 110011 A , ""'Qll lOOC I4IVi1wut 1I.:l11K. & lk;1lI~.llt \X.hltl 
M .... . A. f 't JID C . .. St:oM. l tJQ041 u "''''otlt1 o,A I P I .lloJ ~ • OI . . ... "U .... · fl o __ ' I.oI<JII I. oIIIHt~ "' .· ... ,..:1" 
IN llI ' lICly.' • • " . . ... . ' nlot".otIIWO n. .. Jll t!CH UO' <4 !> l ~l 
5c«I . 1. 61\ . M. (2(lOJ) CooNIIW ~ HI ItklM-:h'II1 wlh bl)GLv chotdlln. l~tdO(JC3I Mo;d(llwt J] 
1M I ' CHI. 
~Na'>lOf\O . I. McI'tKltKln. l lllll ll N. 6 1~otl\._. !..1 1 986l l~alcxIMl tJ.k4fvtn\lt\dlO p"olllllllt« l ol ral"4)tO 
In bIpoIor dlM)fdif'! A PI'~~ IoIlowup 5Il1!ty. AlnI'nloo & NiM-/ .... ond .ku l'lal01 l 'wt:tlalfY )1 GI 00. 
NtIVllll.t/O;)ml«1\ 
t\()tQw .. v. ...... ' '''o«Mrh ont""" ••• (INA t~ " "" JllOI Mioflb' I' I CIII"lC'IlI omll'ASIlrM~ I OI I I< \.:Ih •• 
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Appendix I. Skewness and kurtosis of sample data 
The distribution of mean and variability participant scores was examined by calculating z 
scores for skewness and kurtosis for each of the dependent variables. The skewness z 
score was computed by dividing the skewness value by the standard error for skewness. 
The kurtosis z score was computed by dividing the kurtosis value by the standard error for 
kurtosis. Twelve of the averaged measures and 17 of the variability measures did not 
display a normal distribution of scores. Over 60% of the variables had significant skewness 
and lor kurtosis z scores outwith ±1.96 which indicates with 95% confidence that the 
distributions of these variables were not normal (Kerr et aI, 2002). Tables 1.2 and 1.2 
provide skewness and kurtosis z scores for the mean and variability participant scores. 
Table 1.1: Skewness and kurtosis of participant mean and variability scores 
Mean scores Variability scores 
Variable Skewness Kurtosis Skewness Kurtosis 
z score z score z score z score 
Time in bed 0.73 -0.07 5.54* 11.22* 
Sleep duration -1.05 2.39* 4.16* 5.38* 
Night waking time 3.37* 4.60* 4.50* 6.03* 
Sleep efficiency -3.66* 4.86* 4.11* 4.35* 
Sleep latency 2.13* 0.18 3.17* 2.55* 
Fragmentation index 3.99* 6.40* 3.49* 2.98* 
I nterdaily stability 0.10 -1.13 4.57* 7.81 * 
Intradaily variability -0.52 -0.73 5.43* 8.72* 
Night time activity level 5.04* 7.71 * 4.66* 5.32* 
Night time activity onset time 8.12* 18.23* 
- -
Day time activity level 5.39* 9.72* 3.49* 2.66* 
Day time activity onset time .57 -0.67 
- -
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Mean scores Variability scores 
Variable Skewness Kurtosis Skewness Kurtosis 
z score z score z score z score 
Relative amplitude -2.10'" -0.20 3.03'" 1.61 
SRM regularity -1.07 -0.81 0.72 0.60 
DALI 0.38 2.47'" 0.47 -0.33 
Positive SE -1.39 -1.12 2.57'" 1.23 
Negative SE -0.70 -1.35 1.25 0.32 
SE total -1.09 -1.26 3.20'" 2.29'" 
PA 0.02 -0.75 0.34 -1.12 
NA 5.79'" 10.16'" 2.15'" 0.48 
Elated 1.05 -0.81 0.79 0.10 
Depressed 3.84'" 2.92'" 1.57 -0.28 
BIS -0.23 -1.32 0.86 -0.65 
BAS Reward responsiveness 0.01 -0.27 5.03'" 8.39'" 
BAS Drive 1.45 0.54 3.08* 2.53* 
BAS Fun seeking 3.11'" 3.87'" 2.02'" 0.74 
... Values outwith ±1.96 indicate the distribution is not normal (Kerr et al. 2002) 
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Appendix J. MANOV A results not meeting parametric assumptions 
Although parametric analyses may be considered relatively robust to violation of parametric 
assumptions, consideration of the small sample size suggested caution in the interpretation 
offmdings. Three parametric assumptions were investigated: Box's M homogeneity of 
variance statistic; Levene's homogeneity of variance; and the normal distribution of data. If 
two ofthese assumptions were not met, the multivariate analysis of variance was discarded 
in favour of non-parametric Mann-Whitney tests. Nine groups of variables were 
investigated with MANDV As (see Section 4.3 for more information). Following 
investigation of homogeneity of variance and the normality of data, non-parametric analyses 
were considered more appropriate for seven of these nine groups of variables. The 
MANOVA results discarded are provided in the following tables. 
Table J.t: Averaged sleep measures comparison between groups 
Sleep variable df F Significance 
Time in bed (min.) 23 3.816 0.064 
Sleep duration (min.) 23 0.001 0.977 
Night waking time (min.) 23 4.976 0.036* 
Sleep efficiency (%) 23 4.434 0.047* 
Sleep latency (min.) 23 2.804 0.108 
Fragmentation index 23 5.082 0.034* 
.. 
I Based on participant mean scores over 14 days for N=)4 bipolar disorder participants 
2 Based on participant mean scores over 14 days for N=)O general population participants 
III Indicates large effect size and/or statistically significant finding, p<O.05 
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Table J.2: Sleep variability comparison between groups 
Sleep variable df F Significance 
Time in bed variability (min.) 23 2.183 0.154 
Sleep duration variability (min.) 23 4.189 0.053 
Night waking variability (min.) 23 8.085 0.009* 
Sleep efficiency variability (%) 23 7.052 0.014* 
Sleep latency variability (min.) 23 4.395 0.048* 
Fragmentation index variability 23 6.608 0.017* 
I Based on participant mean scores over 14 days for N=14 bipolar disorder participants 
2 Based on participant mean scores over 14 days for N=10 general population participants 
• Indicates large effect size and/or statistically significant finding. p<O.05 
Table J.3: Social and circadian rhythm variability comparison between groups 
Social/circadian rhythm df F Significance 
variable 
Regularity score variability 21 0.082 0.778 
DALI variability 21 0.441 0.514 
L5 variability 21 3.422 0.079 
M 1 0 variability 21 3.192 0.089 
RA variability 21 4.517 0.046* 
IS variability 21 0.234 0.634 
IV variability 21 3.680 0.069 
.. . . 
I Based on participant mean scores over 14 days for N=12 bipolar disorder participants 
2 Based on participant mean scores over 14 days for N= 10 general population participants 
• Indicates large effect size and/or statistically significant finding. p<O.05 
Variables: DALI. Daily activity level index; L5, Night time activity level; MIO. Day time activity level; 
RA, Relative amplitude; IS, Interdaily stability; IV, Intradaily variability 
296 
Table J.4: Averaged behavioural activation/inhibition measures comparison between 
groups 
BIS/BAS df F Significance 
BIS 25 3.262 0.083 
BAS reward responsiveness 25 0.088 0.770 
BAS drive 25 0.048 0.829 
BAS fun seeking 25 1.621 0.215 
I .. 
-
. . Based on participant mean scores over 14 days for N 16 bipolar disorder participants 
2 Based on participant mean scores over 14 days for N= 1 0 general population participants 
... Indicates large effect size and/or statistically significant finding. p<O.OS 
Table J.S: Averaged self esteem and affect measures comparison between groups 
Self esteem and affect df F Significance 
SE 27 7.156 0.013'" 
PA 27 9.959 0.004'" 
NA 27 2.812 0.106 
Elated 27 4.167 0.051 
Depressed 27 6.355 0.018'" 
I Based on participant mean scores over 14 days for N= 18 bipolar disorder participants 
2 Based on participant mean scores over 14 days for N= 1 0 general population participants 
... Indicates large effect size and/or statistically significant finding, p<O.OS 
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Table J.6: Self esteem and affect variability comparison between groups 
Self esteem and affect df F Significance 
SE variability 27 10.088 0.004* 
P A variability 27 0.962 0.336 
NA variability 27 3.514 0.072 
Elated variability 27 4.520 0.043* 
Depressed variability 27 2.984 0.096 
I . . 
-
.. Based on participant mean scores over 14 days for N-18 bipolar disorder participants 
2 Based on participant mean scores over J 4 days for N= J 0 general population participants 
• Indicates large effect size and/or statistically significant finding, p<O.OS 
Table J.7: Average level and variability of positive and negative self esteem 
comparison between groups 
Self esteem df F Significance 
Positive SE level 27 6.768 0.015* 
Negative SE level 27 6.858 0.015* 
Positive SE variability 27 11.434 0.002* 
Negative SE variability 27 4.465 0.044* 
I Based on participant mean scores over 14 days for N= 18 bipolar disorder participants 
2 Based on participant mean scores over 14 days for N= 1 0 general population participants 
• Indicates large effect size and/or statistically significant finding, p<O.OS 
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Appendix K. Parametric analyses over longer monitoring period for bipolar disorder 
Participants with bipolar disorder prospectively completed questionnaires for two to 24 
weeks (median 8 weeks). The analyses in sections 4.4 to 4.6 were based on participants 
mean and variability scores over a 14 day period. However, preliminary evidence has 
suggested longer monitoring periods may be necessary for bipolar disorder to provide a trait 
level for a measure (e.g. Monk et ai, 1991; Ashman et ai, 1999). The present study 
hypothesised greater variability would be observed during inter-episode periods in bipolar 
disorder since inter-episode symptoms are commonly experienced. Thus, whilst a 14 day 
period may be an accurate reflection of how individuals from the general population 
fluctuate over time, a longer period may be necessary to capture the extent of fluctuations in 
bipolar disorder. Consequently group comparisons were repeated using the level and 
variability of measures for participants with bipolar disorder over their full monitoring 
period and the two week period for general population participants. 
Eight multivariate analyses were produced along with two tests for homogeneity, Box's M 
statistic and Levene's homogeneity test. The eight following tables provide the mean level 
and variability of measures across the full monitoring period for participants with bipolar 
disorder and across a 14 day period for general population participants along with the 
univariate analyses for each measure. In brief, comparing the mean level and variability of 
measures across a longer monitoring period for bipolar disorder participants provided 
similar results to the comparison ofa 14 day monitoring period. The bipolar disorder 
group was observed to have lower levels of self esteem and positive affect and a higher level 
of depressed ratings. Greater variability in bipolar disorder was observed for sleep 
efficiency, fragmentation index, relative amplitude, self esteem, negative affect and 
depressed ratings. All remaining measures were not observed to differ between general 
popUlation and bipolar disorder groups. 
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Table K.l: Averaged sleep measures comparison between bipolar disorder and general population groups 
Sleep variable Bipolar Disorder (N=lS) General Population (N=lO) Effect df F p 
M(SDi 95% CI M (SD)2 9S%CI Size* 
Time in bed (min.) 640 (351) 445-834 499 (45) 467-530 0.5 24 1.573 0.222 
Sleep duration (min.) 416 (88) 367-464 427 (33) 403-451 -0.2 24 0.149 0.703 
I 
; 
Night waking time (min.) 98 (66) 61-134 47 (24) 30-64 0.9* 24 5.281 0.031 
Sleep efficiency (%) 73 (15) 65-81 86 (6) 82-90 -1.0 24 7.335 0.013 
Sleep latency (min.) 55 (59) 23-88 21 (17) 9-32 0.7 24 3.224 0.086 
Fragmentation index 46 (22) 33-58 25 (11) 17-33 1.0* 24 7.173 0.013 
* Indicates large effect size and/or statistically significant finding, p<O.05 Holm correction for multiple compansons 
Multivariate analysis for six averaged sleep measures (pillai's trace) F=3.090, df6, 18, p=O.029 
Box's M=107.970, F=3.547, df2I, 1362.499, p=O.OOO 
Levene's test was significant for sleep duration (F=4.888, df 1, 23, p=0.037), sleep efficiency (F=7.482, df 1,23, p=0.012) sleep latency (F=4.478, dfl, 23, p=0.045) and fragmentation 
index (F=5.179, df 1, 23, p=O.033) 
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Table K.2: Sleep variability comparison between bipolar disorder and general population groups 
Sleep variable Bipolar Disorder (N=15) General Population (N=lO) 
M(SDi 95%CI M (SD)l 95%CI 
Time in bed variability (min.) 99 (64) 64-134 59 (22) 43-75 
Sleep duration variability (min.) 87 (34) 68-106 53 (21) 38-68 
Night waking variability (min.) 55 (57) 24-87 14 (8) 9-19 
Sleep efficiency variability (%) 11 (6) 8-15 4 (2) 3-6 
Sleep latency variability (min.) 54 (65) 18-90 18 (10) 10-25 
Fragmentation index variability 17 (8) 12-21 8 (2) 6-9 
---- .. _-- -- --- .. _- ---- -_ .. - -----
-
,- ---- .. _ .. 
--- -
~ --
- -
* Indicates large effect size and/or statistically significant finding. p<O.05 Holm correction for mUltiple comparisons 
Multivariate analysis for six sleep variability measures (PilIai's trace) F=2.399, df6, 18, p=O.070 
Box's M=73.419, F=2.4I2. df2I. 1362.499, p=O.OOO 
Effect 
Size* 
0.7 
1.0* 
0.9* 
1.2* 
0.7 
1.1 * 
df F Significance 
24 3.584 0.071 
24 7.692 0.011 
24 5.154 0.033 
24 11.797 0.002* 
24 3.082 0.092 
24 10.677 0.003* 
- - - - - -
Levene's test was significant for variability in night waking (F=4.637. df 1.23 p=O.042), sleep efficiency (F=I1.543. df 1,23 p=O.002), sleep latency (F=4.350, df 1.23. p=O.048) and 
fragmentation index (F=14.771. dfl, 23 p=O.OOl) 
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Table 1{.3: Average social and circadian rhythm measures comparison between bipolar disorder and general population groups 
Social/circadian Bipolar Disorder (N=14) General Population (N=10) Effect 
rhythm variables M(SDi 95%CI M (SD)l 95%CI Size* 
Regularity score 3.84 (0.49) 3.56-4.12 3.88 (0.84) 3.28-4.47 -0.1 
DALI 12 (2) 10-13 13 (1) 12-14 -0.5 
L5 1825 (1458) 983-2667 754 (715) 243-1266 0.8* 
MI0 20724 (9300) 15354-26093 17853 (7580) 12431-23275 0.3 
RA 0.84 (0.10) 0.78-0.90 0.91 (0.06) 0.87-0.96 -0.8* 
IS 0.52 (0.11) 0.45-0.58 0.52 (0.14) 0.42-0.62 0 
IV 0.80 (0.17) 0.70-0.90 0.88 (0.15) 0.78-0.99 -0.5 
* Indicates large effect size and/or statistically significant finding, p<O.OS Holm correction for multiple comparisons 
Multivariate analysis of mean and variability for four social rhythm measures (pillai's trace) F=1.l32, df7, 16, p=O.391 
Box's M=73.427, F=1.647, df2S, 1309.213, p=O.OIS 
Levene's test was significant for regularity score (F=8.940, df I, 22, p=0.007) and LS (F=S.7S9, df 1,22, p=0.02S) 
df F Significance 
23 0.019 0.893 
23 3.632 0.070 
23 4.564 0.044 
23 0.644 0.431 
23 3.998 0.058 
23 0.009 0.924 
23 1.569 0.224 
. ___ L--______ .. __ . ____ 
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Table K.4: Social and circadian rhythm variability comparison between bipolar disorder and general population groups 
Social/circadian Bipolar Disorder (N=14) General Population (N=10) Effect df F Significance I 
I rhythm variables M (SD)1 95%CI M (SD)2 95%CI Size* 
Regularity score 0.87 (0.33) 0.68-1.06 0.59 (0.33) 0.35-0.82 0.8* 
variability 
DALl variability 1.55 (0.49) 1.26-1.83 1.15 (0.27) 0.96-1.35 0.9* 
L5 variability 853 (1028) 259-1446 102 (90) 38-167 0.9* 
M 10 variability 6273 (5770) 2941-9604 1752 (1632) 585-2920 0.9* 
RA variability 0.05 (0.04) 0.03-0.08 0.01 (0.02) -0.001-0.02 1.0* 
IS variability 0.09 (0.06) 0.05-0.12 0.05 (0.04) 0.02-0.08 0.8* 
IV variability 0.20 (0.22) 0.07-0.33 0.19 (0.17) 0.06-0.31 0.1 
* Indicates large effect size and/or statistically significant finding, p<0.05 Holm correction for multiple comparisons 
Multivariate analysis of mean and variability for four social rhythm measures (pillai's trace) F=2.762. df7, 16, p=O.044 
Box's M=99.236, F=2.226, df28, 1309.218, p=O.OOO 
23 4.241 
23 5.142 
23 5.235 
23 5.742 
23 9.176 
23 2.938 
23 0.023 
- -
Levene's test was significant for variability in L5 (F=8.557, df 1.22, p=O.008), MIO (F=8.478. df I, 22, p=O.OO8) and RA (F=5.I52. df 1,22. p=O.033) 
I 
0.051 
0.034 
0.032 
0.026 
0.006* 
0.101 
0.880 
- -- --
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Table K.S: Averaged behavioural activation/inhibition measures comparison between bipolar disorder and general population groups 
Self esteem Bipolar Disorder (N=16) General Population (N=10) Effect df F Significance ! 
and affect M (SD)1 95%CI M(SDl 95%CI Size* 
BIS 23 (4) 20-24 20 (5) 16-23 0.8* 25 3.067 0.093 
BAS reward 15 (3) 14-17 15 (2) 14-16 0 25 0.071 0.792 
BAS drive 10 (3) 8-11 10 (2) 8-11 0 25 0.010 0.920 
BAS fun 10 (2) 9-11 9 (1) 9-10 0.5 25 1.327 0.261 
* Indicates large effect size and/or statistically significant finding. p<0.05 Holm correction for multiple comparisons 
Multivariate analysis for five averaged self esteem and affect measures (pilIai's trace) F=1.8S0, df 4,21, p=O.lS7) 
Box's M=2S.935, F=2.072, df 10, 1689.922, p=0.024 
Levene's test was significant for BAS reward (F=8.058, df 1,24. p=0.009) 
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Table K.6: Behavioural activationlinhibition variability comparison between bipolar disorder and general population groups 
Self esteem Bipolar Disorder (N=13) General PopUlation (N=8) Effect 
and affect M(SDi 95% CI M(SDi 95%CI Size* 
BIS variability 1.4 (0.6) 1.1-1.8 1.2 (1.0) 0.3-2.0 0.3 
BAS reward 1.5 (1.0) 0.9-2.1 1.1 (0.9) 0.3-1.8 0.4 
variability 
BAS drive 1.1 (0.9) 0.6-1.7 0.8 (0.8) 0.1-1.5 0.4 
variability 
BAS fun 0.9 (0.5) 0.6-1.1 1.0 (1.1) 0.1-1.9 -0.1 
variability 
Multivariate analysis for five averaged self esteem and affect measures (PiIlai's trace) F=0.344, df 4, 16, p=O.844 
Box's M=19.552, F=1.449, df 10,1011.619, p=O.153 
Levene's test was significant for variability in BAS fun (F=8.417, df 1, 19, p=0.009) 
df F Significance 
20 0.692 0.416 
20 1.105 0.306 
20 0.828 0.374 
20 0.113 0.740 , 
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Table K.7: Averaged self esteem and affect measures comparison between bipolar disorder and general population groups 
Self esteem Bipolar Disorder (N=19) General Population (N=lO) Effect df 
and affect M (SD)1 950/0 CI M (SD)2 95%CI Size* 
SE 42 (14) 35-48 56(8) 50-62 -1.0* 28 
PA 21 (6) 18-25 29 (5) 25-33 -1.1* 28 
NA .19 (9) 15-23 13 (4) 10-16 0.8* 28 
Elated 1.8 (0.7) 1.4-2.1 2.3 (0.7) 1.8-2.8 -0.7 28 
Depressed 2.3 (1.1) 1.7-2.8 1.2(0.3) 0.9-1.4 1.0* 28 
• Indicates large effect size and/or statistically significant finding. p<0.05 Holm correction for mUltiple comparIsons 
Multivariate analysis for five averaged self esteem and affect measures (PilIai's trace) F=2.638, df 5.23. p=O.050 
Box's M=53.027, F=2.681. df 15. 1359286. p=O.OOO 
Levene's test was significant for SE (F=6255, dfl. 27. p=O.019) and depressed (F=12.031, dfl, 27, p=0.002) 
F Significance 
8.770 0.006* 
10.178 0.004* 
4.122 0.052 
2.973 0.096 
9.249 0.005* 
I 
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Table K.8: Self esteem and affect variability comparison between bipolar disorder and general population groups 
Self esteem and affect Bipolar Disorder (N=18) General Population (N=10) Effect df F Significance 
M (SD)I 95% CI M(SDi 95% CI Size* 
SE variability 6.3 (3.7) 4.5-8.2 1.8 (0.8) 1.2-2.4 1.2* 27 14.036 0.001* 
P A variability 5.4 (3.4) 3.8-7.1 5.1 (2.2) 3.5-6.6 0.1 27 0.101 0.753 
NA variability 5.1 (3.2) 3.5-6.7 2.1 (2.3) 0.5-3.7 0.9* 27 6.877 0.014* ! 
Elated variability 0.6 (0.5) 0.4-0.9 0.8 (0.4) 0.5-1.1 -0.4 27 6.869 0.360 
Depressed variability 0.8 (0.4) 0.5-1.0 0.3 (0.3) 0.1-0.5 1.0* 27 9.561 0.005* 
• Indicates large effect size and/or statistically significant finding. p<0.05 Holm correction for multiple compansons 
Multivariate analysis for five self esteem and affect variability measures (Pillai's trace) F=3.403, df 5, 22, p=0.020 
Box's M=26.998, F=l.360, df 15,1390279, p=0.159 
Levene's test was significant for variability in SE (F=923 1, dfl. 26, p=O.005 
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Appendix L Admissions in high and low variability subgroups of bipolar disorder participants 
Admission Fisher's 
Median Interquartile range No Yes Total exact test 
Self Low SE variability 4.0 1.7 6 (60%) 4 (40%) 10 
esteem High SE variability 8.3 5.6 6 (67%) 3 (33%) 9 
Total 4.9 4.4 12 7 19 p=0.570 
Night Low night waking variability 24.4 6.8 5 (62%) 3 (38%) 8 
waking High night waking variability 74.0 30.0 3 (43%) 4 (57%) 7 
Total 31.5 50.0 8 7 15 p=0.405 
Sleep Low sleep efficiency variability 6.4 1.5 5 (71%) 2 (29%) 7 
efficiency High sleep efficiency variability 15.0 8.0 3 (60%) 5 (63%) 8 
Total 9.8 8.8 8 7 15 p=0.214 
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Appendix M. Exploratory Kaplan-Meier survival analyses 
Table M.I: Kaplan-Meier life table analysis of admissions in bipolar disorder 
Time Status Number at Cumulative Cumulative Standard 
(days) risk admissions survival rate error 
40 admission 20 1 0.9500 0.0487 
137 admission 19 2 0.9000 0.0671 
247 admission 18 3 0.8500 0.0798 
252 admission 17 4 0.8000 0.0894 
315 admission 16 5 0.7500 0.0968 
627 admission 15 6 0.7000 0.1025 
1126 admission 14 7 0.6500 0.1067 
1139 censored 13 7 
1157 censored 12 7 
1163 censored 11 7 
1174 censored 10 7 
1240 admission 9 8 0.5778 0.1167 
1258 censored 8 8 
1261 censored 7 8 
1270 censored 6 8 
1286 censored 5 8 
1304 censored 4 8 
1307 censored 3 8 
1314 censored 2 8 
1319 censored 1 8 
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Table M.2: Log-rank statistics for continuous variability in self esteem, night waking and sleep efficiency and admission in bipolar disorder 
Interquartile Total 
Continuous variable Median range N Admission No admission Statistic df p 
Self esteem variability 4.9 4.4 19 7 12 43.98 18 0.0006 
--
Bipolar I Disorder 4.2 3.2 8 5 3 14.07 7 0.0500 
Bipolar IT Disorder 8.9 12.3 4 1 3 3.00 3 0.3916 
Rapid Cycling Disorder 5.9 4.2 7 1 6 6.00 6 0.4232 
! 
Night waking variability 31.5 50.0 15 7 8 33.62 14 0.0023 
Bipolar I Disorder 26.3 135.2 5 4 1 6.91 4 0.1409 
Bipolar IT Disorder . 3l.5 66.8 3 1 2 2.00 2 0.3679 
Rapid Cycling Disorder 32.5 41.7 7 2 5 8.69 6 0.1916 
Sleep efficiency variability 9.8 8.8 15 7 8 33.62 14 0.0023 I 
Bipolar I Disorder 11.6 11.2 5 4 1 6.91 4 0.1409 
Bipolar IT Disorder 6.8 13.6 3 1 2 2.00 2 0.3679 
Rapid Cycling Disorder 9.8 8.8 7 2 5 8.69 6 0.1916 
• Indicates statistically significant finding, p<O.OS 
310 
Exploratory Kaplan-Meier survival analysis of continuous measures of variability in 
self esteem, night waking and sleep efficiency 
The significance of self esteem, night waking and sleep efficiency variability and subsequent 
admission to hospital were investigated with log-rank tests. The results are displayed in 
Table M.2. The Mantel-Cox log-rank tests suggested variability in self esteem, night 
waking and sleep efficiency predicted admission. When diagnostic strata were considered, 
high self esteem variability predicted admission specifically in bipolar I disorder. Findings 
are tentative due to the small sample, particularly when analysed by diagnostic strata. 
Exploratory Kaplan-Meier survival analysis of categorical measures of variability in 
self esteem, night waking and sleep efficiency 
Participants were categorised into low and high variability subgroups for self esteem, night 
waking and sleep efficiency. Log-rank tests were repeated with these categorical groups. 
The results are displayed in Table M.3. Results suggested no significant association 
between variability and subsequent admission. When diagnostic strata were considered, no 
significant associations between diagnosis and categorical variability groups emerged for 
prediction of admission. 
Table M.3: Log-rank statistics for categorical variability in self esteem, night waking 
and sleep efficiency and admission in bipolar disorder 
Categorical variable N Statistic df p 
Self esteem variability 19 0.16 1 0.6903 
Night waking variability 15 0.88 1 0.3471 
Sleep efficiency variability 15 2.80 1 0.0944 
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The cumulative probabilities of survival for self esteem, night waking and sleep efficiency 
variability subgroups were calculated and plotted. The survival rates for subgroups are 
available in Tables, M.4, M.5 and M.6; the plots are displayed in Figures M.I, M.2 and 
M.3. The survival rates for each of the variability subgroups will be briefly outlined in tum. 
The fmal cumulative survival rates for low and high self esteem variability subgroups were 
0.60 at 1314 days and 0.65 at 1319 days. There were four admissions (40% ofN=1 0) 
across 137 to 1126 days in the low self esteem variability subgroup. The remaining six low 
self esteem variability participants were censored across 1139 to 1314 days with no 
admission. There were three admissions (33% ofN=9) across 40 to 1240 days in the high 
self esteem variability subgroup. There was a censored case at 1174 days between the 
second and third admission; the remaining cases were censored across 1258 to 1319 days 
with no admission. No significant differences in time to admission between low and high 
self esteem variability participants were observed. The cumulative survival rates for self 
esteem variability subgroups provided in Table M.4 are plotted in Figure M.l. 
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Table M.4: Kaplan-Meier life table analysis of low and high self esteem variability 
subgroups 
Subgroup Time Status Number Cumulative Cumulative Standard 
(days) at risk admissions survival error 
rate 
LowSE 137 admission 10 1 0.9000 0.949 
variability 252 admission 9 2 0.8000 0.1265 
(N= 1O) 627 admission 8 3 0.7000 0.1449 
1126 admission 7 4 0.6000 0.1549 
High SE 40 admission 9 1 0.8889 0.1048 
variability 315 admission 8 2 0.7778 0.1386 
(N=9) 1240 admission 6 3 0.6481 0.1653 
Figure M.I: Kaplan-Meier survival curve for self esteem variability and admission 
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There were three admissions (38% ofN=8) across 252 to 1240 days in the low night 
waking variability subgroup. The remaining five low night waking variability participants 
were censored, with no admission, across 1139 to 1307 days. There were four admissions 
(57% ofN=7) across 40 to 627 days in the high night waking variability subgroup; three 
participants were censored across 1270 to 1319 days. Although no significant difference 
in time to admission between low and high night waking variability participants was 
observed, the cumulative probabilities of survival for night waking display trends towards 
high variability being associated with earlier time to admission. The cumulative survival 
rates for night waking variability subgroups are provided in Table M.5 and plotted in 
Figure M.2. 
Table M.5: Kaplan-Meier life table analysis of low and high night waking variability 
subgroups 
Subgroup Time Status Number Cumulative Cumulative Standard 
(days) at risk admissions survival error 
rate 
LowNWT 252 admission 8 1 0.8750 0.1169 
variability 1126 admission 7 2 0.7500 0.1531 
(N=8) 1240 admission 5 3 0.5625 0.1989 
High 40 admission 7 1 0.8571 0.1323 
NWT 247 admission 6 2 0.7143 0.1707 
variability 315 admission 5 3 0.5714 0.1870 
(N=7) 627 admission 4 4 0.4286 0.1870 
314 
Figure M.2: Kaplan-Meier survival curve for night waking variability and admission 
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There were two admissions (29% ofN=7) at 1126 and 1240 days in the low sleep efficiency 
variability subgroup, leaving five participants censored across 1163 to 1319 days. In the 
high sleep efficiency variability subgroup, there were five admissions (63% ofN=8) across 
40 to 627 days. The remaining three participants were censored across 1139 to 1304 days. 
No significant differences in time to admission were observed between subgroups. 
Similarly, to night waking variability, the cumulative probabilities of survival for sleep 
efficiency variability display trends towards high variability being associated with earlier 
time to admission. The cumulative survival rates for sleep efficiency variability subgroups 
are provided in Table M.6 and are plotted in Figure M.3. 
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Table M.6: Kaplan-Meier life table analysis of admission in low and high sleep 
efficiency variability subgroups 
Subgroup Time Status Number Cumulative Cumulative Standard 
(days) at risk admissions survival error 
rate 
Low sleep 1126 admission 7 1 0.8571 0.1323 
efficiency 
variability 1240 admission 5 2 0.6857 0.1863 
(N=7) 
40 admission 8 1 0.8750 0.1169 
High sleep 247 admission 7 2 0.7500 0.1531 
efficiency 252 admission 6 3 0.6250 0.1712 
variability 315 admission 5 4 0.5000 0.1768 
(N=8) 627 admission 4 5 0.3750 0.1712 
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Figure M.3: Kaplan-Meier survival curve for sleep efficiency variability and 
admission 
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